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L’important dans la vie ce n’est point le triomphe mais le combat;
l’essentiel ce n’est pas d’avoir vaincu mais de s’être bien battu.
The important thing in life is not victory but the challenge; it is not to have
vanquished but to have fought well.
Pierre de Frédy, Baron de Coubertin,
Founder of the International Olympic Committee
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THESIS SUMMARY
English summary
Cells within multicellular organisms share the same genetic information, yet their shape
and function can differ dramatically. This diversity of form and function is established
by differential use of the genetic information. Early embryonic development describes
the processes that lead to a fully differentiated embryo starting from a single fertilized
cell - the zygote. Interestingly, in metazoan species this early development is governed
by maternally provided factors (nutrients, RNA, protein), while the zygotic genome is
transcriptionally inactive. Only at a specific developmental stage, the zygotic genome
becomes transcriptionally active, and zygotic transcripts drive further embryonic devel-
opment. This major change is called zygotic genome activation (ZGA). While major
regulators of activation of early zygotic genes could be identified recently, the molec-
ular mechanisms that contribute to robust global genome activation during embryonic
development is not fully understood.
In this study, I investigated whether the establishment of histone H3 lysine 4 trimethy-
lation (H3K4me3) is involved in zebrafish zygotic transcription activation and early
embryonic development. H3K4me3 is a chromatin modification that is implicated in
transcription regulation. H3K4me3 has been shown to be enriched at Transcription Start
Sites (TSS) of genes prior to their activation, and is postulated facilitate transcription
activation of developmentally important genes. To interfere with H3K4me3 establish-
ment, I generated histone methyltransferase mutants. I further inhibited H3K4me3
establishment by introduction of histones with lysine 4-to-methionine (K4-to-M) sub-
stitution, which act as dominant-negative inhibitors of H3K4me3 establishment. Upon
H3K4me3 reduction, I studied the resulting effect on early transcription activation. I
found that H3K4me3 is not involved in transcription activation during early zebrafish
embryogenesis. Finally I analyzed possible cues in DNA sequence and chromatin
environment that might favor early H3K4me3 establishment.
These studies show that H3K4me3 is established during ZGA, yet it is not involved in
transcription activation during early zebrafish development. Establishment of H3K4me3
might be a consequence of histone methyltransferase recruitment during a permissive
chromatin state, and might be targeted to CpG-rich promoter elements that are enriched
for the histone variant H2A.z.
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German summary
Jede Zelle eines multizellulären Organismus enthält dieselbe Erbinformation, und doch
können Form und Funktion von Zellen untereinander sehr unterschiedlich sein. Diese
Diversität wird durch unterschiedliches Auslesen - Transkribieren - der Erbinforma-
tion erreicht. Embryogenese beschreibt den Prozess, der aus einer einzelnen Zelle -
der Zygote - einen multizellulären Embryo entstehen lässt. Interessanterweise laufen
frühe Stadien der Embryogenese ohne Transkription der embryonalen Erbinformation
ab, sondern werden durch maternal bereitgestellte Faktoren ermöglicht. Erst nach
einer spezies-spezifischen Entwicklungsphase wird das Erbgut der Zygote aktiv tran-
skribiert und ermöglicht die weitere Embryonalentwicklung. Obwohl bereits wichtige
Regulatoren dieser globalen Genomaktivierung identifiziert werden konnten, sind viele
molekulare Mechanismen, die zur Aktivierung des zygotischen Genoms beitragen, bisher
unbekannt.
In der hier vorliegenden Doktorarbeit habe ich die Rolle von Histon H3 Lysin 4 Tri-
methylierung (H3K4me3) während der frühen Embryogenese des Zebrafischs unter-
sucht. H3K4me3 ist eine Chromatinmodifikation, die mit aktiver Transkription in
Verbindung gebracht wird. H3K4me3 ist an Transkriptions-Start-Stellen von aktiv
ausgelesenen Genen angereichert und es wird vermutet, dass diese Modifikation das
Binden von Transkriptionsfaktoren und der Transkriptionsmaschinerie erleichtert.
Während meiner Arbeit habe ich durch Mutation verschiedener Histon-Methyltransfer-
asen beziehungsweise die Überexpression eines dominant-negativen Histonsubstrats
versucht, die Etablierung von H3K4me3 in frühen Entwicklungsstadien des Zebrafischs
zu verhindern. Anschliessend habe untersucht, welchen Effekt H3K4me3-Reduktion
auf Tranksriptionsaktivität entsprechender Gene hat. Allerdings konnte ich keinen
Zusammenhang zwischen H3K4me3-Reduktion und Transkriptionsaktivität beobachten.
Um herauszufinden, weshalb H3K4me3 dennoch während früher Embryonalstadien
etabliert wird, habe ich nachfolgend untersucht, ob möglicherweise bestimmte DNA-
Sequenzen oder Chromatin-Modifikationen zur Etablierung von H3K4me3 wÃhrend
der Embryogenese des Zebrafischs beitragen.
Aus der hier vorliegenden Arbeit lässt sich schlussfolgern, dass H3K4me3 in Tranksrip-
tionsaktivierung während früher Embryonalstadien des Zebrafischs nicht involviert ist.
Möglicherweise wird H3K4me3 in diesen Stadien in einer permissiven Chromatinumge-
bung etabliert, bevorzugt an Promotoren mit starker H2A.z-Anreicherung und CpG-
reichen DNA-Elementen.
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1 INTRODUCTION
Introduction Summary
Early embryonic development of most vertebrate species is governed by maternally
provided factors (nutrients, RNA, protein) while the zygotic genome is transcriptionally
inactive. Only at a specific developmental stage, the zygotic genome becomes tran-
scriptionally active, and zygotic transcripts drive further embryonic development. This
major change is called zygotic genome activation (ZGA). While major players in activa-
tion of early zygotic genes could be identified recently, the molecular mechanisms that
contribute to robust global genome activation during embryonic development are not
fully understood. Previous studies suggest that chromatin is involved in regulating this
major transcriptional change. During ZGA, multiple histone modifications involved in
transcription regulation are established, raising the possibility that these are involved in
zygotic genome activation.
In this study I focus on the role of Histone H3 Lysine 4 trimethylation (H3K4me3)
during zebrafish embryonic development. H3K4me3 was shown to be enriched at
Transcription Start Sites (TSS) of genes prior to their activation, and is postulated facil-
itate transcription activation of developmentally important genes. To address whether
H3K4me3 is involved in zygotic genome activation, I aim to interfere with H3K4me3
establishment in zebrafish embryonic development and study the resulting effects on
transcription activation.
In this introduction I will briefly describe mechanisms of transcription regulation. I
will summarize our knowledge about chromatin and its influence on transcription, with
emphasis on the role of histone modifications. I will then introduce the histone modifica-
tion H3K4me3, and its establishment and removal. Finally I will introduce embryonic
transcription activation, with a focus on the zebrafish embryonic development as a
model to study embryonic transcription regulation.
1
1 Introduction
1.1 Transcription regulation
In multicellular organisms, the majority of cells share the same genetic information,
yet their shape and function can differ dramatically. This diversity of form and function
is established by differential use of the genetic information. Transcription refers to the
process of the read-out of the genetic information - the DNA - into functional transcripts
- mRNAs - that are the templates for protein synthesis. Understanding regulation of
transcription is fundamental to understand the biological complexity that is the basis of
multicellular life. In the following section I will briefly introduce different aspects of
transcription regulation.
1.1.1 Promoter elements - genetic information that guides transcription initi-
ation
Transcription is initiated at gene promoters. The main role of the promoter sequence is
to recruit and position the basal transcription machinery, which allows for transcription
of the DNA into mRNA by RNA-Polymerase II (Myer and Young, 1998; Tolunay
et al., 1984). The core promoter is the minimal DNA region that recruits the basal
transcription machinery. Four DNA sequences contribute to core promoters: the TATA
box, the B-recognition element, the Initiator element (Inr) and the Downstream Pro-
moter Element (DPE) (Figure 1.1). These sequences specify the binding of the general
transcription factors (TF) TBP and TFII A-D to the gene transcription start site (TSS),
that together help to unwind the DNA and recruit RNA-Polymerase II (Kutyavin et al.,
2000). While all of these sequences are assigned to important regulatory functions, not
all promoters contain all elements.
The TATA-box is an AT-rich sequence positioned 25-35 basepairs (bp) upstream of the
TSS (Lifton et al., 1978). It was the first promoter element to be identified. While it
was long thought to be an essential element for transcription initiation, recent studies
have shown that only 32% of mammalian promoters include this promoter element
(Suzuki et al., 2001). The TATA-box recruits the TATA binding protein (TBP) to the
core promoter.
The Inr element is located at or immediate adjacent to the TSS. It is recognized by
TBP-associated transcription factors of the TFIID complex (Reinberg et al., 1987). This
element is especially important for the activation of genes that do not harbor TATA-Box
motifs (Yang et al., 2007). It specifies accurate initiation and strength of core promoters
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(Hahn et al., 1985; Nagawa and Fink, 1985).
The Downstream Promoter Element is centered 30bp downstream of the TSS, and
is involved in recruitment of transcription factors of the TFIID family (Burke and
Kadonaga, 1997). It is conserved from Drosophila to humans and is typically - but
not exclusively - found in TATA-less promoters (Kutach and Kadonaga, 2000).
The B-recognition element is a GC-rich DNA sequence located 35-45 bp upstream of
the TSS (Lagrange et al., 1998). It is the only core promoter element that is not bound by
TFIID-like transcription factors, but by TFIIB. TFIIB cooperates and stabilizes TFIID
complex binding, especially in the absence of TATA-box sequences (Lagrange et al.,
1998; Tsai and Sigler, 2000).
Next to core promoter sequences that allow for the recruitment of the basal transcription
machinery, the general promoter can further contain recognition sequences for multiple
other transcription factors, that allow lineage-specific and environment-specific regula-
tion of transcription by integration of multiple signals into the transcriptional output of
RNA-Polymerase II.
1.1.2 Enhancers - fine-tuning of transcription by distal DNA elements
While promoters are regulatory DNA sequences in the direct vicinity of the TSS, other
more distant DNA sequences can fine-tune transcriptional activity of respective genes.
These so-called enhancers (of transcription) are short DNA sequences (50-1500bp) that
harbor transcription factor binding sites. Enhancers are in cis-acting sequences that
influence transcription of genes in their local surrounding, however their regulatory
function can extend up to 1 Mb distance (Blackwood and Kadonaga, 1998). By three-
dimensional reorganization of the DNA, transcription factors bound to enhancers are
brought in close vicinity to the basal transcription machinery, and influence its activity
(Li and Noll, 1994; Merli et al., 1996). Enhancer sequences can be found upstream
and downstream of gene bodies, but also within introns of the respective gene. Further-
more, a gene can have multiple enhancers, which allow integration of multiple stimuli.
By combining binding sites for different transcription factors, enhancers can fine-tune
expression of specific genes and thus allow for a higher flexibility in transcription
regulation.
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1.1.3 CpG islands - DNA sequences that allow for epigenetic regulation
The genetic information of individual cells (genotype) alone is not sufficient to describe
the variety of cellular shape and function (phenotype) found in multicellular organ-
isms. This phenomenon was first described by Conrad Waddington, who proposed
the existence of an ’epigenotype’ above the genetic information (Waddington, 2012).
Epigenetics refers to transmittable mechanisms of transcription regulation that are not
directly encoded in the DNA sequence, but allow for differential use of the genetic
information.
Interestingly, DNA itself can confer inheritable changes in transcription regulation
without change of the underlying coding sequence. Specific bases within the DNA
can be methylated. DNA methylation is restricted to cytosine in eukaryotes, where
it typically occurs at CpG dinucleotides. CpG dinucleotides are underrepresented in
vertebrate genomes (Lander et al., 2001), because methylated cytosine is prone to spon-
taneous deamination, resulting in replacement by thymine during subsequent rounds of
replication. While CpG dinucleotides are generally underrepresented, they are found
in high density at specific genomic regions, often in gene promoters (Takai and Jones,
2002). These so-called CpG islands are at least 200bp long and show a higher-than-
expected ratio of CpG dinucleotides (Saxonov et al., 2006). CpG islands are highly
conserved throughout evolution.
In general, DNA methylation is associated with repressed transcription of respective
genes by preventing transcription factors from binding to their target DNA (Comb and
Goodman, 1990; Prendergast et al., 1991). Furthermore, DNA methylation is a hub
for recruitment of repressive transcription regulators (Jones et al., 1998; Sansom et al.,
2007). However, the highly conserved CpG islands can be differentially methylated,
and unmethylated CpG islands allow for transcription of their associated genes. Thus,
DNA methylation is understood as a constitutive repressive modification, and CpG
islands are conserved regulatory elements in the vicinity of gene promoters.
1.2 Chromatin
Another mechanism that allows epigenetic transcription regulation is the change of
chromatin structure. Chromatin is the complex of DNA and DNA-associated proteins.
The basic subunit of chromatin is the nucleosome, which consists of each two histone
proteins H2A, H2B, H3 and H4 (Kornberg, 1974). Their globular domains form a
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positively charged octameric complex around which DNA is wound in 1.65 helical
turns (Luger et al., 1997). Nucleosome-compacted DNA forms a beads-on-the string
structure of 11nm diameter. The DNA between two nucleosomes is of variable length,
and can be bound by linker histone H1 (Allan et al., 1981; Morris, 1976). Nucleosome-
nucleosome contacts allow for a three-dimensional folding that leads to compaction into
the chromatin fiber (Nishino et al., 2012), which is further compacted by loop formation
on a chromatin scaffold, ultimately forming the chromosome.
Chromatin exists in two main states, euchromatin and heterochromatin (Passarge, 1979).
Euchromatin is a less compacted form of chromatin, and is thought to be the predom-
inant state (Abdellah et al., 2004). Euchromatin is enriched in genes that are actively
transcribed, and its decompacted state might allow for easier recruitment of regulatory
factors as well as the transcription machinery.
Heterochromatin refers to a tightly compacted state of chromatin, which is mainly re-
fractory to transcription (Volpe et al., 2002). Heterochromatin can be further subdivided
in two classes: constitutive heterochromatin, which is thought to be stable within one
species and constitutes long-term repression, and facultative heterochromatin, which is
not consistent between cell types and can be dynamically regulated (Grewal and Jia,
2007).
Chromatin poses a physical barrier to DNA binding and read-out (Churchman and
Weissman, 2011; Weber et al., 2014). Processes that change chromatin compaction are
involved in transcription regulation by allowing easier access to genomic information
(reviewed in Narlikar et al. 2013).
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Figure 1.1: Chromatin organization and promoter structure in higher eukary-
otes DNA is compacted into the small volume of the nucleus by tight association
to nucleosomes. Nucleosomes and DNA form a beads-on-the-string structure, called
the 11nm fiber, that is further compacted into the chromatin fiber by internucleosomal
interactions. This chromatin fiber forms loops on a scaffold, that ultimately
compacts chromatin into the chromosome. Chromatin compaction hinders DNA
read-out, while open chromatin allows for DNA-association and gene transcription.
Transcription start sites (TSS) are surrounded by regulatory sequences. The union of
regulatory sequences at TSS is called promoter. The core promoter of eukaryotes
can contain Initiator sequence (Inr), TATA-box (TATA), Trancription factor II B
recoginition element (BRE) and the Downstream Promoter Element (DPE). Together,
these regulatory sequences allow for binding of general transcription factors, and
ultimately RNA-Polymerase II recruitment. Enhancers are DNA sequences that
can be situated in up to one megabase distance to TSS. These can recruit further
regulatory proteins, that interact with the transcription machinery by threedimen-
sional chromatin rearrangements. CpG islands are sites of epigenetic transcription
regulation by differential DNA-methylation. Adapted from Sparmann and van
Lohuizen 2006.
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1.2.1 Histone variants
One mechanism to regulate DNA accessibility is by nucleosome replacement. Besides
canonical histones H2A, H2B, H3 and H4, replacement histones with slightly different
protein composition exist (reviewed in Kamakaka and Biggins 2005). The best-studied
variants are histone H3.3, a replacement for canonical H3, and H2A.z for histone H2A
(Grove and Zweidler, 1984; Wu et al., 1982). Both histone variants are incorporated
at specific genomic locations. H3.3 is one of the most conserved proteins in eukary-
otes (Malik and Henikoff, 2003). It is incorporated into chromatin in a replication-
independent manner at actively transcribed genes (Ahmad and Henikoff, 2002).
H2A.z has high similarity to canonical H2A in its globular domain, but differs in its
C-terminal domain structure (Clarkson et al., 1999; Subramanian et al., 2013). H2A.z
is incorporated at TSS via histone exchange by the nucleosome remodeling complex
SWR1 (Kobor et al., 2004; Mizuguchi et al., 2004).
Together, H3.3 and H2A.z were found to destabilize nucleosomes by weakening in-
tranucleosomal interactions in vitro, and thus increase nucleosome turnover and DNA
accessibility (Jin and Felsenfeld, 2007). Furthermore, H3.3 and H2A.z were found to
overlap with active histone modifications at TSS (Creyghton et al., 2008; McKittrick
et al., 2004).
In conflict with these findings, nucleosomes containing two H2A.z proteins but no H3.3
have been shown to be stabilized (Park et al., 2004; Thakar et al., 2010). Additionally,
H2A.z-containing nucleosomes favor a compact chromatin fiber formation by stabiliz-
ing inter-nucleosomal interactions (Park et al., 2004). H2A.z has been further shown to
favor recruitment of proteins involved in transcriptional repression (Creyghton et al.,
2008; Fan et al., 2004; Surface et al., 2016). Unifying these conflicting results, it
has been hypothesized that H2A.z allows for a switch-like behaviour in transcription
regulation (Subramanian et al., 2015). While H2A.z incorporation alone seems to
favor transcriptional repression, in combination with H3.3 and possible other activating
signals it favors DNA accessibility and thus facilitates transcription activation.
1.2.2 Posttranslational histone modifications
Another mechanism how chromatin compaction could be regulated is posttranslational
histone modification. Histones contain flexible N-terminal tails which protrude from
the globular structure. While these N-terminal tails are not essential for nucleosome
formation (Ausio et al., 1989)), they are hubs for various posttranslational modifications
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(reviewed in Bannister and Kouzarides 2011). These modifications can influence the
local compaction of chromatin. Histone lysine acetylation for example changes the net
charge of basic histones, which weakens the electrostatic interaction with the negatively
charged DNA (Grunstein, 1997; Sterner and Berger, 2000).
However, not all histone modifications directly affect nucleosome-DNA interaction.
The molecular mechanisms by which histone modifications regulate transcription regu-
lation are often elusive. Their general role is often assessed by their local enrichment in
either euchromatin or repressive heterochromatin, or by correlation with transcription
activity of respective genes. However, functional validation of these hypotheses are
scarce. Most histone modifications elicit their effects by serving as a recruitment
platform for effectors of chromatin accessibility and transcription regulation (Bannister
and Kouzarides, 2011). This is especially exemplified by histone lysine methylation.
Figure 1.2: Posttranslational histone modifications. The N-terminal tails of
histones protrude from the octameric protein complex. These tails are sites for
various posttranslational modifications, from which the most common modifications
are depicted.
1.2.3 Histone Lysine methylation
Histone methylation was among the first modifications to be identified, and is conserved
in all eukaryotes (Allfrey et al., 1964; Woo and Li, 2012). Lysine residues within
histones can be mono-, di- or trimethylated at the ε-amino group. Histone lysine
methylation is believed to be the primary determinant of chromatin structure (K et al.,
2001). In contrast to histone acetylation, transcription regulation by histone lysine
methylation is multifaceted. The effect of histone lysine methylation depends on the
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exact positon within histone proteins, and specific binding partners.
Trimethylation at histone H3 lysine 9 (H3K9me3), is associated with transcriptionally
inactive genes (Barski et al., 2007). H3K9me3 is considered to be a hallmark of
condensed, transcriptionally inactive constitutive heterochromatin. H3K9me3 has been
shown to recruit heterochromatin protein 1 (HP1), which is involved in formation
and maintenance of heterochromatin (Lehnertz et al., 2003). Together, H3K9me3 and
HP1 are involved in establishment of DNA methylation, which further consolidates
transcription repression (Lehnertz et al., 2003).
Like H3K9me3, H3K27me3 is found to be associated with inactive gene promoters
(Barski et al., 2007). H3K27me3 is established by the repressive protein complex
PRC2 (Margueron and Reinberg, 2011). In contrast to H3K9me3, it is mainly found in
facultative heterochromatin. H3K27me3 is thought to be permissive for chromatin reg-
ulation, and can be lost at developmentally important genes during cell differentiation
(Bernstein et al., 2006).
Histone trimethylation at lysine 36 (H3K36me3) is enriched in gene bodies of actively
transcribed genes (Bannister et al., 2005). H3K36me3 has been shown to be the result of
elongating RNA Polymerase II activity (Joshi and Struhl, 2005), and is experimentally
used as marker for active transcription (Zhang et al., 2014). However, its general role
in transcription regulation is repressive, as it recruits histone deacetylases (Carrozza
et al., 2005) and H3K9 methylation to its chromatin locations to prevent erroneous
transcription initiation within gene bodies (Bartke et al., 2010).
Methylation at lysine 4 of histone H3 is implicated in different regulatory processes
depending on its methylation state. H3K4 monomethylation (H3K4me1) in the absence
of di- and trimethylation is found at enhancer elements (Heintzman et al., 2007), where
it is thought to recruit histone acetyltransferases (Jeong et al., 2011). Furthermore,
H3K4me1 has been found to prevent recruitment of repressive chromatin modifiers to
enhancer sites (Lan et al., 2007; Nady et al., 2011).
H3K4 dimethylation (H3K4me2) is predominantly found in broad domains at promoter
regions of actively transcribed genes (Bernstein et al., 2005; Heintzman et al., 2007).
Little is known about specific functions of H3K4me2, as proteins that show binding
affinity to H3K4me2 are often also associated with H3K4me3 (Pinskaya and Morillon,
2009). H3K4me2 has been reported to specifically recruit Histone deacetylases at active
promoters, thus confining histone acetylation towards the promoter region bound by
H3K4me3 (Kim and Buratowski, 2009).
H3K4 trimethylation (H3K4me3) is found largely overlapping with H3K4me2, but
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with higher spatial restriction towards the TSS (Barski et al., 2007). This histone
modification has been found to correlate with active transcription (Barski et al., 2007;
Heintzman et al., 2007). Activating Histone acetyltransferases were shown to have in
vitro binding affinity towards H3K4me3 (Hung et al., 2009). Furthermore, H3K4me3
has been reported to facilitate the recruitment of the general transcription factor TFIID
and the chromatin remodeller CHD1 (Flanagan et al., 2005; Vermeulen et al., 2007).
However, while these findings suggest for a role of H3K4me3 in active transcription,
its direct involvement in transcription initiation remains to be tested.
1.2.4 H3K4me3 in embryonic development
In embryonic stem cells, H3K4me3 was not only found at actively transcribed genes,
but also at transcriptionally repressed promoters, where it overlap with the histone
modification H3K27me3 (Bernstein et al., 2006). This specific chromatin state was
termed ’bivalent’, as it combines active and repressive chromatin modifications. Bi-
valent domains are preferentially found at genes important during cell differentiation
(Bernstein et al., 2006). Further studies found that bivalently marked promoters be-
come resolved into either repressive or active chromatin states during differentiation
(Bernstein et al., 2006; Dhar et al., 2016). These cell culture experiments suggest that
in pluripotent stem cells, genes are marked by H3K4me3 to allow robust activation,
yet H3K27me3 restricts activation towards a later differentiation state. Indeed, further
studies were able to identify bivalent promoters in developing embryos of multiple
species, where bivalent chromatin modification is enriched in genes involved in devel-
opmental processes (Lindeman et al., 2011; Rugg-Gunn et al., 2010; Schertel et al.,
2015; Vastenhouw et al., 2010). These results suggest that bivalent promoters are a
conserved feature of development, and H3K4me3 might be essential for transcriptional
activation of genes during embryonic development. However, functional validation of
the role of H3K4me3 in transcription activation in developing organisms is scarce (Hödl
and Basler, 2012).
1.3 Establishment and removal of H3K4me3
Histone lysine methylation is established by Set-domain containing proteins. The Set-
domain is named after the three most-studied enzymes that contain this protein motif:
Supressor-of-variegation 3-9, Enhancer of zeste, and Trithorax (Jenuwein et al., 1998).
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The first enzyme that was found to have H3K4 methylation activity was the Set1 protein
in yeast, where it is the only H3K4-specific histone methyltransferase (HMT) (Roguev
et al., 2001). In Drosophila, two other H3K4-specific HMTs are known, Trithorax
(Trx) and Trithorax-related (Trr) (Ingham, 1998; Mohan et al., 2011). These proteins
were identified in Drosophila mutant screens, where their mutation induced homeotic
transformations (Ingham, 1998; Lewis, 1978). In vertebrates, further diversification
has led to the existence of at least six different H3K4-specific HMTs. These HMTs
are classified in three subgroups based on their homology to the three Set1-homologs
in Drosophila. They are involved in multi-component complexes, which are called
COMPASS complexes (see subsection 1.3.4, reviewed in Shilatifard 2012).
1.3.1 Set1 homologs - Set1a and Set1b
In yeast, Set1 is the only H3K4-specific HMT (Roguev et al., 2001). Two copies of Set1-
homologs are found in vertebrates: Set1a and Set1b (Lee and Skalnik, 2005; Lee et al.,
2007). Little is known about the developmental roles of Set1 proteins. Setd1a knock-
out in mice results in embryo lethality due to gastrulation failures in preimplantation
stages (Bledau et al., 2014). Set1a was further shown to regulate Oct4 activity in in the
inner cell mass of embryos (Fang et al., 2016b). In Drosophila, Set1 is thought to be
the main H3K4-specific methyltransferase in development, as Set1 knock-out leads to
a significant reduction of H3K4me2 and H3K4me3 levels (Hallson et al., 2012). Set1
complexes have been shown to be recruited to chromatin via active RNA-Polymerase
II (Krogan et al., 2003; Ng et al., 2003), thus their function might be restricted to
transcription-coupled H3K4me3 establishment.
1.3.2 Trithorax homologs - Mll1 and Mll2
In constrast to Set1, the Trithorax homologs Mll1 and Mll2 have been shown to bind
chromatin independent of active transcription, and thereby could establish H3K4me3
prior to active transcription (Bach et al., 2009; Birke et al., 2002; Milne et al., 2002;
Yokoyama and Cleary, 2008; Zeleznik-Le et al., 1994). Mll1 is the most-studied H3K4-
specific HMT. Initially, mll1 was identified as a gene involved in chromosome translo-
cations that are causal for acute myeloid/lymphoid leukemia (MLL) (Ziemin-van der
Poel et al., 1991). Mll1 has been shown to regulate hematopoiesis both in cell culture
experiments as well as during embryonic development (Ernst et al., 2004; Mishra et al.,
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Figure 1.3: The COMPASS complexes of vertebrates. Three H3K4-specific HMT
complexes (termed COMPASS) are found in vertebrates: Set1a/Set1b, Mll1/Mll2
and Mll3/Mll4 complexes. Each of the complexes contains only one HMT. The
four light blue subunits (Ash2l, Wdr5, Rbbp5 and Dpy-30) are shared among all
complexes and essential for full enzymatic activity. Subunits in red are complex-
specific and confer target-gene specificity (Cfp1 and Wdr82 for Set1a/Set1b; Menin1
for Mll1/Mll2; PA1, PTIP and NCOA6 for Mll3/Mll4). Utx (violet) is specific to
Mll3/Mll4 complex and is described as a H3K27-specific Lysine-demethylase.
2014; Yagi et al., 1998). Furthermore, genetic ablation of Mll1 in mouse has been
shown to result in embryonic lethality (Yagi et al., 1998; Yu et al., 1995).
The second homolog of Trithorax, Mll2, has been found to be involved in solid tumor
cell proliferation (Huntsman et al., 1999).Like Mll1, Mll2 mutation results in embry-
onic lethality (Glaser et al., 2006). Additionally, conditional knock-out of Mll2 in
the germline leads to infertility due to interference with bulk H3K4me3 establishment
(Andreu-Vieyra et al., 2010; Glaser et al., 2009).
Despite their importance in development, both Mll1 and Mll2 interference in cell cul-
ture experiments did not result in global changes of H3K4me3 levels, suggesting that
both proteins are not the main H3K4-specific HMTs in differentiated cells (Guenther
et al., 2005; Hu et al., 2013b; Lubitz et al., 2007; Terranova et al., 2006; Wang et al.,
2009, 2012; Zhang et al., 2016). Furthermore, deletion of the enzymatic active Set-
domain of Mll1 in mouse resulted in viable offspring, suggesting that the Set-domain
is dispensible for embryonic development (Terranova et al., 2006). Cancer-inducing
chromosome translocations did not contain the enzymatic active Set1-domain either,
suggesting that its tumorigenic function cannot be explained by its role in H3K4me3
establishment (Hess, 2004; Mishra et al., 2014).
Mll1 and Mll2 share an enzymatic protein complex scaffold (Dou et al., 2006; Miller
et al., 2001; Yokoyama et al., 2004) (Figure 1.3), therefore they might be redundant
to each other in establishing H3K4me3. However, while loss of Mll1 seems to be
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compensated for by the presence of other HMTs, Mll2 has been reported to play a
unique role in establishing H3K4me3 in bivalent domains in development (Denissov
et al., 2014). Thus Mll2 might be crucial for establishing chromatin signatures that are
essential for embryonic development, and both Mll1 and Mll2 might be involved in
establishing H3K4me3 at transcriptionally inactive promoters.
1.3.3 Homologs of Trithorax-related - Mll3 and Mll4
Mll3 and Mll4 are the vertebrate homologs of Drospophila Trr (Morgan and Shilatifard,
2013). Similar to Mll1 and Mll2, Mll3 and Mll4 have been reported to be involved
in disease progression of multiple types of cancer (Kim et al., 2014; Li et al., 2013;
O’Meara et al., 2014; Ortega-Molina et al., 2015; Wang et al., 2011; Watanabe et al.,
2011). While Mll3 and Mll4 have H3K4 trimethylation activity in vitro, recent reports
have shown that their function is restricted to H3K4 monomethylation in cell culture
experiments, which is mainly found at enhancer chromatin (Herz et al., 2012; Hu et al.,
2013a; Schuettengruber et al., 2009). Thus, HMT complexes containing Mll3 and Mll4
might be preferentially involved in chromatin regulation at enhancer elements (Lee
et al., 2013a).
1.3.4 COMPASS complex proteins
H3K4-specific HMTs are involved in a multi-component complex, which is called
COMPASS complex. Each individual COMPASS complex contains one of the HMTs
described above.
Four COMPASS components have been shown to be essential for full enzymatic activity
in vivo: Ash2l, Wdr5, Dpy-30 and Rbbp5 (Cao et al., 2010; Chen et al., 2012; Wysocka
et al., 2005). These core complex subunits allow for substrate recognition and sub-
strate presentation to the enzymatic pocket the COMPASS complex (Dou et al., 2006).
Especially Ash2l has been shown to be essential for cell proliferation. In stem cells,
Ash2l is involved in bulk H3K4me3 establishment (Wan et al., 2013). Furthermore,
ash2l knock-out in mouse results in embryonic lethality (Stoller et al., 2010). Studies
of Rbbp5, Wdr5 and Dpy-30 in embryonic stem cells show that knock-out of each
of these components affects self renewal and maintenance of pluripotency (Ang et al.,
2011; Jiang et al., 2011), supporting their essential role in differentiation processes.
Next to these core complex proteins, COMPASS complexes can contain unique pro-
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tein components depending on their central histone methyltransferase. Menin1 is an
essential component for complexes containing Mll1 or Mll2, and is involved in DNA
sequence selectivity and protein complex assembly (Agarwal and Jothi, 2012; Matkar
et al., 2013; Yokoyama et al., 2004). The same role is fulfilled by Wdr82 in COMPASS-
complexes containing Set1a or Set1b (Lee and Skalnik, 2008). Furthermore, Set1-
containing COMPASS complexes contain Cfp1, that has been shown to interact with
hypomethylated CpG islands (Clouaire et al., 2012; Lee et al., 2007). COMPASS com-
plexes with Mll3 and Mll4 contain the four proteins PTIP, Utx, PA1 and NCOA6, that
regulate DNA recognition and modify the chromatin environment around COMPASS
recruitment sites (Cho et al., 2007; Kim et al., 2014; Lee et al., 2008; Mansour et al.,
2012). Together, these complex proteins allow for improved substrate recognition and
DNA binding specificity of the different H3K4-specific HMTs.
1.3.5 H3K4me3 removal.
H3K4me3 is biochemically stable, and it was hypothesized that removal of H3K4
methylation relies on eviction and degradation of respective histone proteins. In subse-
quent in vitro studies, Lsd1 could be identified as an enzyme capable to remove methyla-
tion marks from histone tails without protein degradation (Shi et al., 2004). However, its
enzymatic activity is restricted to removal of H3K4 mono- and di-methylation. Further
studies identified the Jarid1/KDM5 protein family as H3K4-specific demethylases that
are able to demethylate H3K4me3 as well (Iwase et al., 2007; Secombe and Eisenman,
2007; Seward et al., 2007). In vertebrates, four KDM5 proteins were identified. While
all are able to demethylate H3K4, little is known about their isoform-specific regulation
and locus-specificity. Their differential expression and regulation might present an
additional mechanism for negative transcription regulation by H3K4me3 removal at
promoter elements.
1.4 Transcription activation in embryos
Early embryonic development of almost all metazoans relies on maternally provided
factors, while the zygotic transcriptome is transcriptionally inactive (Schier, 2007).
Only after a species-specific period of development, the embryonic genome becomes
permissive for transcription, and zygotic transcripts take over further embryonic devel-
opment (Foe and Alberts, 1983; Kane and Kimmel, 1993; Oron and Ivanova, 2012;
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Sulston et al., 1983; Wu and Gerhart, 1980). Enucleation experiments in sea urchins
were the first to demonstrate that transcription from the zygotic genome is essential
for further embryonic development (reviewed in (Laubichler and Davidson, 2008)).
Furthermore, transcription inhibition in Xenopus eggs has shown that gastrulation relies
on zygotic transcription (Newport and Kirschner, 1982). Thus, zygotic transcription
activation is essential to allow for embryonic development. We use zebrafish as a model
to study transcription regulation during zygotic genome activation.
1.4.1 Zebrafish early embryonic development
The zebrafish Danio rerio is a small fresh-water fish native to the tropical Himalayan
region. It was established as a model organism for vertebrate genetics during the 1970s
by George Streisinger and colleagues at the University of Oregon (Streisinger et al.,
1981). Over the years it has been established as an outstanding model organism for
developmental biology, for which numerous molecular biology and transgenic tech-
niques are established (Grunwald and Eisen, 2002). Mating of zebrafish gives rise
to hundreds of embryos, that develop synchronously ex utero. This makes zebrafish
embryos amenable for manipulation and easy observation of developmental processes.
Furthermore, embryos are transparent, which makes them an excellent experimental
system for microscopy.
The early embryonic development in zebrafish is well characterized (Kane and Kim-
mel, 1993; Kimmel et al., 1995). After fertilization, the animal cap forms as a single
cell by influx of cytoplasmic material from the underlying large yolk cell (Zygote
period, 0-0.75 hours post fertilization, hpf). This initial stage is followed by rapid,
synchronous cell divisions, which lead to an exponential increase of cell numbers while
the cytoplasmic volume stays constant. After 10 cell divisions, the embryo enters
the so-called midblastula transition (MBT). MBT is characterized by a slowdown and
desynchronization of cell cycles, the beginning of cell motility, and the activation of the
zygotic genome.
The early embryonic development occurs in the absence of zygotic transcription. Al-
though a subset of genes is activated as early as 128-cell stage (Heyn et al., 2014), the
major wave of zygotic genome activation occurs at the 1000cell stage, coinciding with
MBT. Recent studies have demonstrated that specific transcription factors are essential
for embryonic genome activation (Liang et al., 2008). In zebrafish, the transcription
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Figure 1.4: Zebrafish embryonic development. Zebrafish embryonic development
starts from a fertilized egg that soon forms a single cell on top of a big yolk cell
by influx of cytoplasmic material from the yolk. Until genome activation (at around
3 hours post fertilization), cells divide synchronously. Shortly after (stages high,
oblong, sphere), zygotic transcription commences (green), and maternal factors (red)
are gradually degraded. Genome activation is accompanied by establishment of
H3K4me3 (green leaflets) and H3K27me3 (red leaflets). H3K4me3 is found on
genes that are transcriptionally active, but also on inactive genes. Genes marked with
both H3K4me3 and H3K27me3 (bivalent genes) are initially repressed but thought
to become resolved to either active state (only H3K4me3) or repressed state (only
H3K27me3) during cell differentiation that happens in the gastrulation period. Stages
of embryonic development adapted from Kimmel et al. 1995.
factors Pou5f3 (Oct4 homolog), sox19b (sox2 homolog) and Nanog were found to be
crucial for genome activation (Lee et al., 2013b; Leichsenring et al., 2013). However,
these transcription factors are present during earlier stages of embryonic development
as well. Thus it is still unclear which mechanisms keep the zygotic genome inactive
during early stages, and which mechanisms allow for transcription factor binding and
thus genome activation at a specific developmental stage. Unpublished observations in
our laboratory suggest that histone content might be a general repressive mechanism
that prevents genome activation in early stages. Histones might compete with transcrip-
tion factors and other proteins for binding to DNA during early developmental stages
16
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(Joseph et al., in preparation), thus their excess might prevent chromatin modification
and transcription factor binding prior to ZGA.
1.4.2 H3K4me3 during early zebrafish development
Zygotic genome activation is accompanied by major changes in chromatin organization.
These changes might be involved in genome activation, as previous experiments have
shown that chromatin might be involved in transcription repression prior to ZGA (Har-
vey et al., 2013; Newport and Kirschner, 1982; Wiekowski et al., 1993). In zebrafish
it has been shown that nucleosomes are equally distributed, yet unstructured, in earlier
stages, and become well-positioned at specific promoters during ZGA (Zhang et al.,
2014). Furthermore, multiple histone modifications were found to be absent from chro-
matin prior to genome activation, and are established coinciding with ZGA (Lindeman
et al., 2011; Vastenhouw et al., 2010). In this context, H3K4me3 is of particular interest,
as it might facilitate transcription activation during genome activation (Flanagan et al.,
2005; Hung et al., 2009; Vermeulen et al., 2007). H3K4me3 has been shown to be
established during ZGA, and was found on genes that are actively transcribed, but also
genes that are transcriptionally inactive genes. So far it is not known, whether early
H3K4me3 establishment is involved in transcription activation, and whether H3K4me3
is essential for zygotic genome activation and embryonic development.
1.5 Thesis aim
The aim of my thesis is to investigate the role of H3K4me3 during early embryonic
development. I applied genetic ablation strategies as well as introduction of inhibitors
to interfere with global H3K4me3 establishment. Upon H3K4me3 interference I aim
reveal whether promoter-associated H3K4me3 establishment is essential for transcrip-
tion activation in zebrafish embryos. Finally I address possible DNA sequence and
chromatin that might allow for early H3K4me3 establishment at the majority of pro-
moters during early embryonic development. Together, these experiments will shed
light on the importance of H3K4me3 in transcriptional processes, and will increase our
understanding of the interplay of chromatin modifications and transcription regulation
in embryonic development.
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2.1 Materials
Chemicals
Name Supplier Order number
NaCl Merck Millipore 1064041000
Glycine Merck Millipore 1042011000
NaOH Pellets Merck Millipore 1064981000
Sodium dodecylsulfate
(SDS)
Serva 20765
Tricaine / MS-222 Sigma-Aldrich E10521-10G
UltraPure Agarose Invitrogen 16500-500
Red Sea Salt Read Sea Europe R11070
Methylene Blue AppliChem A4084,0025
Blotting-Grade Blocker Bio-Rad 170-6404
NaOCl Roth 9062.3
Bovine Serum Albumine
(BSA)
Sigma-Aldrich A8022-50G
Tris Pufferan Roth 48552
CaCl2 Merck Millipore 102378500
KCl Merck Millipore 104936500
NaHCO3 Merck Millipore 1063291000
Glycerol bidistilled VWR Chemicals 24388.295
Dithiothreitol (DTT) Serva 2071004
Bromophenolblue Chroma Gesellschaft
Münster
4F-093
Ethylenediaminetetraacetic
acid (EDTA)
Merck Millipore 1084181000
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LiCl Merck Millipore 1056791000
Deoxycholic acid (DOC) Merck Millipore 264101-100GM
2-[4-(2-hydroxyethyl)-
piperazin-1-yl]-
ethanesulfonic acid
(HEPES)
Roth 91053
Commercial Solutions and Reagents
Name Supplier Order number
cOmplete Protease
Inhibitors
Roche Science 11697498001
AccuGENE PBS Lonza 51225
Formaldehyde, 37%
solution
Amresco 0493-200ML
NuPAGE Transfer Buffer
(20x)
Thermo Scientific NP00061
NuPAGE MOPS SDS
Running Buffer (20x)
Thermo Scientific NP0001
NuPAGE MES SDS
Running Buffer (20x)
Thermo Scientific NP0002
Restore WB Stripping
Buffer
Thermo Scientific 21059
PageRuler Plus
Prestained Protein Ladder
Thermo Scientific 26619
Lambda DNA
EcoRI+HindIII Digest
New England Biolabs N3012S
Rhodamine-Dextrane
solution
Thermo Scientific R1371
Phenol Red 0.5% solution Sigma-Aldrich P0290-100ML
dead end Morpholino GeneTools LLC custom order
N-terminal H3 Peptide,
30 mg
GenScript custom order
Ambion NaAc, pH=5.5 Thermo Scientific AM9740
20
2.1 Materials
β-Mercaptoethanol Sigma-Aldrich M6250-500ML
Methanol VWR Chemicals 20847307
HCl Fisher Scientific J/4315/17
Tween20 Sigma-Aldrich P1379-10ML
Triton X-100 Sigma-Aldrich T9284-100ML
IGEPAL CA-630 Sigma-Aldrich I3021-100ML
Consumables
Name Supplier Order number
1.5ml tubes Sarstedt 72.690.001
2ml tubes Sarstedt 72.695.500
1.5ml Low Retention
tubes
Kisker Biotech G017
ABgene 96well PCR
plates
Thermo Scientific AB0600
white 96well Multiwell
480 qPCR plate
Roche Scientific 0472969200.1
96well sealing foil Thermo Scientific 121860
8well stripes Axygen 321-11-051
0.1-10ul tips Axygen 12541298
2-200ul tips Axygen 12571288
100-1000ul tips Axygen 12551308
1-200ul Gel tip round Sigma-Aldrich CLS4853-400EA
6well plates Thermo Scientific 140675
24well plates Thermo Scientific 142475
cell culture dishes Greiner Bio-One 639102
Glass capillary w/
filament
World Precision
Instruments
TW100F-4
Glass capillary w/o
filament
World Precision
Instruments
TW100-4
Glass pasteur pipettes Sigma-Aldrich Z310727-1PAK
LuerLok syringe 1 ml BDScience 309628
Parafilm M Sigma-Aldrich P7793-1EA
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Slide-A-Lyzer G2
Dialysis Cassettes
Thermo Scientific 87729
Dynabeads Protein G Thermo Scientific 10005
NuPAGE Novex 12%
Bis-Tris Protein Gels,
10-well
Thermo Scientific NP0341BOX
NuPAGE Novex 4-12%
Bis-Tris Protein Gels,
10-well
Thermo Scientific NP0321BOX
Amersham Hybond P
0.45 PVDF membrane
GE LifeSciences 10600023
Whatman 3mm Blotting
Paper
GE LifeSciences 3030-917
Enzymes
Name Supplier Order number
Pronase Sigma-Aldrich 000000010165921001
Proteinase K Sigma-Aldrich 000000003115887001
XhoI New England Biolabs R0146S
XbaI New England Biolabs R0145S
EcoRI New England Biolabs R0101T
SnaBI New England Biolabs R0130L
StuI New England Biolabs R0187S
PstI New England Biolabs R0140S
SacII New England Biolabs R0157S
BsrI New England Biolabs R0527S
Hin4L New England Biolabs discontinued
HincII New England Biolabs R0103S
TSP45I New England Biolabs R0583S
T4 DNA Ligase New England Biolabs M0202S
T7 Endonuclease I New England Biolabs M0302S
Taq DNA Polymerase MPI-CBG internal
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Micrococcal Nuclease
(MNase)
Sigma-Aldrich N5386-50UN
Commercial Kits
Name Supplier Order number
Qubit dsDNA HS Assay Thermo Scientific Q32854
iScript cDNA Synthesis
Kit
BIO-RAD 1708891
FastStart SYBR Green
Master
Roche Science 04673484001
ABsolute qPCR SYBR
Green Mix
Thermo Scientific AB-1158
CloneJET PCR Cloning
Kit
Thermo Scientific K1231
mMESSAGE
mMACHINE SP6
Transcription Kit
Thermo Scientific AM1340
QIAprep Spin Miniprep
Kit
Qiagen 27106
QIAquick PCR
Purification Kit
Qiagen 28104
QIAquick Gel Extraction
Kit
Qiagen 28704
MinElute PCR
Purification Kit
Qiagen 28004
RNeasy Mini Kit Qiagen 74106
Amersham ECL WB
Detection Reagent
GE LifeSciences RPN2106
Pfu DNA Polymerase Kit Promega M7741
Blot Developper RP
X-Omat LO
Carestream 124 9259
Blot Developper X-Omat
ExII
Carestream 113 5433
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TruSeq ChIP Library
Preparation Kit
Illumina IP-202-1012
High Sensitivity DNA Kit Agilent 5067-4626
RNA 6000 Nano Kit Agilent 5067-1511
ProbeSet for Nanostring Integrated DNA
Technologies (IDT)
custom order
nCounter Elements
TagSet-96
Nanostring Technologies 112008
Elements Master-Kit Nanostring Technologies 110054
Laboratory Equipment
Name Supplier Order number
Benchtop centrifuges
Mini Star
VWR Chemicals 521-2844
Vortex-Genie 2 Scientific Industries SI-0236
Cooling centrifuge 5415R Eppendorff Z605212
Thermomixer C Eppendorff 5382000015
Pipetman Classic set Gilson F167300
Bel-Art Pipette Pump Fisher Scientific 13-683C
Accurpette VWR Chemicals 612-4552
Qubit 2.0 Fluorometer Thermo Scientific Q32866
2100 BioAnalyzer Agilent G2939AA
Nanodrop 1000 Thermo Scientific discontinued
LightCycler 96 Roche Science 05815916001
Mx3000P QPCR Agilent 401512
Micropipette puller
Model P-97
Sutter Instruments P-97
Pneumatic PicoPump World Precision
Instruments
SYS-PV820
Microinjection stand Narishige MN-153
Stereomicroscope 2000 Carl Zeiss discontinued
Ultrasound probe sonifier Branson W-450
DynaMag 2 Magnet Thermo Scientific 12321D
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XCell SureLock
Mini-Cell
Thermo Scientific EI0001
XCell II Blot Module Thermo Scientific EI9051
Odyssey SA Infrared
Imaging
LI-COR 9260-11
MasterCycler Pro Eppendorf 6321000515
Zebrafish incubator Memmert PP400
Photofilm Developer
X-Omat 2000
Kodak/Carestream discontinued
HiSeq2000 NextGen
Sequencer
Illumina discontinued
Plasmids
Insert Vector Purpose Source
zebrafish H3.1
zgc:173552,
C-terminal HA-tag
pCS2+ mRNA in vitro
transcription (SP6
RNA-Polymerase
+ NotI restriction)
this study, see
chapter 6.6
zebrafish H3.1
zgc:173552,
K4-to-M
substitution,
C-terminal HA-tag
pCS2+ mRNA in vitro
transcription (SP6
RNA-Polymerase
+ NotI restriction)
this study, see
chapter 6.6
zebrafish H3.1
zgc:173552,
K4-to-E
substitution,
C-terminal HA-tag
pCS2+ mRNA in vitro
transcription (SP6
RNA-Polymerase
+ NotI restriction)
this study, see
chapter 6.6
zebrafish eGFP +
nanos1-3’UTR
pCS2+ mRNA in vitro
transcription (SP6
RNA-Polymerase
+ NotI restriction)
Schier Lab,
Harvard
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zebrafish Kdm5Bb pSport6.1 subcloning Schier Lab,
Harvard
zebrafish
KDM5Bb,
C-terminal
Flag-Tag
pCS2+ mRNA in vitro
transcription (SP6
RNA-Polymerase
+ NotI restriction)
this study, see
chapter 6.6
mouse
KDM5A/Jarid1A
pSp1 cell culture
expression
Anastassiadis Lab,
Dresden
mouse
KDM5B/Jarid1B
pSp1 cell culture
expression
Anastassiadis Lab,
Dresden
mouse
KDM5C/Jarid1C
pSp1 cell culture
expression
Anastassiadis Lab,
Dresden
mouse
KDM5D/Jarid1D
pSp1 cell culture
expression
Anastassiadis Lab,
Dresden
mouse
KDM5A/Jarid1A,
C-terminal
Flag-Tag
pCS2+ mRNA in vitro
transcription (SP6
RNA-Polymerase
+ NotI restriction)
this study, see
chapter 6.6
mouse
KDM5B/Jarid1B,
C-terminal
Flag-Tag
pCS2+ mRNA in vitro
transcription (SP6
RNA-Polymerase
+ KpnI restriction)
this study, see
chapter 6.6
mouse
KDM5C/Jarid1C,
C-terminal
Flag-Tag
pCS2+ mRNA in vitro
transcription (SP6
RNA-Polymerase
+ NotI restriction)
this study, see
chapter 6.6
mouse
KDM5D/Jarid1D,
C-terminal
Flag-Tag
pCS2+ mRNA in vitro
transcription (SP6
RNA-Polymerase
+ NotI restriction)
this study, see
chapter 6.6
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Antibodies
Epitope Type Working
concentration
Supplier Order
number
Flag-Tag mouse
monoclonal
(M2)
WB 1:500 Sigma-Aldrich F1804
HA-Tag,
ChIP-Grade
rabbit
polyclonal
WB 1:5000 Abcam ab9110
Ash2l rabbit
polyclonal
WB 1:100 Abcam ab192906
Ash2l rabbit
polyclonal
WB 1:500 Abcam ab84732
Mll1 rabbit affinity-
purified
WB 1:500 Bethyl Labs A300-375A-1
Mll/HRX rabbit
polyclonal
WB 1:500 Active Motif 61295
H2A.z,
ChIP-Grade
rabbit
polyclonal
WB 1:500,
ChIP 10ug
Abcam ab4174
pan-H3 rabbit
polyclonal
WB 1:10000,
ChIP 10ug
Abcam ab1791
H3.1 rabbit
polyclonal
WB 1:500 Abcam ab183627
H3K4me1 rabbit
polyclonal
WB 1:500 Abcam ab8895
H3K4me2 rabbit
polyclonal
WB 1:500 Millipore 07-030
H3K4me3 rabbit
polyclonal
WB 1:500,
ChIP 10ug
Millipore 07-473
H3K9me3 rabbit
polyclonal
WB 1:500 Abcam ab8898
Tubulin mouse
monoclonal
WB 1:10000 Sigma-Aldrich T6074
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HRP-coupled
anti-mouse
IgG
rabbit affinity-
purified
WB 1:20000 Jackson Im-
munoResearch
315-035-003
HRP-coupled
anti-rabbit IgG
goat affinity-
purified
WB 1:20000 Jackson Im-
munoResearch
111-035-003
IRDye 800CW
anti-rabbit IgG
donkey
affinity-
purified
WB 1:20000 LI-COR 925-32213
IRDye 680RD
anti-mouse
IgG
goat affinity-
purified
WB 1:20000 LI-COR 925-68070
Primer Sequences
Name Sequence Annealing temperature
Jarid1A fw (KDM5A) CCCCCATCGATGCCA
CCATGGCGTCCGTGG
GCCCG
67◦C
Jarid1A-Flag rev
(KDM5A)
GCTCTAGATTACTTG
TCATCGTCATCCTTG
TAATCTTTTTTATTC
TTCTCTTCTTCCGTT
ACAAATACAAC
59/81◦C
Jarid1B fw (KDM5B) CCCCGCTCGAGGCCA
CCATGGAGCCGGCCA
CCACG
64◦C
Jarid1B-Flag rev
(KDM5B)
GCTCTAGATTACTTG
TCATCGTCATCCTTG
TAATCCTTTCGGCTT
GGTGCGTCCTTCC
64/80◦C
Jarid1C fw (KDM5C) CCCCCATCGATGCCA
CCATGGAGCTGGGGT
CCGAC
60◦C
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Jarid1C-Flag rev
(KDM5C)
GCTCTAGATTACTTG
TCATCGTCATCCTTG
TAATCCAATTGTTGC
AGAGATGGCTGC
59/81◦C
Jarid1D fw (KDM5D) GAAGGCCTGCCACCA
TGAAGCCAGGATCTG
ACG
55◦C
Jarid1D-Flag rev
(KDM5D)
GCGCCTACGTATTAC
TTGTCATCGTCATCC
TTGTAATCTAATTTT
TGCTGATGAAAATAA
GATAGGTG
55/78◦C
KDM5Bb fw CCCCCATCGATGCCA
CCATGACCCAGCAGG
GCCCG
64◦C
KDM5Bb-Flag rev GCTCTAGATTACTTG
TCATCGTCATCCTTG
TAATCCTTCCGGCGG
TCCATGTGAC
62/81◦C
H3.1 zgc:173552 fw
(gene-specific)
CCATGCAGCGGCGTA
TTCAG
56◦C
H3.1 zgc:173552 rev
(gene-specific)
GCCTTTGGGGTTTGA
CGTGT
54◦C
H3.1 fw ATGGCCAGAACCAAG
CAGACCGC
67◦C
H3.1-HA rev TTAAGCGTAGTCTGGC
ACGTCGTAGGGGTAG
CCTGATCCTGATCCA
GCGCGCTCTCCGCGG
58/71◦C
H3.1 K4-E fw CTTGGCATGGCCCGT
ACTGAGCAGACCGCG
CGTAAATC
72◦C
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H3.1 K4-E rev GATTTACGCGCGGTC
TGCACAGTACGGGCC
ATGCCAAG
72◦C
H3.1 K4-M fw CTTGGCATGGCCCGT
ACTATGCAGACCGCG
CGTAAATC
72◦C
H3.1 K4-M rev GATTTACGCGCGGTC
TGCATAGTACGGGCC
ATGCCAAG
72◦C
ash2l F2 ATCATTTACTCACCC
TCCACTTGTC
60◦C
ash2l R2 AAAGCAAAATGAAAC
TGATGTCCAG
59◦C
mll TALEN F2 ACCCACACTGAGCTC
CTGATCC
65◦C
mll TALEN R2 GGTCCCATAGTAAGA
AAAACAGCAC
63◦C
mll 5-1 fw TCAGCATTCTCACCT
CTGTG
54◦C
mll 5-4 rev TTGTTGCTGATCTCT
CAAAGC
55◦C
mll2 TALEN seq-fw TCCATTGCCTCATTT
CAGATG
57◦C
mll2 TALEN seq-rev GTCCCATGCCTACTT
AAAAGAAC
57◦C
eif4g2a qfw GAGATGTATGCCACT
GATGAT
57◦C
eif4g2a qrev GCGCAGTAACATTCC
TTTAG
57◦C
ash2l qfw CACCAGTACCAGCAG
AATGAT
57◦C
ash2l qrev CAACCCATATCGCTC
ATTGG
57◦C
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mll1 qfw CTGTGGGTGTCTATA
GATCAG
57◦C
mll1 qrev GAGTGGTTAATGAAA
CGGGC
57◦C
mll2 qfw TCTGTACGCTGCTAA
AGACC
57◦C
mll2 qrev GAATGATTGACATAA
CGAGCAGG
57◦C
efna1 qfw TGTTGGACCTCACGG
TTC
57◦C
efna1 qrev AGACCAGTGTCCATA
AAGCC
57◦C
skib qfw TACTCCTCACAGATT
GAGGATC
57◦C
skib qrev TCTTGATCTCCTTTG
GTGGG
57◦C
slc30 qfw GAAGGCTGCCGATAT
GTGT
57◦C
slc30 qrev CAATGTTGACCCGAA
CAAGG
57◦C
akap12b qfw AGAATCCAGAGGTCC
AGACT
57◦C
akap12b qrev TTACAGGCCGACTGC
TC
57◦C
rpl26 qfw CTGCGGCAGAAATAC
AACG
57◦C
rpl26 qrev CTGGTGATCACAACC
TTGC
57◦C
rpl26 upstream qfw GGTTGTAGAGCGAAG
ATGC
57◦C
rpl26 upstream qrev GAAGGTAAATCTGTT
GCGTAAC
57◦C
rpl26 intron qfw AGTTCTCGAGTCTCTT
TTCCG
57◦C
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rpl26 intron qrev TGTGTGAGTGTTTTC
ATGTCG
57◦C
All Primers were obtained from Europrim-Invitrogen via Thermo Scientific in the min-
imal scale and quality possible for the respective oligo length.
Buffers
Zebrafish medium (for 20 liter)
Chemical Amount Comments
Red sea salt 5 g test pH for being
Methylene-blue, 10%
solution
20 ml between 7 and 8
fill up to 20 l with
desalted water
TBS (Tris-buffered saline)
Chemical Final concentration Comments
Tris-chloride 50 mM adjust pH to 7.5 with HCl
NaCl 150 mM
TBS-Tween (Tris-buffered saline with 1/Tween20)
Chemical Final concentration Comments
Tris-chloride 50 mM adjust pH to 7.5 with HCl
NaCl 150 mM
Tween20 1% v/v
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Deyolking Buffer
Chemical Final concentration Comments
NaCl 55 mM add 10% Glycerol
KCl 1.8 mM for deyolking of stages
NaHCO3 1.25 mM prior to MZT
Deyolk Wash Buffer
Chemical Final concentration Comments
NaCl 110 mM add 10% Glycerol
KCl 3.5 mM for deyolking of stages
CaCl2 2.7 mM prior to MZT
Tris-Cl, pH 8.5 10 mM
SDS Loading Buffer
Chemical Final concentration Comments
Tris-Cl 70 mM
Glycerol 5% v/v
SDS 0.7 mM
DTT 1.5 mM
Bromophenol blue 0.3 nM
ChIP Cell Lysis Buffer
Chemical Final concentration Comments
Tris-Cl 10 mM pH to 7.5,
NaCl 10 mM add 1x Protease Inhibitors
NP-40/IGEPAL 0.5% v/v fresh for each experiment
ChIP Nuclear Lysis Buffer
Chemical Final concentration Comments
Tris-Cl 50 mM pH to 7.5,
EDTA 10 mM add 1x Protease Inhibitors
SDS 1% v/v fresh for each experiment
33
2 Materials and Methods
IP Dilution Buffer
Chemical Final concentration Comments
Tris-Cl 16.7 mM pH to 7.5,
NaCl 167 mM add 1x Protease Inhibitors
SDS 0.01% v/v fresh for each experiment
EDTA 1.2 mM
ChIP Washing Buffer
Chemical Final concentration Comments
HEPES 50 mM pH to 7.6,
EDTA 1 mM add 1x Protease Inhibitors
DOC 0.7% v/v fresh for each experiment
NP-40/IGEPAL 1% v/v
LiCl 500 mM
ChIP Elution Buffer
Chemical Final concentration Comments
NaHCO3 50 mM pH must be above 10.5
SDS 1% v/v
MNase Digestion Buffer
Chemical Final concentration Comments
Tris-Cl 50 mM pH to 7.5,
CaCl2 1 mM add 1x Protease Inhibitors
and PMSF
Triton X-100 0.2% v/v fresh for each experiment
MNase Dilution Buffer
Chemical Final concentration Comments
Tris-Cl 50 mM pH to 8
CaCl2 126 mM
NaCl 10 mM
Glycerol 5% v/v
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MNase Stop Buffer
Chemical Final concentration Comments
Tris-Cl 10 mM pH to 7.6
EDTA 20 mM
Chromatin IP Buffer
Chemical Final concentration Comments
Tris-Cl 27.8 mM pH to 7.5
NaCl 111 mM
SDS 0.34% v/v
EDTA 4.1 mM
Triton X-100 0.8% v/v
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2.2 Methods
2.2.1 Zebrafish husbandry and care
Zebrafish were maintained at 28◦C according to standard procedures. For mating, male
and female fish were separated overnight. After combining individual fish of opposite
sex, embryos were collected after 15 minutes. If necessary for experimental procedures,
embryos were dechorionated by brief Pronase treatment (~3 minutes) and subsequent
washes with Zebrafish Medium (see Table 2.1). Embryos were left to develop to the
desired stage at 28◦C in agarose-coated culture dishes. Staging was performed by
developmental time and according to morphological criteria based on Kimmel et al.
1995.
To assess the genotype of mutant zebrafish, adult fish were anesthetized by Tricaine
treatment (0.0001% in Zebrafish medium) and fin biopsies were taken. Fins were lyzed
in 100mM NaOH for 15 minutes at 95◦C, and fin lysate was neutralized by addition of
10mM of 1M Tris (pH 7.5). After brief spin-down, 2ul of fin lysate were used for regular
PCR using genotype-specific primers. The resulting PCR products were incubated with
specific restriction enzymes (see below), and the resulting band pattern was analyzed
by DNA gel electrophoresis.
2.2.2 Generation of zebrafish knock-out lines by TALEN mutagenesis
TALEN constructs were generously provided by the Schier lab at Harvard. mRNA syn-
thesized from provided constructs were injected into one-cell stage embryos through the
chorion, and embryos raised under standard conditions. To optimize TALEN construct
concentration, different amounts of TALEN mRNA were injected, and mutagenesis
activity was assessed by T7E1 restriction. In brief, DNA of multiple TALEN-injected
embryos was extracted and PCR was performed with primers flanking the targeted
mutation site. The obtained PCR product was denatured at 95◦C for 10 minutes, and hy-
bridized to wildtype PCR product by slow cool-down to 65◦C on a PCR machine. After
hybridization, T7E1 enzyme was added. This enzyme would cause DNA restriction if
basepair mismatches between hybridized strands occur. The amount of degraded DNA
was assessed by Agilent DNA High Sensitivity kit analysis according to manufacturers
protocols.
The workflow to generate mutant zebrafish by TALEN expression is depicted in Fig-
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Genotyping protocols
Genotype Primers PCR
program
Enzyme Expected
bands
ash2l TALEN ash2l F2 +
ash2l R2
40 cycles;
95◦C 20sec,
60◦C 20sec,
72◦C 30sec
PstI, 37◦C, 2h wt: 250 +
400bp;
mutant: 640bp
mll TALEN mll TALEN
F2 + mll
TALEN R2
40 cycles;
95◦C 20sec,
65◦C 20sec,
72◦C 30sec
SacII, 37◦C,
2h
wt: 470bp;
mutant: 160 +
310bp
mll sa137 mll 5-1 fw +
mll 5-4 rev
40 cycles;
95◦C 20sec,
54◦C 20sec,
72◦C 30sec
BsrI, 65◦C, 2h wt: 250bp;
mutant: 500bp
mll2 TALEN mll2 TALEN
seq-fw + mll2
TALEN
seq-rev
40 cycles;
95◦C 20sec,
57◦C 20sec,
72◦C 30sec
Hin4L, 37◦C,
2h
wt: 200 +
300bp;
mutant: 500bp
ure 3.1. Optimal TALEN construct concentrations were injected into one-cell stage
embryos through the chorion. Subsequently, these fish were raised to adulthood. T7E1
restriction assay (described above) was performed on biopsies of the adult fin, to iden-
tify individual fish harboring mutated alleles. These fish were mated with wildtype fish,
and the resulting offspring was used for an T7E1 restriction assay, to test for germline
transmission of mutated alleles. Validated founder fish were mated with wildtype fish,
and the resulting F1 generation was raised to adulthood. F1 fish were individually
tested for mutant alleles by sequencing of PCR products spanning the mutation site. F1
fish that harbor validated protein-disruptive mutations were crossed against wildtype to
obtain stable lines of a single mutated allele. These fish lines were crossed at least twice
against wildtype fish before incrossing them to obtain homozygous mutants.
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2.2.3 Generation of plasmids for mRNA production
Plasmids coding for mouse Jarid1/KDM5 constructs were generously provided by the
Anastassiadis (Biotec, Dresden) and Neugebauer (MPI-CBG, Dresden) labs. The cod-
ing sequence from KDM5 constructs was amplified by PCR with Pfu-Polymerase. Construct-
specific primers were designed that further encoded sequences for zebrafish KOZAK
sequence and restriction enzyme sites. Furthermore, C-terminal Flag-tag sequence was
encoded in reverse primers (Table 2.9). Specific PCR products were identified by DNA
gel electrophoresis and purified by Qiagen Gel Extraction kit according to manufac-
turers protocols. Restriction digest of PCR products was performed for 3 hours at
37◦C (KDM5A, KDM5C and zebrafish KDM5Bb: XbaI+ClaI; KDM5B: XbaI+XhoI;
KDM5D: StuI+SnaBI) and products were purified by Qiagen PCR purification kit
according to manufacturers protocols. The purified products were ligated with empty
pCS2+ vector backbone by T4 DNA Ligase overnight at 16◦C and cultured in Strata-
Clone competent bacterial cells.
Zebrafish sequence for H3.1 was obtained by PCR for the gene locus zgc:173552 from
genomic DNA, and integration of the PCR product into pJet vector using the CloneJET
PCR Cloning kit according to manufacturers protocols. From this construct, H3.1 was
amplified by Pfu-Polymerase PCR with primers further encoding a C-terminal HA tag.
The resulting PCR product was used for restriction digest with XhoI and XbaI at 37◦C
for two hours, and inserted into empty pCS2+ vector-backbone by T4 ligation at 25◦C
for two hours.
The resulting wildtype histone construct was used for primer-guided mutation. For
each substitution, two primers were designed that overlap the site of interest, and
single basepair substitutions were used to change amino acid 4 (Lysine, AAG) to either
Methionine (ATG) or Glutamate (GAG). With these primers, Pfu-Polymerase PCR was
performed to amplify the complete vector. The resulting PCR product was digested
with XhoI for two hours at 37◦C and religated by T4 DNA ligase at 25◦C for two hours
to produce a circular vector.
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2.2.4 Microinjection
mRNA was synthesized in vitro from respective linearized plasmids using the Ambion
mMessage mMachine kit with respective RNA polymerase (mostly SP6 polymerase)
according to manufacturers protocol. The resulting RNA was purified using Qiagen
RNeasy Mini kit according to manufacturers protocols, and RNA quality was assessed
by gel electrophoresis.
For injection, dechorionated one-cell stage embryos were lined up in agarose-molds to
allow for embryo positioning. If not stated otherwise, 1ng of RNA (or 100ng peptide)
were injected via filamented glass capillaries into the animal cap. Microinjections
were performed at 20◦C. After injections, embryos were staged and raised at standard
conditions described in subsection 2.2.1.
2.2.5 Germline transplantation
Germline transplantation was performed according to published protocols (Ciruna et al.,
2002). Embryos of the genotype of interest were used to extract germline progenitors
(referred to as ’donors’) that were transplanted into wildtype embryos with interfered
germline development (’hosts’).
In detail, an incross of heterozygous fish for the respective genotype was performed.
One-cell stage embryos were dechorionated and injected with 50pg RNA coding for
GFP with the 3’UTR of nanos1 mRNA (subsection 2.2.3). This construct restricts RNA
localization and thus GFP expression to germline progenitors. This labelling approach
allows to follow integration of GFP-positive donor germline into GFP-negative host
embryos. In parallel, wildtype embryos were dechorionated at the one-cell stage and
injected with 1nl of 0.25mM dead end Morpholino. This Morpholino inhibits transla-
tion of dead end mRNA. Inhibition of dead end expression results in mislocalization of
germline-specific mRNAs and consequently absence of germline progenitors, resulting
in infertility of dead end-Morpholino-injected embryos.
Both host and donor embryos were raised until sphere stage, and transplantation was
performed between sphere stage and 30% epiboly stage. For each donor, 5 host em-
bryos were lined up in agarose molds with animal cap facing up. Glass capillaries
without filament were cut to match cell size of zebrafish embryos. Care was taken
to achieve blunt needles. From donor embryos, the cells around the margin towards
the yolk were sucked into the needle by careful underpressure applied by 10ml sy-
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ringe, avoiding yolk contamination. After cell uptake, each 20-30 cells were carefully
transplanted to the middle of the animal cap of 5 host embryos. Immediately after
transplantation, the respective donor embryo was transferred into an 8well-stripe for
subsequent genotyping. Only host embryos with transplanted cells from homozygous
mutant donors were further raised under standard conditions.
Successfully transplanted germline progenitor cells migrate to the correct position for
developing germline in the wildtype host, which do not contain germline progenitors
themselves due to dead end Morpholino interference. At 24-36 hours post fertilization,
transplanted embryos were screened for the presence of GFP-positive germ cells at the
expected position of the germline. These fish were further raised to adulthood. An
outcross against wildtype fish was used to test for fertility and to validate the genotype
of the transplanted germline.
dead end Morpholino: 5’-GCTGGGCATCCATGTCTCCGACCAT-3’
2.2.6 Western Blot Assays
To generate protein lysates of zebrafish embryos, the animal cap has to be separated
from the yolk cell, otherwise protein gels are overloaded with yolk material (Link
et al., 2006). Embryos were dechorionated at one-cell stage (subsection 2.2.1) and
raised to respective developmental stages. At each stage, 10 or more embryos were
transferred into ice-cold Deyolking Buffer. Embryos were homogenized by pipetting,
and 20 seconds agitation at 1000rpm. Cells were spun down by centrifugation at 300g
for one minute, washed with Deyolk Washing Buffer, subjected to agitation and spun
down as before. The resulting cell pellet was resuspended in SDS-Loading Buffer and
inactivated by incubation at 95◦C for 10 minutes. Sample material was collected by
brief centrifugation, and stored at -80◦C until use.
For standard electrophoresis, 4-12% gradient gels and 1xMOPS Running Buffer were
used to probe for multiple proteins at the same time. For histone modification blotting,
12% gels and 1xMES Running buffer were used to achieve highest resolution at small
molecular weight proteins. A sample equivalent to 10 embryos was loaded per lane
onto NuPage Bis-Tris gels. Electrophoresis was performed at 150V for 70 minutes at
room temperature. Gels were blotted onto PVDF membrane by semidry transfer with
1X Transfer buffer containing 15% methanol at 150mA for 3 hours. Membranes were
dried on Whatman Blotting paper until further use.
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Membranes were blocked in TBS-Tween with 5% dry milk powder for one hour at
room temperature, washed three times for 5 minutes with TBS-Tween, and treated
with the respective primary antibody for one hour on Parafilm sealing foil at room
temperature. Membranes were washed again three times for 5 minutes with TBS-
Tween, and then treated with respective secondary antibody for one hour at room
temperature on Parafilm sealing foil.
For standard protein detection, membranes were washed three times for 5 minutes
with TBS-Tween, and subjected to ECL detection reagents for three minutes at room
temperature. After removal of excess detection reagents, membranes were sealed into
foil. Photosensitive film was exposed to the membranes for different time intervals in
the dark, and developed using the Kodak Photofilm Developer X-Omat 2000.
For quantitative protein detection, secondary antibodies coupled to fluorophors were
used. After secondary antibody treatment, the membranes were washed three times for
5 minutes with TBS-Tween, and rinsed with desalted water. Membranes were dipped
into Methanol to allow for quick drying. Dry membranes were scanned and quantified
using the Li-Cor Odyssey Infrared imaging systems with the provided analysis soft-
ware.
If multiple immunoblotting of one membrane was necessary, membranes were washed
three times 5 minutes in TBS and subjected to antibody stripping using ReStore Strip-
ping Buffer for 15 minutes at room temperature. Membrane was rinsed twice with
desalted water and washed three times 5 minutes with TBS before treatment with
respective primary and secondary antibodies as described above.
2.2.7 RNA extraction and quantification assays
qRT-PCR analyses
Total RNA was extracted from zebrafish embryos by homogenization of 25 embryos
per sample in 350ul RLT buffer (from Qiagen RNeasy Mini Kit) complemented with
3.5ul β-mercapto-Ethanol. Subsequent RNA cleanup was performed using the RNeasy
Mini Kit protocols according to manufacturers protocols. RNA quality was assessed by
gel electrophoresis.
cDNA synthesis was performed on 500ng of RNA by using the iScript cDNA synthesis
kit following the maufacturers protocol. The resulting cDNA was 10 times diluted
before use in qRT-PCR experiments.
For qRT-PCR quantification of mRNA transcript levels, primers were generally de-
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signed to span at least one exon-exon border within the 3’-end of the coding sequence.
For qRT-PCR, 5ul of respective cDNA samples were mixed with each 0.625ul 10mM
forward and reverse primer, and 6.25ul Roche FastGreen MasterMix. PCR was per-
formed in white 96-well plates on the Roche LightCycler following a three-step ampli-
fication protocol with each 20 seconds denaturation (95◦C), 57◦C annealing and 72◦C
elongation for 45 cycles. Melting peaks were tested for the presence of a single specific
PCR products before subsequent analyses.
Nanostring assays
To allow for a direct quantification of multiple lowly-expressed mRNAs in parallel, a
fluorescent probe-based Nanostring assay was applied to zebrafish genome activation
(Geiss et al., 2008). Probes were designed to capture mRNA molecules from 12 genes
that are stably expressed during zebrafish embryogenesis (’Normalizers’), and 84 genes
that are not present prior to genome activation, but actively transcribed after MZT
(Aanes et al., 2011; Harvey et al., 2013; Lee et al., 2013b; Pauli et al., 2012). Custom
oligo probes matching these genes were obtained from IDT, and were used in a custom
RNA Nanostring assay.
Total RNA was extracted as described above (subsection 2.2.7), and quality was as-
sessed by performing Agilent RNA 6000 Nano Kit electrophoresis. RNA samples
with RNA Integrity Number above 8 (Agilent BioAnalyzer) were subsequently used
for Nanostring analyses. 100 ng of respective total RNA samples were mixed with
Probe Sets and hybridized according to manufacturers protocols. The RNA samples
were loaded onto Nanostring cartridge via Nanostring consumables by an Nanostring
pipetting robot. Analysis was performed by nCounter Digital Analyzer with maximum
scanning fidelity. Assay-internal negative controls were used for background substrac-
tion, and counts were normalized by Nanostring nCounter software to internal positive
controls as well as to zebrafish-specific normalizer genes. The resulting normalized
counts were used for subsequent analyses.
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2.2.8 Chromatin immunoprecipitation (ChIP)
Preparation of spike-in Lambda Phage DNA
Lambda Phage DNA was used as exogenous DNA added to immunoprecipitated DNA
to allow for normalization of overamplification during sequencing (Figure 4.4). In the
process of library preparation, DNA samples are subjected to size-selection, which
would exclude non-fragmented DNA. To achieve Lambda DNA fragments compara-
ble to fragment sizes obtained by immunoprecipitation protocols, Lambda DNA was
subjected to restriction digest.
DNA was extracted from commercially available DNA ladders, where Lambda Phage
DNA was fragmented by EcoRI+HindIII double-restriction. DNA purification was
performed by Qiagen PCR purification kit according to manufacturers protocols. The
purified DNA was subjected to HincII restriction for 3 hours at 37◦C and subsequent
Tsp45I restriction for 3 hours at 65◦C. Reaction was inactivated by incubation for 10
minutes at 95◦C and gel electrophoresis was performed. From a 1% agarose gel, a
region matching 100-700bp DNA was excised and DNA was extracted by Qiagen Gel
Extraction kit. Successful digest was validated by performing DNA quantification in
fragment sizes of interest by Agilent DNA High Sensitivity kit analysis. For ChIP-Seq
experiments, an amount of fragmented Lambda DNA representing 5% of chromatin
sample was added to immunoprecipitated DNA.
Sonication-based ChIP-Seq
To monitor local enrichment of chromatin features, Chromatin Immunoprecipitation
(ChIP) was performed. To provide enough material for immunoprecipitation, around
1000 embryos of stages up to oblong, and around 500 embryos for later stages were
used. For conventional sonication ChIP, embryos of the respective stage and treatment
were fixed in PBS containing 2% formaldehyde for 15 minutes at room temperature
under regular agitation. Formaldehyde was quenched by adding 1M Glycine (1/8th of
the sample volume) for 5 minutes. Fixed embryos were washed three times with PBS.
Afterwards, embryos were homogenized by pipetting in 1ml ice-cold ChIP Cell Lysis
Buffer containing Protease Inhibitors. While 15 minute incubation on ice, homoge-
nization was repeated regularly by pipetting through a 200ul tip. Cells were collected
by centrifugation at 1300g for 5 minutes at 4◦C, and nuclear lysis was performed by
resuspension in 650ul ChIP Nuclear Lysis Buffer containing Protease Inhibitors. After
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incubation on ice for 10 minutes, lysis was stopped by addition of 1350ul of IP Dilution
Buffer containing Protease Inhibitor. The sample was transferred into a 15ml tube
and subjected to probe-based sonication for a total of 2:45 minutes at 30% amplitude
with one-second pulses of sonication. After sonication, 160ul of 10% Triton X-100
was added to 2ml of chromatin, and the cell debris was precipitated by high-speed
centrifugation of 13000g for 10 minutes at 4◦C. 50ul of the resulting chromatin sample
were used for Input DNA extraction. The chromatin sample was incubated overnight
with respective antibody-coated magnetic beads. The target-bound beads were washed
six times with ChIP Washing Buffer, and once with 1xTBS, while beads were collected
via a magnetic stand. Afterwards, chromatin was eluted from beads by two subsequent
incubation steps with each 150ul of Elution Buffer for 15 minutes at 25◦C. Beads
beads were collected via high-speed centrifugation at 13000g for 5 minutes. Input
samples were filled up to 300ul with Elution Buffer, and 20ul of 5M NaCl was added
to each input and eluate sample. Samples were reverse-crosslinked overnight at 65◦C,
and DNA was precipitated at -80◦C for 2 hours by addition of 800ul 100% Ethanol.
After centrifugation at 13000g for 10 minutes at 4◦C, the resulting DNA pellet was
resuspended in 100ul desalted water, and purified by using the Qiagen MinElute PCR
purification kit according to manufacturers protocol.
DNA was eluted in 12ul TE buffer, from which 1ul was used to quantify DNA content
using the Qubit DNA High Sensitivity kit, and 1ul was used to control for ChIP effi-
ciency by standard qPCR of validated ChIP target regions.
For Next generation sequencing, the calculated amount of fragmented Lambda Phage
DNA (see subsection 2.2.8) was added to the samples, and the whole 10ul were used for
Library preparation and Sequencing according to manufacturers protocols at the Deep
Sequencing Facility of the BioTec, Dresden. Sequencing was performed to a depth of
50 Mio reads of 75bp length, which is twice the amount of data that is recommended
for locally enriched histone modifications (Jung et al., 2014).
MNase-ChIP-Seq
For nucleosome-resolution enrichment analysis of chromatin features, chromatin was
digested by Micrococcal Nuclease (MNase) prior to immunoprecipitation. While the
general procedures were similar to sonication-based ChIP experiments (subsection 2.2.8),
the nuclear lysate preparation and MNase treatment differ. Embryos were fixed in PBS
containing 1% formaldehyde for 5 minutes under constant agitation. Formaldehyde
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was quenched by adding 1M Glycine (1/8th of the sample volume) for 5 minutes. Fixed
embryos were washed three times with PBS. Afterwards, embryos were homogenized
by pipetting in 1ml ice-cold ChIP Cell Lysis buffer containing Protease Inhibitors, and
incubated for 5 minutes on ice with regular homogenization. Cells were collected by
centrifugation at 1300g for 5 minutes at 4◦C, washed once with ice-cold PBS and
collected by centrifugation at 1300g for 5 minutes at 4◦C. The resulting cell pellet
was resuspended in MNase Digestion Buffer in a volume to match one embryo per
microliter. Chromatin samples were divided into 200ul aliquots, and heated to 25◦C
for two minutes. 0.08U of MNase were added to each aliquot of chromatin, and
digestion was performed for 8 minutes for high and oblong samples, 10 minutes for
sphere samples, and 15 minutes for dome samples. MNase activity was stopped by
adding 100ul of MNase Stop Buffer to each aliquot, and pooling aliquots into one
tube. The sample was dialyzed against 250ml Chromatin IP Buffer for 4 hours at 4◦C
using Slide-A-Lyzer dialysis chambers. After dialysis, samples were spun at 13000g
for 10 minutes at 4◦C to separate cell debris, and supernatant was used for chromatin
immunoprecipitation as described before (subsection 2.2.8).
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2.3 Bioinformatics Analyses
2.3.1 Quality control, alignment and peak calling
Raw Sequencing reads were obtained from the Deep Sequencing Facility at the Biotec
Dresden. Reads were demultiplexed and converted to FastQ format by Offline Linux
Basecalling (OLB, version 1.9) and CASAVA (version 1.7) software packages pro-
vided by Illumina Inc. Sequencing quality was assessed for each sequencing experi-
ment by using FastQC (version 0.11.1). Reads were mapped to the zebrafish genome
Zv9/danrer7 (Ensembl release v79, March 2015) using bowtie (version 2.2) with local
alignment (option –local) to allow for soft trimming of reads. Reads that were annotated
to more than one position in the zebrafish genome (’multimappers’) were removed by
only retaining reads with a reported unique mapping. For visualization, a coverage track
from the alignment was built using bedtools (version 2.25) and UCSC wigtobigwig
(version 4). Lambda Phage library size was used to scale samples of different treatment
to allow for direct comparison.
MACS2 (version 2.1) was used to identify enriched genomic regions from the generated
bam files for each sample separately. Sequencing libraries for input chromatin samples
were merged for all stages, to be used as consistent control background sample for peak
calling. The following options were applied:
-g 1.59e9 (genome size); –bdg (report score values); -q 0.01 (q-value cutoff); –nomodel
(no fragment size calculation); –extsize 160 (experimental fragment size).
2.3.2 Lambda normalization
Lambda DNA was added to immunoprecipitated materials to allow for correction of
overamplification during sequencing. Each sample was mapped to Lambda Phage
DNA separately, using bowtie2 as described above. The number of uniquely mapped
reads was reported per sample (’lambda library size’). The lambda library size for
two samples of the same stage were used to calculate the overrepresentation factor
by dividing the two lambda library sizes. This factor was used to scale graphical
representations (bigwig files), and was used during calculation of H3K4me3 enrichment
in the following analyses.
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2.3.3 Differential ChIP enrichment analysis
To identify H3K4me3-positive regions, peak clusters identified by MACS2 were further
merged and filtered. In experiments comparing wildtype and mll-/- fish, peak clusters
of all stages were merged by bedtools (version 2.25), to obtain maximal-inclusive peak
regions. Bedtools and ChipPeakAnno (version 3.7.3) were used to further annotate
peak clusters to the closest gene. The annotated peak clusters were filtered to retain the
peaks within +/-5kb distance to annotated transcription start sites.
For experiments comparing H3HA and K4M overexpression, peak regions of all stages
of H3HA injection were merged by bedtools (version2.25), and only regions retained
that are supported by a peak in at least 3 of 5 samples (custom R script). These regions
were annotated by bedtools and ChipPeakAnno, and further filtered to be within +/-5kb
distance to annotated transcription start sites.
Reads falling within the obtained merged peak regions were counted for each stage. To
analyze differential binding, a fold change calculation was applied based on Pataskar
et al. 2016. To each count, a constant value of 8 was added, to avoid overrepresentation
of low-enrichment regions. Counts were normalized by lambda library size for each
sample, and fold change was calculated by division of normalized read counts for
samples of different treatment.
To allow for filtering of regions with low enrichment, FPKM values for each peak
cluster and sample were calculated by division of read counts with the respective library
size and peak cluster width. Additionally, a p-value to the fold-change was calculated
for each peak cluster based on Bayesian statistics published in Shao et al. 2012.
2.3.4 Data integration
Enrichment for H3K4me3 and H3K36me3 for dome stage, as well as promoter CpG
density were obtained from Zhang et al. 2014. Promoter GC content was calculated
using EMBOSS geecee for regions +/-2.5kb of annotated transcription start sites. For
H2A.z enrichment, data obtained by a sonication-ChIP during the course of this study
was used. Enrichment was calculated for regions +/-2.5kb of annotated TSS based on
Zhang et al. 2014. Datasets were integrated to the results obtained in this study by
matching of gene loci via ENSEMBL gene-IDs.
47
2 Materials and Methods
2.3.5 Gene classification
Genes were classified according to their transcription levels based on Pauli et al. 2012.
Grouping was performed in the following order:
Not transcribed: FPKM value for all stages <1
Zygotic late activated: FPKM value <1 until dome stage earliest, and
FPKM>2 for all subsequent stages
Zygotic early activated: FPKM value <1 until 1k stage, FPKM>4 for any stage
until dome, and FPKM>2 for all subsequent stages
Stable transcript levels: FPKM>2 for all stages, and transcript level covariant
of variation of <30% over all stages
Maternal late degraded: FPKM>2 for all stages until dome, and decreasing
FPKM for later stages
Maternal early degraded: FPKM>2 for all stages until oblong, and decreasing
FPKM for later stages
Maternal late activated: FPKM>2 for all stages until dome, and at least 2fold
increase at any stage later
Maternal early activated: FPKM>2 for all stages until oblong, and at least 2fold
increase at any stage later
Random expression: Genes that do not match any of the criteria above.
Either genes with strong transcript level fluctuations,
or weak expression at random stages.
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HISTONE METHYLTRANSFERASE MUTATION
To investigate the role of histone H3 lysine 4 trimethylation (H3K4me3) in embry-
onic transcription activation, I aimed to interfere with H3K4me3 establishment dur-
ing early zebrafish development. My first approach to achieve H3K4me3 reduction
was to genetically interfere with expression of proteins involved in H3K4me3 estab-
lishment. I generated mutations in genes of the histone methyltransferases (HMT)
mll1 and mll2, as as well as the essential HMT complex component ash2l by TALEN
mutagenesis (section 3.1). I analyzed the generated mutants for resulting phenotypes
(section 3.1) and possible effects on total H3K4me3 levels in zebrafish embryos (sec-
tion 3.2). I further investigated whether mll1 mutation results in locus-specific changes
of H3K4me3 levels in zebrafish embryos (section 3.3). Finally I analyzed whether
changes in H3K4me3 promoter levels resulted in a transcriptional change in mll1 mu-
tant embryos (section 3.4).
3.1 Generation and phenotypic description of histone methyl-
transferase mutants
3.1.1 HMT TALEN mutagenesis workflow
H3K4me3 is absent from early embryos, and is only established during MZT (Linde-
man et al., 2011; Vastenhouw et al., 2010; Zhang et al., 2014). To allow for rapid
H3K4me3 establishment at zygotic genome activation, it is likely that histone methyl-
transferases (HMTs) and their complex partners are maternally provided. Due to a
genome duplication in fish (Postlethwait et al., 2000), orthologs of Mll3 and Mll4 as
well as Set1b are found in two copies in the zebrafish genome. All components of
H3K4-specific HMT complexes have been shown to be ubiquitously expressed through-
out early embryonic development (Pauli et al., 2012; Sun et al., 2008). Among these,
the Set1-orthologs setd1ba, setd1bb and the Trr-ortholog mll3b show weak transcription
levels, while setd1a and mll4b show highest expression levels (Table 3.1).
The establishment of H3K4me3 coincides with transcription activation, and many pro-
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Table 3.1: Expression of COMPASS components in zebrafish embryogenesis
Expression levels were derived from Pauli et al. 2012. Displayed are RPKM values
for transcripts of each gene over early stages until gastrulation (dome stage).
Gene 2-4cell stage 256cell stage 1K stage oblong dome
mll1 13.47 8.95 16.30 9.74 4.31
mll2 32.13 26.09 33.28 28.00 29.28
mll3a 7.03 9.76 16.73 11.16 7.47
mll3b 0.84 2.96 2.96 2.27 1.53
mll4a 115.07 53.17 56.57 36.48 13.06
mll4b 7.70 7.94 9.27 7.65 4.98
setd1a 82.07 55.88 75.25 53.06 35.87
setd1ba 3.68 1.97 3.99 2.53 2.70
setd1bb 0.00 0.01 0.01 0.01 0.01
wdr82 86.23 91.38 62.01 82.97 55.74
ash2l 253.46 95.52 72.22 69.71 32.02
wdr5 77. 46 138.95 108.76 141.89 100.40
dpy-30 377.01 168.99 84.32 168.87 108.40
rbbp5 184.55 77.95 57.24 50.48 15.36
menin1 6.46 2.64 2.44 2.43 0.76
paxip1 134.00 109.75 89.52 93.62 34.95
PA1 132.88 30.66 19.75 17.58 12.33
moter regions are reported to gain H3K4me independent of transcription (Vastenhouw
et al., 2010). Therefore I hypothesized that H3K4-specific HMTs that are able to bind
chromatin independent of transcription are necessary for bulk H3K4me3 establishment
during early zebrafish embryogenesis. While Set1 proteins are thought to be the main
H3K4-specific methyltransferase (Hallson et al., 2012), they have been shown to be
recruited to chromatin via active RNA-Polymerase II (Krogan et al., 2003; Ng et al.,
2003). Mll3 and Mll4 have been reported to be restricted to H3K4 mono-methylation
in vivo. Therefore I decided to target Mll1 and Mll2. Additionally, I chose to target
the essential COMPASS component Ash2l, which is shared by all H3K4-specific HMT
complexes (Cao et al., 2010).
To generate HMT and HMT complex mutants, I targeted the first coding exon of respec-
tive genes for mutagenesis by transcription activator-like effector nuclease (TALEN)
constructs (obtained from the Schier lab, Harvard). TALEN constructs were injected
into one-cell stage embryos, and the resulting fish were screened for mutated alleles by
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T7E1 restriction (see subsection 2.2.2 and workflow in Figure 3.1). To validate germline
Figure 3.1: Description of TALEN mutagenesis A) TALEN constructs were
designed to bind within the first coding exon of targeted genes. TALEN constructs
were injected into one-cell stage zebrafish embryos. Upon expression, they induce
DNA doublestrand breaks that are repaired by non-homologous end joining. B)
TALEN-injected founder fish (F0) were raised to adulthood, and fin biopsies as well
as embryo clutches taken for C) T7E1 mutation screen. PCR products spanning the
putative mutation site were hybridized to wildtype PCR products, and subjected to
T7E1 restriction. This enzyme only digests unpaired DNA, resulting in restricted
DNA if a mutation was induced. D) F1 of mutant Founder fish was raised to
adulthood, and fin biopsies were taken. E) Fin biopsies were screened for mutations
that destroy the coding potential of the targeted genes by Sanger sequencing.
transmission, identified fish fish with mutant alleles were mated with wildtype fish, and
the resulting offspring was screened for mutations by T7E1 restriction. Fish that carried
mutations and that passed these alleles on to their offspring were kept as founders (F0).
TALEN mutagenesis results in DNA double-strand breaks that are repaired by impre-
cise non-homologous end joining. Therefore, each cell within the developing embryo
could harbor mutated alleles, which are different to other cells within the embryo.
Consequently, multiple mutations can be introduced within a single organism, and
founder fish could be mosaic for their mutated alleles. Indeed, I observed up to three
different mutations in offspring from individual founder fish. To obtain a fish line with a
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single mutation, the F1 generation of founder fish was raised to adulthood, and screened
for frameshift-mutations by sequencing of PCR products that span the targeted genomic
locus. For each identified mutation, at least two outcrosses against wildtype were
performed before analysis, to reduce the chance of retaining off-target mutations that
could possibly contribute to phenotypic changes. The identified mutations for genes of
interest are described in the following paragraphs.
3.1.2 Ash2l TALEN mutation does not result in a larval or adult phenotype
Using TALEN mutagenesis, I was able to establish two separate lines with mutations
in the ash2l gene (see Figure 3.2 A):
(1) an 11bp-deletion that deletes the Start codon of ash2l coding sequence (referred to
as ATG deletion), and
(2) an 8bp deletion within the first exon, that results in a frameshift and a premature
stop of the coding sequence within the first exon.
The start codon within the first exon of ash2l is essential to define the full-length protein-
coding sequence of the mRNA. I therefore focused on the mutation that deletes the
start codon for further analyses. Heterozygous ash2l mutant fish did not display any
phenotypic differences. To determine whether homozygous ash2l mutants manifest a
phenotype, I performed an incross of heterozygous fish. Until 5 days post fertilization
(dpf), no phenotypic difference became apparent when comparing homozygous mutant
embryos with their heterozygous siblings and wildtype fish. During further develop-
ment, homozygous mutant offspring did not show phenotypic changes compared to
wildtype fish. The adult fish were fertile and produced viable offspring.
Because zebrafish embryos rely on maternally provided mRNA and protein for their
early development, the presence of maternally-provided RNAs and proteins could com-
pensate for zygotic mutations during early embryonic development (Perrimon et al.,
1984). To study early effects of mutations, it is therefore essential to generate embryos
devoid of wildtype maternal contribution - maternal-zygotic mutants. This can be
achieved by an incross of homozygous-mutant parents. Ash2l mRNA is maternally
provided to zebrafish embryos (Table 3.1; Sun et al. 2008). However, maternal-zygotic
ash2l mutants did not display an early embryonic phenotype, and did not show in-
creased mortality until fertility age when compared to wildtype fish (see Figure 3.2 B).
Thus, deletion of the start codon of zebrafish ash2l does not appear to affect zebrafish
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development.
Figure 3.2: Ash2l TALEN mutations A) Ash2l gene structure, with mutations
within the first exon generated by TALEN mutagenesis. Possible rescueing in-frame
Start codons are indicated. B) Survival curve of wildtype versus ash2l maternal-
zygotic mutants. n = 40. C) Relative expression of ash2l mRNA in ash2l mutants
compared to wildtype embryos at stages around genome activation. n = 4, error bars
= s.d., *** p<0.001
Ash2l is an essential component of all H3K4-specific HMT complexes (Roguev et al.,
2001; Southall et al., 2009), and mutation of ash2l in mouse leads to embryonic lethality
(Stoller et al., 2010). Therefore it is surprising that the here described mutation of ash2l
does not have an influence on zebrafish development. One reason could be that the
deletion of the start codon does not result in a complete loss of functional Ash2l protein
in zebrafish embryos.
RNAs that lose their coding potential can be degraded by nonsense-mediated decay
(Chang et al., 2007). To test whether the introduced mutation results in a loss of ash2l
mRNA, I isolated RNA from maternal-zygotic ash2l mutant embryos at stages before
(512 cell stage) and after genome activation (high and dome stage). I performed RT-
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qPCR on the resulting cDNA with primers specific for ash2l. In mutants, I observed a
reduction of ash2l mRNA to approximately 50% of wildtype RNA levels (see Figure 3.2
C). Thus, even though the deletion of the start codon was validated by sequencing of
cDNA, ash2l mRNA is still produced from the mutated allele. It cannot be excluded
that the remaining RNA retains coding potential. Indeed, ash2l has two in-frame start
codons within the second exon, which encode a truncated Ash2l protein with all known
functional domains. It is important to note that the second mutant line described above
results in a truncated open reading frame that ends before these inframe start codons.
Thus, this mutation will probably not lead to a different outcome than the described
ATG deletion. While no increased larval mortality was observed for these frameshift
mutants as well, further phenotypic tests remain to be performed.
Since mRNA levels are still present in ash2l mutants and could encode for a truncated
protein, it would have been important to test for Ash2l protein levels in ash2l mutants.
I tested two antibodies designed against mouse Ash2l C-terminal domains which has
high homology to zebrafish Ash2l. However, neither of these antibodies could detect
zebrafish Ash2l protein. Therefore it cannot be excluded that a truncated Ash2l protein
from remaining mRNA functionally compensates the introduced start codon deletion
within the ash2l gene. Since ash2l mutation is thought to be detrimental for embryonic
development (LaJeunesse and Shearn, 1995; Stoller et al., 2010), it is likely that the here
described mutations did not result in a complete loss of functional Ash2l protein. Since
the ash2l gene is rich in in-frame ATG througout its gene body, a whole gene deletion
approach would be a better strategy to achieve ash2l mutants. Recent advances in
targeted deletion by homology-guided CRISPR-Cas9 in zebrafish might allow for this
gene deletion approach (Hwang et al., 2013).
3.1.3 Mll2 mutation results in increased larval mortality, while adult fish are
healthy and fertile
By introduction of TALEN constructs targeting the first exon of mll2, I was able to
generate three different gene-disruptive mutations. These mutations were deletions of
different lengths, that all resulted in an early premature stop codon within the first exon
of the coding sequence (Figure 3.3 A).
I focused further analysis on the 5bp frameshift mutation. To analyze potential pheno-
types induced by mutating mll2, I performed an incross of heterozygous F2 fish. No
phenotypic differences became apparent when comparing homozygous mutant embryos
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with heterozygous siblings and wildtype embryos. However, in adult fish, homozygous
mutants were underrepresented, even though there was no apparent adult phenotype.
The fish were fertile and produced viable offspring.
To address whether mll2 is important for embryonic development, I next analyzed
Figure 3.3: Mll2 TALEN mutations A) Mll2 gene structure, with mutations within
the first coding exon generated by TALEN mutagenesis. B) Survival curve of
wildtype versus mll2 maternal-zygotic mutants. n = 65 C) Relative expression of
mll2 mRNA in mll2 mutants compared to wildtype embryos at stages around genome
activation. n = 4, error bars = s.d., *** p<0.001
maternal-zygotic mll2 mutants. Mutant embryos did not show an early developmental
phenotype nor increased mortality until 5 days post fertilization when compared to
wildtype embryos. However, during further larval development, homozygous mutants
showed an increased mortality rate. Only 30% of mutant fish survived until 3 months
post fertilization (Figure 3.3 C). The surviving adult fish did not show significant mor-
phological differences compared to wildtype fish, and were able to produce offspring.
Thus, while mll2 mutation apparently does not lead to defects during embryonic devel-
opment, it seems to make larval devlopment less robust, leading to increased mortality
in the absence of a morphological phenotype.
To test whether the introduced mutation has an effect on mll2 mRNA levels, I performed
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RT-qPCR experiments as described above (subsection 3.1.2). RNA levels of mll2 were
reduced to 10% of wildtype levels in mll2 mutants, suggesting that mRNA is cleared
due to nonsense-mediated decay (Figure 3.3 C). This suggests that similar to mll2 RNA
levels, Mll2 protein is depleted in mll2 mutant embryos as well. Unfortunately, I was
unable to validate the absence of Mll2 protein due to the lack of commercial antibodies
that recognize zebrafish Mll2 protein.
In conclusion, the frameshift mutation within the first exon of mll2 results in an almost
complete loss of mll2 mRNA in maternal-zygotic mutant embryos. Maternal-zygotic
mll2 mutants do not show an early embryonic phenotype, however increased mortality
is observed during larval stages. Taken together, and in contrary to mouse knock-out
studies (Glaser et al., 2009, 2006), mll2 mutation does not lead to embryonic lethality
and infertility. Instead, mll2 mutant embryos develop normally, but increased mortality
during larval development is observed, while escapers do not manifest an apparent adult
phenotype and are able to produce fertile offspring.
3.1.4 Mll1 mutation results in increased larval mortality and a severe adult
phenotype
Using TALEN mutagenesis, I generated two different frameshift mutations for mll1
within the first exon. These mutations lead to a premature stop codon within 60 base-
pairs of the coding sequence (Figure 3.4 A). In addition, I obtained an mll1 mutant
(sa137) generated by the Wellcome Trust Sanger Institute. This mutation was generated
by treatment of zebrafish embryos with N-ethyl-N-nitrosourea (ENU), followed by a
sequencing-based screening for knock-out alleles of annotated protein-coding genes
(Kettleborough et al., 2013). The obtained point mutation in mll1 results in a premature
stop (TGG to TGA) of the protein coding sequence in exon 10. Therefore, the resulting
mRNA encodes a truncated Mll1 protein that contains DNA binding domains, but
neither protein interaction domains that are necessary for complex formation, nor the
enzymatic active C-terminal SET-domain (mutant sa137, Figure 3.4 A).
For further analysis, I focused on analyzing the Sanger mutation. To analyze a possible
phenotype resulting from mll1 mutation, I performed an incross of heterozygous mu-
tants. Homozygous mutant fish were severely underrepresented in several incrosses of
heterozygous mutants. The escapers displayed a severe phenotype, which manifests
in an overall smaller size, small waist circumference and an atypical yellow color
(Figure 3.5). While heterozygous mutant fish were viable and fertile, homozygous
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mutants died before reaching fertility age. This suggests that mll1 is essential for
zebrafish larval development.
Figure 3.4: Mll1 mutations A) Mll gene structure, with sequences generated by
TALEN mutagenesis within the first coding exon (below gene), as well as Sanger
point mutation within exon 10, leading to a premature stop codon (above gene). B)
Survival curve of wildtype versus mll1 maternal-zygotic mutant embryos. n = 110 C)
Relative expression of mll1 mRNA in mll1 mutants compared to wildtype embryos
at stages around genome activation. n = 4, error bars = s.d., * p<0.05, *** p<0.001
To analyze whether mll1 is also involved in early embryonic development, I next set out
to generate maternal-zygotic mutants. Since raising homozygous mutant fertile fish was
not possible due to the severe adult phenotype, I performed germline transplantation
(described in (Ciruna et al., 2002)). This technique allows for the introduction of
homozygous-mutant germline progenitors into wildtype embryos where germline pro-
genitor development was ablated (see subsection 2.2.5). In spite of germline transplanta-
tion carrying the mll1 mutation, these fish developed without phenotypic abnormalities,
57
3 Results I: H3K4me3 interference by Histone methyltransferase mutation
and reached fertility age. To test whether germline replacement was successful, these
fish were incrossed and the resulting offspring screened for giving rise to homozy-
gous mutant embryos. Using this technique, I was able to generate both germline-
transplanted fertile males and females (16 and 3, respectively).
To validate that germline-transplanted females do not contribute wildtype mRNA cod-
ing for mll1 to their offspring, I tested whether RNA in maternal-zygotic embryos con-
tains the mutation. I extracted mRNA from maternal-zygotic mutants, and performed
a PCR for mll1 on the resulting cDNA. The obtained PCR products from stages before
and after genome activation were sequenced, and confirmed that no wildtype RNA was
present in these embryos.
Next I tested whether mll1 mutation leads to clearance of the respective mRNA by
nonsense-mediated decay. I performed RT-qPCR experiments as described above (sub-
section 3.1.2). While mll1 RNA levels were not significantly changed before genome
activation (512 cell stage), RNA was reduced to approximately 50% of wildtype levels
in mll1 mutants at stages post genome activation (Figure 3.4 C). This suggests that the
mRNA might be partly subjected to nonsense-mediated decay during later stages of
development.
The analyzed Sanger mutation results in a premature stop codon, that allows for the
expression of a truncated N-terminal protein. However, while this protein still contains
domains involved in DNA association, it lacks essential domains to form an enzymatic
functional complex, and lacks the enzymatic active Set1-domain. In order to validate
the absence of Mll1 protein with H3K4 methylation activity, I obtained two different
antibodies that were raised against C-terminal domains of mouse Mll1 protein with high
homology to zebrafish Mll1. However, both antibodies failed to detect a specific band
at the expected height in zebrafish embryos. Therefore no validation of the absence
of the protein could be performed. Thus it is possible that two truncated versions of
Mll1 are made, one each for the N-terminus and the C-terminus. It cannot be excluded
that functional complexes are assembled with truncated Mll1 proteins. Further efforts
should focus on validating the absence of the Mll1 C-terminal protein in zebrafish
mutant embryos, either by raising a zebrafish-specific antibody, or by targeted Mass-
Spectrometry.
Next I set out to determine whether maternal-zygotic mutants show an early embry-
onic phenotype. I focused on analyzing morphological differences in embryonic de-
velopment until bud closure. I was unable to observe any differences in embryonic
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Figure 3.5: Mll1 mutation results in a severe adult phenotype A) Zebrafish
embryo body shape at 48hpf. Left figures from Wan et al. 2011, wildtype (top) and
mll1 Morpholino-treated (bottom); right figures from this study, comparing wildtype
(top) and mll1 maternal-zygotic mutants (bottom). n = 60. B) Brain development
in 48 hpf embryos. Left figures from Huang et al. 2014, wildtype (top) and mll1
Morpholino-treated (bottom); right figures from this study, comparing wildtype (top)
and mll1 maternal-zygotic mutants (bottom). White arrowheads indicate midbrain-
hindbrain boundaries. n = 14. C) Adult zebrafish at 4 months age. Top, wildtype
male; bottom, mll1 maternal-zygotic mutant. D) Heart rate in anesthetized fish at 48
hpf. n = 12, error bars = s.d., p = 0.007
morphology over the first 12 hours of development (data not shown). Additionally, I
assessed larval morphology at 24 hpf and 48 hpf. However, maternal-zygotic mutants
were indistinguishable from wildtype mutants in general morphology, but also in em-
bryonic brain structures (see Figure 3.5). Mll1 mutants developped without any obvious
morphological phenotype until 5 dpf. These results are contradictory to previous knock-
down experiments using synthetic oligonucleotides (Morpholino). Interference with
mll1 expression by two different Morpholinos resulted in severe defects during early
embryonic development. At 24 hpf and 48 hpf, zebrafish injected with mll1 Moropholi-
nos displayed an abnormal body shape with a kinked tail. Furthermore, phenotypic
differences in brain folding (Huang et al., 2014) as well as a significant reduction in
embryonic hematopoiesis were observed (Wan et al., 2011). However, recently it was
reported that embryonic phenotypes described by Morpholino injections are seldom
recapitulated in maternal-zygotic mll1 mutants, suggesting that the previously described
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phenotypes of mll1 knock-down might have been the result from off-target effects (Kok
et al., 2014).
Even though no apparent phenotype could be observed in early embryonic development,
severe premature death was observed in maternal-zygotic mutants from 2 weeks of
development onwards, with no mutant fish developing to fertility age (Figure 3.4).
Interestingly, the onset of increased mortality coincides with the time when zebrafish
larvae become dependent on blood circulation to provide the body with oxygen. To
understand whether defects in blood circulation could be the cause for increased lar-
val mortality, I analyzed the heart rate of zebrafish embryos at 28 hpf, when blood
circulation is fully established. I mounted embryos for imaging in Zebrafish medium
containing Tricaine, a drug that blocks signal transduction in motor neurons and thus
prevents larval movement. Interestingly, the heart rate of mll1 mutants was reduced by
35% compared to wildtype fish of the same age (Figure 3.5 C). In rare occassions (1 out
of 20 observed fish), the embryonic heartbeat became asynchronous, with sometimes
no heartbeat for up to one minute before resuming to slower, synchronous heartbeat
again. These observations indicate that maternal-zygotic mll1 mutants might have a
weakened heart that could result in heart failure and ultimately death during later larval
development.
Together, these results show that mll1 is dispensable for early embryonic development.
However, mll1 mutants die during larval development from 5 days post fertilization, and
do not reach fertility age. While the molecular mechanism remains to be understood,
initial observations suggest that mll1 mutants display heart failures from 1 day post
fertilization onwards.
3.2 HMT mutations do not affect global H3K4me3 levels in early
zebrafish embryos
H3K4me3 is absent from early zebrafish embryos, and is established during genome
activation (Lindeman et al., 2011; Vastenhouw et al., 2010; Zhang et al., 2014). To
robustly establish H3K4me3, zebrafish embryos thus rely on the presence of HMT
complex proteins. Therefore I hypothesized that ash2l knock-out results in strong
reduction of H3K4me3 levels, as was shown in mouse embryonic stem cells (Wan et al.,
2013). Furthermore, since H3K4me3 is also found at genes that are not transcriptionally
active (Vastenhouw et al., 2010), I hypothesized that Mll1 and Mll2 are involved in
establishment of H3K4me3 during early embryonic development.
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Figure 3.6: HMT mutation does not result in reduction of global H3K4me3 levels
A) A representative Western Blot of oblong, sphere and dome stages comparing
wildtype H3K4me3 levels to levels in ash2l and mll2 mutant embryos. Tubulin serves
as loading control. ash2l sphere stage shows reduced protein content by Tubulin
blotting. B) As in A) comparing mll1 maternal-zygotic mutants to wildtype embryos.
To screen for global H3K4me3 reduction in HMT mutants, I performed Western Blot
analyses at different stages after genome activation. I chose to test H3K4me3 at ob-
long stage, the earliest stage after genome activation when H3K4me3 can be detected,
and the following two developmental stages, sphere and dome. H3K4me3 levels in
maternal-zygotic mutants at oblong stage are barely detectable, and do not allow for a
conclusion about H3K4me3 reduction. At sphere and dome stages, H3K4me3 levels did
not show significant differences for any of the mutations when compared to H3K4me3
levels in wildtype embryos (representative Western Blot see Figure 3.6).
The unchanged H3K4me3 levels in ash2l mutants could be explained by a possible trun-
cated protein produced in the here used TALEN mutants (subsection 3.1.2). However,
the reduction of RNA levels and the abrogated coding potential of mll and mll2 mutant
mRNA suggest against a functional rescue from remaining RNA in these mutants. One
possible explanation is that other H3K4-specific HMT are functionally redundant to the
mutated genes. Mll1 and Mll2 share the same complex components, and thus could
compensate for their mutual loss (Dou et al., 2006; Miller et al., 2001; Yokoyama et al.,
2004). Indeed it has been shown that loss of Mll1 in mouse cell culture experiments
results in changes of less than 5% of all genes (Wang et al., 2009; Yu et al., 1998).
Furthermore, a recent study found that loss of Mll1 is compensated by the presence of
other HMTs, and thus is dispensible for H3K4me3 establishment in mouse embryonic
stem cells (Denissov et al., 2014). However, the same study has shown that Mll2 has
a unique role in establishing H3K4me3 at bivalent promoters. Thus, even though Mll2
and Mll1 seem not to be involved in global H3K4me3 establishment in zebrafish, they
might be uniquely responsible for local H3K4me3 establishment at a subset of genes.
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To identify local changes of H3K4me3 against global unchanged H3K4me3 levels,
Western Blotting is not sensitive enough. Thus, the question of whether loss of HMT
results in local changes of H3K4me3 levels in a distinct set of genes has to be analyzed
by other experimental approaches.
3.3 Mll1 mutation results in local H3K4me3 reduction of a small
subset of genes
To identify specific promoters whose H3K4me3 levels may be affected by mll1 muta-
tion, I performed Chromatin immunoprecipitation followed by Deep Sequencing (ChIP-
Seq). In ChIP-Seq experiments, proteins were covalently crosslinked to DNA. The
crosslinked material was subjected for Micrococcal nuclease (MNase) digestion, which
restricts accessible DNA and results in chromatin fragmentation to nucleosomal size.
Next, immunoporecipitation with antibodies specific for H3K4me3 allowed for the
enrichment of nucleosomal regions marked with H3K4me3. The crosslinked DNA was
purified and subjected to Next-generation sequencing, which allowed for the identifica-
tion of genomic regions enriched for H3K4me3. The resulting DNA was sequenced to
a depth of 50 million reads of 75 bp length, which is twice the recommended sequenc-
ing depth for this histone modification (Jung et al., 2014). These experiments were
performed in parallel for wildtype and maternal-zygotic mll1 mutant embryos for two
developmental stages:
(1) Oblong stage, when less than 10% of zebrafish genes are actively transcribed, but
H3K4me3 is already detectable, and
(2) Dome stage, when H3K4me3 is present on more than 60% of all genes (Zhang et al.,
2014).
Because active transcription can result in local H3K4me3 establishment (see subsec-
tion 1.3.1, Miller et al. 2001; Ng et al. 2003), it is important to analyze oblong stage.
At this stage, most genes are not transcribed yet, thus transcription would contribute to
H3K4me3 establishment at a small set of genes. Analyzing dome stage allows for the
analysis of the dynamics of H3K4me3 establishment during embryonic development.
Furthermore, the two different stages serve as biological replicates to identify regions
specifically affected by mll1 mutation. To account for the quantitative differences in
cell number - and thus target DNA for immunoprecipitation - between these stages, I
performed ChIP on 1200 embryos at oblong stage, and 400 embryos at dome stage.
H3K4me3 has been shown to be enriched at promoter regions, but depleted from most
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enhancers, where H3K4me1 is found (Barski et al., 2007; Heintzman et al., 2009).
To analyze whether the H3K4me3 is enriched at promoters in zebrafish development,
I plotted the density of obtained sequencing reads over annotated gene bodies. As
expected, a strong enrichment of H3K4me3 at transcription start sites (TSS) was ob-
served, both for oblong and dome stage (Figure 3.7 A and B). H3K4me3 enrichment
was generally higher at dome stage. Next I only considered the region of +/-3kb around
TSSs. Interestingly, read enrichment was slightly higher in mll1 mutants compared
to wildtype samples (Figure 3.7 C and D). It can be excluded that this is a bias in
general higher read number in mll1 mutant samples, as read density was normalized to
uniquely mappable reads. Furthermore, in both stages H3K4me3 levels are higher in
mll1 mutants, suggesting that it is a reproducible observation. However the difference
in H3K4me3 enrichment is rather small. The density plot does not allow to speculate
whether this increase is due to more H3K4me3 at all loci, or whether a gain in otherwise
H3K4me3-negative TSSs accounts for the observed difference.
I further tested for H3K4me3 enrichment at enhancer elements. I extracted zebrafish-
specific enhancer regions from a recent study that used chromatin modifications for
de novo annotation of putative enhancers (Bogdanovic et al., 2012). However,while a
slight enrichment of H3K4me3 could be found, these levels are marginal when com-
pared to average enrichment at transcription start sites (Figure 3.7 E and F). Thus I
conclude that H3K4me3 is preferentially enriched at promoter elements, as described
before (Barski et al., 2007; Zhang et al., 2014), and mll1 mutation leads to slightly
higher H3K4me3 levels at promoter elements.
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Figure 3.7: H3K4me3 is enriched at promoters in wildtype and mll1 mutant
embryos Metagene profiles displaying enrichment of ChIP-Seq reads for input
chromatin (black), wildtype (blue) and mll1 mutant (red) H3K4me3 ChIP-Seq
samples over different genomic locations. A,B) H3K4me3 enrichment over gene
bodies of annotated zebrafish genes at oblong and dome stage, respectively. C,D)
H3K4me3 enrichment at TSS +/- 3kb at oblong and dome stage, respectively. E,F)
H3K4me3 enrichment over enhancer regions (Bogdanovic et al., 2012) at oblong and
dome stage, respectively. Plot scaled to TSS enrichment.
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Identification of H3K4me3-reduced loci in mll1 mutant fish
Next I analyzed whether H3K4me3 levels at specific promoter regions are affected
by mll1 mutation. To determine quantitative differences in H3K4me3 enrichment, I
tested previously established bioinformatics tools (reviewed in Steinhauser et al. 2016).
However, none of these tools were applicable to the here obtained data. First, most
of the tools are designed for transcription factor ChIP, thus they rely on locally more
defined binding profiles than achieved histone modification ChIP data. Second, many
tools rely on the presence of replicates to estimate biological variation between similar
data. While I included two different stages in my experimental design, their general
H3K4me3 enrichment varies dramatically, since H3Kme3 becomes increasingly es-
tablished. Thus, samples of different stages cannot be treated as replicates, correct
estimation of biological variation cannot be performed.
Instead of using published tools, I implemented a custom fold change analysis, that
uses predefined regions of interest to identify differentially bound regions in each stage
individually.
I excluded reads mapped to multiple positions from further analyses, as these cannot be
confidently included into locus-specific quantification of H3K4me3 enrichment. The
remaining reads were used to identify enriched regions for H3K4me3 (called ’peaks’
from now on) by using the peak calling tool MACS2. Next I merged overlapping peaks
from all obtained samples, and filtered for regions in +/-5kb distance to annotated TSS.
I then counted sequencing reads falling into identified H3K4me3-positive regions, and
normalized these counts by the sample-specific read library size (the number of all reads
mapping to the zebrafish genome). The fold change ratio was calculated between wild-
type and maternal-zygotic mll1 mutant samples from the same stage at each genomic
region. In total, 20,625 H3K4me3-positive regions were compared between wildtype
and mll1 mutants.
At oblong stage, 10% of those regions showed increased H3K4me3 levels, while
1.8% were decreased in H3K4me3 levels (Figure 3.8 A). At dome stage, only 0.98%
showed increased H3K4me3 levels, while only 0.54% have decreased H3K4me3 levels
(Figure 3.8 B). Since I hypothesized that mll1 mutation leads to reproducible changes
at specific loci, I consider regions as true target, if one region is significantly reduced
(or increased) in H3K4me3 levels at both developmental stages. However, only 8 out
of 20265 analyzed promoter regions show reduced H3K4me3 levels at both stages
(Figure 3.8 C). In contrast, and opposite to my expectations, 40 of the changed re-
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Figure 3.8: Fraction of promoters with changes in H3K4me3 levels Depicted are
the fractions of H3K4me3-enriched regions that are unchanged (grey), more than
2fold increased (red) or more than 2fold decreased (green) in mll1 mutants when
compared to wildtype samples. H3K4me3-positive regions within 5kb of annotated
TSS were considered. A) Oblong stage, B) Dome stage and C) Fractions of regions
that show the same trend in both stages.
gions in both stages show higher H3K4me3 peaks at promoter regions in mll1 mutants.
These results indicate, that H3K4me3 levels are rather increased than decreased in mll1
mutants, however most of H3K4me3 regions do not change significantly in maternal-
zygotic mll1 mutant embryos.
In conclusion, ChIP-Seq analysis revealed that only a small subset of zebrafish pro-
moter regions displayed a change in H3K4me3 levels (12% at oblong and 1.5% at
dome). Interestingly, H3K4me3 levels seem to be rather increased than decreased, both
genome-wide (Figure 3.7) as well as on specific promoters (Figure 3.8). It is possible
that the loss of Mll1 allows for more efficient recruitment of other H3K4-specific HMTs
to these targeted loci. Alternatively it is possible, that shared HMT complex proteins
are free to be recruited to other H3K4-specific HMT complexes, and thus stimulate their
H3K4me3 activity. It is further possible that functions of Mll1 are redundant to other
HMTs (as described in section 3.2).
While the original aim - to significantly reduce H3K4me3 levels at many promoters
- was not achieved, the presence of a subset of promoters significantly changed in
H3K4me3 levels allowed for further investigation of the role of H3K4me3 in their
transcription activation.
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3.4 Early embryonic transcription is not altered in mll1 maternal-
zygotic mutants
Mll1 mutation did not lead to a reduction of H3K4me3 levels at many genes in early
embryos. However, I was able to identify changes in H3K4me3 levels at individual
promoters. To understand whether these changes in H3K4me3 levels result in changes
in transcriptional activity, I analyzed the onset of transcription of chosen target genes.
H3K4me3-affected genes do not alter their transcription levels
Of eight genes that had significantly reduced H3K4me3 levels in mll1 mutant embryos,
only efna1b is actively transcribed during early embryogenesis. Four of the other genes
were not transcribed until 24 hpf, while three others were maternally provided and
show decreasing transcript levels in early zebrafish embryos. To increase the number
of genes that could be studied, I included two genes that showed significantly increased
H3K4me3 levels at promoters in maternal-zygotic mll1 mutants. These should show
the opposite trend in transcriptional output compared to efna1b, thus might show higher
transcription levels in mll1 mutants. I extracted RNA at 6 stages post genome activation,
when the respective genes become transcribed. I performed RT-qPCR on the resulting
cDNA with primers targeting the last coding exons of the chosen target genes. Expres-
sion levels were normalized to eif4g2a, a gene that shows stable expression throughout
zebrafish embryonic development. When comparing the relative expression levels for
each of the genes, no significant difference in mRNA abundance could be seen for any
of the three genes at all stages (Figure 3.9). Thus, changes in H3K4me3 levels seem
not to influence transcription activation of respective genes in mll1 mutants.
Genes activated during maternal-zygotic transition are not affected by mll1
mutation
Mll1 mutation resulted in changes of H3K4me3 levels in a small subset of genes (Fig-
ure 3.3). These changse in H3K4me3 levels did not result in transcriptional changes of
the respective genes (section 3.4). However, I observed larval mortality and a severe
adult phenoptype in escapers (subsection 3.1.4). These results suggest that the larval
phenotype of mll1 mutants might not be caused by the loss of H3K4me3 establishment,
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Figure 3.9: Change of H3K4me3 levels in mll1 mutants does not affect transcrip-
tion Relative expression levels of efna1b (A)(reduced H3K4me3 in mll1 mutants),
skib (B) and slc30a1a (C) (both increased H3K4me3 in mll1 mutants) to normalizer
gene eif4g2a from dome to 70% epiboly. n = 3, error bars = s.d.
but by other molecular mechanisms. Several studies in mouse have shown that deletion
of the enzymatic functional Set1-domain of Mll1 does not recapitulate phenotypes of
full mll1 knock-out (Jude et al., 2007; Mishra et al., 2014; Terranova et al., 2006).
To address whether mll1 mutation has an influence on embryonic transcription acti-
vation, I applied an RNA-quantification assay from NanoString Technologies. This
technology allows for direct quantification of multiple specific RNA molecules in par-
allel, while not being disturbed by the abundance of other RNAs that are not of interest
for the respective assay. It is based on immobilization of target RNAs by synthetic
oligonucleotide probes, and subsequent fluorescent labelling of individual RNAs by
specific fluorescent probes (Geiss et al., 2008).
To quantify transcriptional changes during zebrafish development, I focused on genes
that are not maternally provided, but are activated early during zebrafish development
(termed ’zygotic genes’). This allows for the detection of subtle changes in transcription
activation that is solely influenced by processes in the developing embryo. Together
with Mate Palfy from our lab, I chose 84 zygotic genes by integrating transcription
data from four different studies (Aanes et al., 2011; Harvey et al., 2013; Lee et al.,
2013b; Pauli et al., 2012). To control for differences in sample RNA quantity, we
further included 12 ’normalizer genes’ that show stable transcription throughout early
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embryonic development until gastrulation stages. We included genes with different
stable transcript levels to account for possible biases in transcription analysis based on
RNA abundance.
To test whether mll1 mutation has an influence on early transcription activation, I per-
Figure 3.10: Transcription of early activated genes is not changed upon mll1
mutation Depicted are scatterplots comparing mRNA counts of 84 zygotic genes in
wildtype (x-axis) and mll1 mutant (y-axis) samples. (A) Oblong and (B) dome stage.
RNA quantification was performed by custom NanoString assays.
formed the described NanoString analyses comparing RNA samples from wildtype and
mll1 mutant embryos on six subsequent stages at zygotic genome activation (512cell
to dome stage). Correct staging between mutants and wildtype was controlled by cell
number counting at each stage by whole-embryo fluorescent microscopy.
RNA counts obtained by NanoString analysis were normalized over internal standards
and the normalizer genes. Counts for wildtype and mll1 mutants were compared at all
stages. As expected, RNA counts gradually increased from 512cell stage to dome stage
for all zygotic genes, confirming that the chosen target genes are indeed transcription-
ally activated during early embryonic development.
To identify transcriptional differences, I plotted normalized count values for wildtype
samples against mll1 mutant samples in a scatterplot with logarithmic scale. Examples
for oblong and dome stage are shown in Figure 3.10, which are the stages that were
chosen for H3K4me3 ChIP-Seq experiments. No significant difference could be ob-
served for any of the analyzed stages. While at individual stages, a few genes seem
to be affected, these changes were not reproducible over other developmental stages,
suggesting that mll1 mutation has no influence on zygotic genome activation. Further
detailed, genome-wide transcription analysis are necessary to identify, whether specific
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target genes are affected by mll1 mutation.
3.5 Conclusion
Concluding this chapter, I established maternal-zygotic mutant zebrafish for ash2l, mll2
and mll1. Ash2l mutation did not result in phenotypic differences compared to wildtype
fish, possibly due to the expression of an N-terminal truncated, yet functional protein
from the remaining mRNA. Both mll1 and mll2 mutation resulted in increased larval
mortality, while early embryonic development occured without phenotypic dfferences,
suggesting for their importance in zebrafish larval development. However, none of the
mutations led to global reduction of H3K4me3 levels. Thus, the here generated mutants
do not allow to assess the influence of H3K4me3 on transcription activation during early
embryonic development. I therefore decided to reduce H3K4me3 levels by introduction
of inhibitors of H3K4me3 establishment in early zebrafish embryos.
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Genetic ablation of the histone methyl transferases mll1, mll2 and the complex com-
ponent ash2l did not result in global changes of H3K4me3 levels, and in mll1 mutants
only few loci with changed H3K4me3 levels could be observed.
Because these genetic interference approaches did not allow me to analyze the role of
H3K4me3 in zebrafish embryonic genome activation, I set out to identify a method that
inhibits genome-wide establishment of H3K4me3 in zebrafish embryos.
I established a Western Blot assay to identify global changes in H3K4me3 levels (sec-
tion 4.1) and used it to test the efficiency of different H3K4me3 interference approaches
(section 4.2, section 4.3, section 4.4). Introduction of H3K4-methylation-defective
K4M histones was identified as a method to drastically reduce global H3K4me3 levels
(subsection 4.4.2). I analyzed the resulting H3K4me3 reduction genome-wide by com-
parative ChIP-Seq experiments (section 4.5). Finally I analyzed whether local changes
in H3K4me3 promoter levels have an effect on transcription activation during early
zebrafish development (section 4.6).
4.1 Establishing a Western Blot assay to monitor H3K4me3 re-
duction
In order to achieve global H3K4me3 reduction, I applied different strategies. These
follow a similar scheme: (I) Interfering constructs were injected into dechorionated
one-cell stage embryos, (II) controlling for equal developmental progression, and (III)
assessing the effect of interfering constructs at stages shortly after genome activation
(Figure 4.1). To test for the effectiveness of H3K4me3 interference, I established a West-
ern Blot assay. H3K4me3 is established during genome activation, and levels rapidly
increase during embryonic development. As shown in Figure 4.1, H3K4me3 levels
significantly change even within 15 minutes of developmental progression. Therefore,
differences in H3K4me3 levels between samples might erroneously be due to misstag-
ing rather than due to experimental treatment. Thus, precise staging is very important to
identify successful H3K4me3 reduction. However, small staging differences between
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treatment cannot be excluded. Thus, I developed a strategy to stage-match samples of
different treatments during analysis. I probed for the histone modification H3K9me3
in parallel to H3K4me3. H3K9me3 is established during zebrafish development with
similar dynamics as H3K4me3, but should not be affected by interference with H3K4-
specific methylation establishment (Figure 4.1). To probe for H3K4me3 reduction,
20 embryos of each sample were deyolked and subjected to Western Blotting on two
separate denaturing protein gels at selected developmental stages. The resulting blots
were probed for H3K4me3 and H3K9me3, respectively. H3K9me3 levels were used
to identify samples of the same developmental stage, before H3K4me3 levels were
compared between different treatments. H3K4me3 interference approaches were con-
sidered successful if a reduction of >50% in H3K4me3 levels was achieved.
Figure 4.1: Western Blot assay to monitor H3K4me3 reduction A) Embryos were
injected at the one-cell stage with respective constructs, and left to develop until
genome activation (1000cell stage). A sample of 20 embryos per stage and treatment
was taken every 15 minutes until dome stage. Samples were split in half and used
for Western blotting on two separate denaturing gels to probe for H3K9me3 and
H3K4me3 in parallel. B) Western Blot results for H3K4me3 and H3K9me3 over
developmental time. A sample of 10 wildtype embryos was used per lane. Tubulin
and H3 serve as controls for equal loading, H3K4me3 and H3K9me3 were probed on
separate denaturing gels.
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4.2 Overexpression of H3K4-specific histone demethylases does
not result in global H3K4me3 reduction
In contrast to other histone modifications, H3K4me3 is biochemically robust and re-
moval relies on active processes (Byvoet et al., 1972; Duerre and Lee, 1974). Recently,
specific histone lysine demethylases (KDM) were found to remove H3K4me3 from its
genomic targets, thus counteracting H3K4me3 establishment (Seward et al., 2007; Shi
et al., 2004). In vertebrates, four different isoforms of the H3K4-specific KDM5 family
are known (Iwase et al., 2007). To remove newly established H3K4me3 in zebrafish
embryos, I obtained constructs encoding each of the four KDM5 homologs found in
mouse (KDM5 A through D), which were found to reduce global H3K4me3 levels
in mouse stem cell cultures (Bieberstein et al., Neumann et al., unpublished). To
monitor for successful expression, KDM5 constructs were subcloned and fused with
an N-terminal Flag-tag.
To analyze whether overexpression of KDM5 constructs resulted in H3K4me3 reduc-
tion, I injected in vitro-transcribed RNA from respective KDM5 constructs into dechori-
onated one-cell stage embryos. Samples of uninjected embryos were taken as wildtype
control. To control for effects resulting from RNA injection alone, I used RNA coding
for GFP with nanos-3’UTR, which should not be involved in H3K4me3 establishment.
For each KDM5 construct, 3 biological replicates of the described Western blot assay
were performed over multiple stages. However, when comparing H3K4me3 levels
between uninjected, mock RNA-injected and KDM5-injected embryos, neither of the
four mouse KDM5 constructs alone resulted in a significant reduction of H3K4me3
levels during early embryogenesis (Figure 4.2 A and B).
It is possible that the four KDM5 isoforms have different DNA recruitment mechanisms.
Therefore overexpression of one KDM5 isoform could result in local demethylation at
a subset of genes. To test whether a combination of KDM5 isoforms results in global
H3K4me3 reduction, I overexpressed a mix of all for mouse KDM5 isoforms. However,
injecting a KDM5 construct mix did not result in significant reduction of H3K4me3
levels either (Figure 4.2 C).
Because KDM5 recruitment could be regulated by species-specific mechanisms, it is
possible that mouse KDM5 proteins were unable to demethylate H3K4me3-marked
regions in zebrafish embryos. I therefore I obtained a construct coding for zebrafish
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Figure 4.2: Global levels of H3K4me3 are not affected by KDM5 overexpression
or injection of N-terminal histone tails Representative results from Western Blot
assays for H3K4me3 reduction. Each lane represents a sample of 10 embryos.
H3K9me3 serves as staging control, Tubulin and H3 serve as loading control between
samples. A-C) Comparison of uninjected and mock RNA (GFP with nanos-3’UTR)
injection samples with overexpression KDM5A and KDM5B (A), KDM5C and
KDM5D (B) or overexpression of zebrafish KDM5Bb and a mix mouse KDM5
construct overexpression samples (C). For each construct, 1 ng of RNA was injected.
D) Representative Western Blot comparing uninjected samples to samples injected
with mock protein (BSA, 100 ng) and injection of 50 ng and 100 ng of inhibitory
N-terminal H3 peptide.
KDM5Bb from the Schier lab at Harvard. I subcloned the coding sequence of KDM5Bb
and fused an N-terminal Flag-tag to the coding sequence. I used the resulting in
vitro-transcribed RNA to perform the Western Blot reduction assay as described above.
However, overexpression of zebrafish KDM5Bb did not result in global H3K4me3
reduction when compared to uninjected and mock RNA injected embryos.
From these results I conclude that overexpression of KDM5 constructs is not a valuable
strategy to achieve global H3K4me3 reduction in early embryos. There may be several
reasons for this. First, although overexpression of these constructs could be confirmed
by the presence of Flag-tagged proteins of the expected height, their levels might be
too low to achieve efficient reduction of H3K4me3 levels. Additionally, the presence
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of the protein monitored by Western Blotting does not allow for the conclusion that
this protein is fully functional in the embryo. It cannot be excluded that the short time
from RNA injection to collection of samples for monitoring of H3K4me3 interference
(approximately 4 hours) is too little to allow for complete protein folding of these large
proteins (>150kDa). Finally, while it has been shown that KDM5 proteins have chro-
matin binding domains (Liu and Secombe, 2015), it is possible that they need further
complex partners to achieve efficient H3K4me3 demethylation in zebrafish embryos.
4.3 Global reduction of H3K4me3 could not be achieved by small-
molecule inhibition of HMT activity
H3K4me3 establishment relies on the recognition of histone H3 Lysine 4 by specific
histone methyl transferase complexes, and the transfer of a methyl-group from the co-
substrate S-Adenosyl-methionine (SAM) to the lysine side chain. HMT specificity
towards H3K4 is achieved by binding to the protein N-terminus of H3, as well as to
amino acids in close vicinity to lysine 4.
To achieve reduction of H3K4me3 levels, I attempted to inhibit H3K4-specific HMTs
by competing with histone H3 substrate binding. To that end I obtained a peptide
that is equal to the 8 N-terminal amino acids of H3 from GenScript. I injected 50
and 100 ng N-terminal peptide into 1-cell-stage embryos. These amounts represent
57- and 115-fold excess of inhibitory peptide compared to H3 protein levels in the
zebrafish embryo, respectively (100 ng peptide are 6.46 ∗ 1013 molecules, while ze-
brafish embryos contain 5.58 ∗ 1011 H3 proteins; Joseph et al., in preparation). Peptide-
injected embryos were subjected to the Western Blot assay described above. As a
control for possible erroneous effects of protein injection, 100 ng of BSA was injected.
Protein injection itself seems to have an influence on H3K4me3 establishment, as
peptide-injected as well as BSA-injected embryos show lower levels of H3K4me3 (one
representative blot shown in Figure 4.2 D). However, when comparing peptide-injected
embryos to BSA-injected embroys, no significant change in H3K4me3 levels could
be observed over three biological replicates. Higher amounts of protein could not be
injected without causing developmental defects both in peptide-injected as well as BSA-
injected embryos. Thus, competitive inhibition of H3K4me3 establishment by peptides
was not successfull to achieve H3K4me3 reduction.
Another strategy to inhibit enzymatic activity is to introduce cofactor analogues. How-
ever, SAM is a widely used co-metabolite that is not only used in H3K4-methylation,
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but also in other protein methylation processes, as well as for DNA methylation and
multiple metabolic pathways (Etchegaray and Mostoslavsky, 2016; Kalhan and Mar-
czewski, 2012; Moussaieff et al., 2015). Thus, interference with SAM is not a promis-
ing strategy to specifically interfere with H3K4me3 establishment. Recently, two H3K4-
specific inhibitors were published to reduce H3K4me3 levels in vitro (Cao et al., 2013;
Grebien et al., 2015). Both drugs target the interaction interface of the essential co-
factor Wdr5 with Mll1 HMT complexes. However, I have shown that interference
with mll1 does not result in global H3K4me3 level changes (section 3.3), making these
drugs unlikely candidates for global H3K4me3 reduction. Additionally, recent reports
have shown that inhibition of Mll1 complexes by these drugs resulted in a decrease of
H3K4me1 - but not H3K4me3 - levels in mouse epiblast stem cells (Zhang et al., 2016).
Thus, no H3K4me3-specific inhibitor could be found to reduce H3K4me3 levels in
zebrafish embryos.
4.4 Overexpression of K4-specific methylation-defective H3 re-
sults in global H3K4me3 reduction
Inhibition of global H3K4me3 establishment could not be achieved by small-molecule
interference with H3K4-specific HMTs. However, inhibition of H3K4me3 establish-
ment could also be achieved by inhibition of H3K4me3 establishment within its ge-
nomic recruitment sites. Introducing full length histone proteins that cannot be methy-
lated at amino acid 4 could be a valuable strategy to prevent H3K4me3 establishment.
To this end, I introduced histone proteins with amino acid substitutions at lysine 4. I
tested two constructs with different amino acid substitution for their effect on global
H3K4me3 establishment.
4.4.1 Overexpression of H3K4-to-E constructs does not affect global H3K4me3
establishment
I chose to substitute H3 lysine 4 by glutamate (K4E). Glutamate has a similar size but
an opposing charge compared to lysine. K4E has been predicted to prevent the HMT
enzymatic pocket from binding to these histone proteins by the negative charge. Re-
placement of H3 proteins with K4E constructs was used previously to reduce H3K4me3
specifically on the histone variant H3.3 in Xenopus embryos (Ng and Gurdon, 2008).
To test whether H3 K4-to-E substitution results in a reduction in global H3K4me3
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levels, I overexpressed K4E constructs C-termianlly tagged with HA-tag in zebrafish
embryos. To that end I injected in vitro-transcribed RNA for full length H3 with K4-to-
E substitution into one-cell-stage embryos. To control for effects resulting from RNA
injection alone, I used RNA coding for GFP with nanos-3’UTR, which should not be
involved in H3K4me3 establishment. Histone proteins have been described to affect
embryonic genome activation and development (Amodeo et al., 2015, Joseph et al.,
in preparation). To control for developmental effects caused by histone overexpression
alone, I further injected embryos with RNA coding wildtype H3 with C-terminal HA tag
(H3HA). For each experiment, embryos were injected with either mock RNA, H3HA
RNA or K4E RNA at one-cell stage and H3K4me3 levels were monitored by Western
Blotting as described above (section 4.1). When comparing stage-matched H3HA-
injected and K4E-injected samples for their H3K4me3 levels, no significant difference
in H3K4me3 levels were observed in three biological replicates of multiple stages
(one representative example shown in Figure 4.3 A). These results showed that K4E
overexpression did not result in global H3K4me3 interference in zebrafish embryos. A
possible reason is that the achieved protein levels from overexpression are not enough to
outcompete the maternal load from wildtype histone proteins. Despite the injection of
high amounts of RNA, only 20% of additional H3 protein was added to already present
histone pools.
4.4.2 H3K4-to-M constructs act as dominant-negative substrate for H3K4me3
establishment
Recently, spontaneous mutations resulting in a lysine-to-methionine (K-to-M) substitu-
tion within histone H3 were identified in multiple cancer samples (Fang et al., 2016a).
Interestingly, already if this mutation occurs in only one out of multiple gene copies,
methylation levels of the respective lysine residue were significantly reduced. These
observations were found to target H3K27 (Chan et al., 2013; Lewis et al., 2013) as well
as H3K36 (Shah et al., 2014) methylation marks. These findings suggest that K-to-M
substitution within histones act as dominant-negative inhibitor of histone methylation
processes, and might be applicable to other histone lysine residues as well. To test
whether K-to-M substitution results in global reduction of H3K4me3 levels in zebrafish,
I designed constructs coding for Histone H3 with K4 to M substitution (referred to as
K4M). I introduced a C-terminal HA-tag to allow for detection of protein overexpres-
sion.
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Figure 4.3: H3K4M, but not H3K4E introduction leads to global H3K4me3
reduction A,B) Representative Western Blots comparing samples of mock RNA
injection (GFP with nanos-3’UTR) with injection of H3HA and H3K4E (A) or
H3HA and H3K4M constructs (B). Each lane represents a sample of 10 embryos.
HA-tag controls for equal expression of H3 constructs, Tubulin and H3 serve as
loading control, H3K9me3 serves as developmental control. C) Western Blot of
mock-injected and H3K4M-injected samples at sphere stage probed for H3.1 protein
content with an antibody that recognizes C-terminally tagged histone H3. Arrowhead
indicates band resulting from introduced C-terminal HA-tagged histone H3. D)
Quantification of H3K4me3 level reduction upon K4M (red) overexpression when
compared to H3HA overexpression (blue) at stages oblong, sphere and dome. n = 4,
error bars = s.d., * p<0.05
Histone H3 proteins and mRNA are maternally provided, and histone genes belong
to the earliest activated genes during early zebrafish development (Heyn et al., 2014;
Pauli et al., 2012). To analyze how the protein levels of introduced K4M constructs
compare to wildtype H3 in early embryos, I injected in vitro-transcribed mRNA into
one-cell stage embryos, and I tested histone H3 expression at sphere stage. To detect
both wildtype H3 and K4M proteins, I used an antibody that recognizes the globular
domain of H3. The C-terminal HA-tag is shifting the molecular weight of introduced
K4M constructs by 1kDa, which allows for differential detection of wildtype and K4M
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proteins with one antibody (Figure 4.3 C). Quantitative comparison of the two distinct
bands by fluorescent Western Blotting revealed that K4M proteins comprise around
20% of wildtype H3 levels.
Next I set out to test whether K4M overexpression results in H3K4me3 reduction. I in-
jected wildtype embryos with RNA encoding K4M constructs in parallel with RNA cod-
ing for wildtype histone H3 tagged with HA (H3HA). Similar expression levels were
monitored by HA-tag expression (Figure 4.3 B, HA band intensity). Again, H3K9me3
levels were used to stage-match samples of different treatment (section 4.1). While
only 20% of extra histone protein could be achieved by injection H3 RNA injection, a
drastic effect on H3K4me3 levels could be observed upon K4M overexpression when
compared to H3HA injection (Figure 4.3 B). Four independent experiments consistently
resulted in more than 50% reduced H3K4me3 levels over multiple stages (Figure 4.3
D). These results suggest that K4-to-M substitution indeed acts as a dominant negative
inhibitor of global H3K4me3 establishment in zebrafish embryos. These results are
in line with recent findings where H3K27me3 and H3K9me3 levels can be reduced in
Drosophila imaginal wing discs by overexpression of respective lysine-to-methionine
substitutions (Herz et al., 2014). H3K4-to-M substitution is regularly used in protein
chrystallography to mimic dimethylated lysine residues (Fang et al., 2013). Therefore it
is hypothesized that the presence of methionine in the context of full-length histones is a
dominant substrate for the enzymatic pocket of histone methyltransferases (Lewis et al.,
2013). In conclusion, overexpression of K4M constructs in zebrafish embryos results in
a drastic reduction of H3K4me3 levels, possibly by representing a dominant-negative
substrate for H3K4-specific HMTs.
4.5 H3K4me3 levels at gene promoters are reduced upon intro-
duction of methylation-defective Histone H3
Overexpression of K4M histone constructs resulted in a significant reduction of global
H3K4me3 levels when analyzed by Western Blotting. Western Blot analysis do not
allow for an interpretation of the local distribution of H3K4me3 reduction. The drastic
reduction in total H3K4me3 levels could be either the result of a complete loss of
H3K4me3 levels on a significant fraction of genes, or a significant reduction on all
gene promoters. These options are not mutually exclusive. To understand how the
achieved reduction of global H3K4me3 levels is reflected in local changes in H3K4me3
levels, I performed Chromatin Immunoprecipitation experiments followed by Deep
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Sequencing (ChIP-Seq). ChIP-Seq experiments were performed at four subsequent
stages after genome activation (high, oblong, sphere dome) in parallel for H3HA and
K4M overexpression, to control for effects that could be caused by overexpression of
histone H3 proteins alone.
Introduction of Lambda phage-DNA allows for correction of overamplifica-
tion
Figure 4.4: Lambda DNA spike-in allows for correction of overamplification
during Sequencing If interference with a histone modification (here H3K4me3)
results in a global reduction, Chromatin Immunoprecipitation results in less purified
DNA. During Library Preparation and Next Generation Sequencing, sample DNA is
amplified to reach a predefined amount of Sequencing reads. Samples with initially
less DNA is overamplified to reach the same information. Thus, normalization
of sample data by library size does not represent changes in initial DNA quantity.
Introduction of a given amount of spike-in DNA (here Lambda DNA) allows
for monitoring overamplification during sequencing, and is a valid tool to allow
normalization for DNA quantity differences in initial samples.
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Multiple recent studies found that global reduction of histone modification is not re-
flected in standard ChIP-Seq approaches (Bonhoure et al., 2014; Chen et al., 2016;
Orlando et al., 2014). This is explained by increased amplification of material in sam-
ples with lower DNA quantity during the process of library preparation and sequencing.
This overamplification is not reflected in the sample library size (the amount of reads
that can be mapped to genomic positions) after sequencing, which is usually used to
normalize quantitative differences in subsequent data analyses.
Most studies address sample normalization by post-procession of the acquired data by
bioinformatics analysis. These strategies rely on normalization over specific genomic
locations that are known to be not affected by the experimental treatment. Therefore,
this post-processing does not allow for analysis of experiments where global changes in
histone modifications are expected, and no prior knowledge about not-targeted regions
exist. Therefore, spike-in strategies to correct for overamplification of immunoprecipi-
tated material are essential for a successful quantitative comparison between different
samples.
To allow for quantitative comparison of my ChIP experiments, I added a given amount
of fragmented Lambda phage DNA to each sample (10% of reference sample DNA).
After sequencing, the amount of reads mapped to Lambda phage were used to nor-
malize quantitative differences between samples of the same stage (subsection 2.3.2).
If Lambda DNA spike-in allows for normalization of overamplification during library
preparation and sequencing, the ratio of Lambda Phage reads between two samples
should reflect the quantitative difference of DNA prior to sequencing better than the
actual library size. Indeed, my data showed that the ratio of Lambda Phage-specific
reads after sequencing directly reflects the quantitative differences in input DNA, es-
pecially in early stages (Table 4.1, compare Lambda ratio to DNA ratio at individual
stages). Therefore I conclude that the amount of Lambda Phage-specific reads is a good
reference to normalize for quantitative differences of immunoprecipitated DNA that are
the result of global reduction of targeted histone modifications.
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Table 4.1: Lambda Phage library size reflects differences in sample DNA
content The amount of DNA in each sample (in ng) compared to total mapped reads
(Total library), Lambda library size, and their relative ratios to respective H3HA
samples. Lambda library factor reflects best the observed differences in DNA
content.
sample DNA
content
Total
library
Lambda
library
DNA
factor
Library
factor
Lambda
factor
H3HA high 12.01 6,165,525 937,701 1.000 1.000 1.000
K4M high 1.09 6,410,505 6,809,612 0.091 1.040 0.138
H3HA oblong 11.69 3,927,642 206,535 1.000 1.000 1.000
K4M oblong 0.70 5,050,954 11,949,412 0.060 1.286 0.078
H3HA oblong2 2.80 13,954,143 7,276,341 1.000 1.000 1.000
K4M oblong2 n.d. 6,910,026 31,579,042 n.d. 0.495 0.230
H3HA sphere 4.01 11,770,538 4,331,846 1.000 1.000 1.000
K4M sphere 3.80 12,482,032 4,663,928 0.951 1.060 0.929
H3HA dome 16.70 12,193,878 221,680 1.000 1.000 1.000
K4M dome 13.80 9,257,326 261,696 0.834 0.759 0.847
K4M overexpression results in a strong reduction of promoter-associated H3K4me3
peaks
I have shown before that H3K4me3 levels are enriched at gene promoters during early
embryonic development (Figure 3.7). Western blot experiments have shown that K4M
overexpression results in drastic reduction of global H3K4me3 levels (Figure 4.3). To
analyze whether this reduction is also reflected in H3K4me3 levels at gene promoters,
I analyzed the obtained ChIP-Seq data for its enrichment at promoter regions. I plotted
the density of reads within +/-3kb of transcription start sites (TSS) annotated in the
zebrafish genome assembly. Read density was normalized to Lambda phage library, to
allow for cross-sample and cross-stage comparison. Enrichment of H3K4me3 around
TSS increased dramatically over developmental stages (Table 4.1, note the different y-
axis scale for dome stage). While almost no enrichment at TSSs is found at high stage,
H3K4me3 are high at dome stage when averaged over all genes. This is in line with
the increase of global H3K4me3 levels over developmental stages observed by Western
Blot analyses (Figure 4.1). When comparing samples from H3HA-injected embryos
(blue line) with samples from K4M overexpression (red line), it becomes apparent that
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Figure 4.5: H3K4me3 is reduced at promoter regions upon K4M introduction
Metagene profiles displaying enrichment of H3K4me3 ChIP-Seq reads over promoter
regions. Depicted are input chromatin enrichment (black), and H3K4me3 enrichment
upon H3HA (blue) or K4M introduction (red) at high (A), oblong (B), sphere (C) and
dome (D) stage. Enrichment plots were scaled to Lambda DNA library size.
H3K4me3 enrichment is significantly reduced at all stages upon K4M overexpression
(Figure 4.5). Especially at early stages shortly after genome activation, H3K4me3 levels
are dramatically reduced at TSS. While the difference in H3K4me3 levels is not as
strong for later stages, H3K4me3 stages are significantly reduced in all stages. It is
possible that the initial loss of H3K4me3 is compensated by H3K4me3 establishment
coupled to active transcription at a subset of genes.
To understand whether the reduction in H3K4me3 enrichment at promoters is also
reflected in H3K4me3 reduction at individual promoters, I analyzed Lambda Phage-
normalized H3K4me3 enrichment tracks of H3HA-overexpressed and K4M-overexpressed
samples. By manual inspection I observed that the majority of promoter regions showed
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a significant H3K4me3 reduction. If a locus was reduced in H3K4me3 levels at one
stage, this locus showed H3K4me3 reduction at other stages, too (one representative
example shown in Figure 4.6 A). Interestingly, not all loci show H3K4me3 reduction.
A small subset of genomic regions was unaffected by K4M overexpression (Figure 4.6
B) over different stages, suggesting that these regions are not susceptible to K4M
introduction.
Figure 4.6: K4M overexpression reduces H3K4me3 levels reproducibly at TSS
A) Representative genomic region showing a region (in dashed lines) that is
signficantly reduced upon K4M overexpression (red) in all stages. B) Representative
genomic region showing a region that is not significantly changed between H3HA
(blue) and K4M overexpression (red). Dashed lines indicate analyzed regions.
To quantify the differences of H3K4me3 levels for individual regions over the whole
genome, and to allow for the identification for loci with strongest H3K4me3 reduction,
I developed a bioinformatics pipeline. This work was performed in collaboration with
Holger Brandl from MPI-CBG. The following steps were applied to ChIP-Seq data
from all stages and both treatments (H3HA and K4M overexpression).
1. I filtered sequencing reads based on standard quality criteria. Furthermore, I
rejected reads that map to more than one position in the genome (genome version
danRer7/Zv9 from April 2010 was used).
2. Using the remaining reads, I performed peak calling by MACS2.
3. To reduce false-positive calls by MACS2, I reasoned that true H3K4me3-enriched
regions should be present at the same genomic location in more than one sample.
Since no biological replicates for single stages were performed, I reasoned that
true peak regions should be stable over developmental stages. Since K4M results
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in strong reduction of H3K4me3 levels, I only considered samples from H3HA
injection, and rejected peak regions that are present in less than 3 of 5 ChIP-Seq
datasets.
4. The retained peak regions from all samples were merged to obtain a set of regions
that reflects a common peak region over all developmental stages.
5. Additionally, I only retained peak regions which were within +/-5kb distance to
annotated transcription start sites, to allow for inclusion of promoter-associated
H3K4me3 peak in the vicinity of annotated transcription start sites.
6. Next, for each treatment and developmental stage, the number of reads that cover
each of the identified peak regions was assessed.
7. The resulting counts were normalized by Lambda library size, and fold change
was calculated comparing K4M overexpression samples versus H3HA overex-
pression samples at each stage (Pataskar et al., 2016).
In my experimental set-up, different developmental stages reflect biological replicates.
By manual inspection I observed that local H3K4me3 level changes induced by K4M
overexpression are reproducible over developmental stages. To assess whether this
observation is true when considering all promoter regions, I correlated local H3K4me3
reduction over successive stages (high versus oblong, and sphere versus dome). Scat-
terplot analysis of the fold change (K4M versus H3HA overexpression) are shown in
Figure 4.7 A and B.
A clear correlation between fold changes can be observed, suggesting that local H3K4me3
reduction is reproducible over developmental stages. Taken together, these results sug-
gest that K4M overexpression results in local H3K4me3 reduction that is reproducible
over developmental stages and biological replicates.
Next I wanted to understand, how many regions are reduced upon H3K4me3 levels.
I plotted the number of regions that show more than 2fold and 4fold reduced (or in-
creased) levels of H3K4me3 enrichment. At none of the analysed stages, regions that
are more than 2fold increased in H3K4me3 levels in K4M-overexpressed samples were
identified. In contrast, upon K4M overexpression around 90% of genomic regions
show more than 2fold reduced H3K4me3 levels at each individual stage. At high
and oblong stages, the majority of regions is even more than 4fold decreased (58 and
64%, respectively). I further assessed which regions show a reproducible decrease in
85
4 Results II: H3K4me3 interference by introduction of HMT inhibitors
Figure 4.7: K4M overexpression reduces H3K4me3 levels reproducibly at TSS
Scatterplots of H3K4me3 fold changes observed at high (y-axis) and oblong (x-axis)
(C), as well as sphere (y-axis) and dome (x-axis) stage (D). Blue line represents linear
fit.
H3K4me3 levels in all the analyzed stages. Of almost 33,000 analyzed region, 1,264
regions (3.84%) show more than 4fold reduced H3K4me3 levels at each analyzed
stages, and more than 75% of these regions are at least 2fold reduced. This again
reflects that K4M robustly and reproducibly reduces H3K4me3 levels in early zebrafish
development.
Taken together, these results identify overexpression of histone H3 constructs with
lysine-4-to-methionine substitution as a dominant negative histone methyl transferase
inhibitor in zebrafish development. Overexpression of these histone constructs resulted
in a drastic and reproducible reduction of H3K4me3 levels at individual promoters
throughout the zebrafish genome. Thus, K4M overexpression is a valuable tool to study
the effects of H3K4me3 reduction on transcription initiation in zebrafish development.
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4.5 H3K4me3 levels at gene promoters are reduced upon introduction of
methylation-defective Histone H3
Figure 4.8: The majority of promoters shows reduced H3K4me3 levels Depicted
are the fractions of genes with indicated fold change difference of H3K4me3 levels at
promoter regions. Percentage of promoters that are significantly changed are shown
at high (A), oblong (B), sphere (C) and dome stage (D). Peak regions that show the
same trend in all stages are shown in (E).
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4.6 Early transcription activation is not altered upon K4M over-
expression
Figure 4.9: K4M overexpression does not result in transcriptional change of
zygotic genes Depicted are Scatterplots correlating transcript counts of 84 zygotic
activated genes in H3HA overexpression (x-axis, blue) versus K4M overexpression
(y-axis, red). Counts were measured by Nanostring assays at high (A), oblong (B),
sphere (C) and dome (D) stage.
K4M overexpression resulted in at least two-fold reduced H3K4me3 levels on more
than 90% of gene promoters in stages shortly after genome activation (high and oblong,
see Figure 4.8). To investigate whether H3K4me3 reduction affects transcription al-
ready at the first stages after genome activation, I analyzed the onset of zygotic transcrip-
tion using the previously described NanoString assay (section 3.4 and subsection 2.2.7).
The here applied NanoString assay probes for 12 genes with stable expression levels
during early developmental stages (’normalizer genes’) and 84 genes that are not ma-
ternally provided, but activated early during zebrafish development (’zygotic genes’).
To compare expression levels of early activated genes, I extracted RNA from H3HA-
injected and K4M injected embryos at six consecutive stages during genome activa-
tion (512cell stage to dome stage). RNA levels were quantified by NanoString assay,
and normalized RNA counts for each individual gene were compared between H3HA-
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injected and K4M-injected samples. No significant difference of transcript levels could
be observed at early stages (high, oblong and sphere). At dome stage, slightly reduced
transcript levels were observed for the majority of genes (Figure 4.9 D). While the
reduction of individual transcript levels was low (less than 20% for each individual
gene), the majority of genes showed the same trend (see individual time courses of
genes in chapter 6.6).
It is possible that reduction of H3K4me3 levels is causative for the observed subtle
changes in RNA transcript levels. To understand whether H3K4me3 reduction directly
correlates with changes in transcript levels, I plotted the transcriptional change observed
by NanoString assays against the fold change of promoter-associated H3K4me3 levels
at oblong (early after genome activation) and dome stage (when strongest transcrip-
tional changes are observed). If H3K4me3 level changes are causative for transcrip-
tional changes, strong reduction of H3K4me3 levels should result in strong reduction of
RNA transcript levels, while genes that show no H3K4me3 reduction should not show
transcription level changes. However, scatterplot analyses that correlate H3K4me3
level changes against transcriptional change did not reveal a significant correlation of
transcriptional changes to changes in H3K4me3 (Figure 4.10). Instead, strong reduction
in transcription levels was observed for both, genes that show increased as well as
decreased transcription levels. Furthermore, genes with increased and decreased tran-
scription levels were found for almost similar H3K4me3 level changes both at oblong
and dome stage. Thus, no correlation between H3K4me3 levels and transcriptional
activity could be observed, suggesting that H3K4me3 reduction does not cause the
observed changes in transcript levels.
Early zygotic genes need to be robustly activated to allow for further developmen-
tal progression (Kane et al., 1996; Newport and Kirschner, 1982). Therefore it is
possible that early activated genes have robust activation mechanisms that overcome
interference with chromatin modifications. Thus, early transcription activation might
not rely on H3K4me3 to be established. However, H3K4me3 has been suggested
to poise developmental regulators for transcriptional activation, as genes important
for embryonic development are enriched in H3K4me3 levels prior to their activation
(Bernstein et al., 2006; Vastenhouw et al., 2010). Many of these genes are only activated
at later stages, when the embryonic genome might be less permissive for transcription
activation (Bogdanovic et al., 2011; Schneider et al., 2011; Wen et al., 2009). I therefore
reasoned that perhaps H3K4me3 levels might have an effect on transcription activation
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Figure 4.10: Transcriptional change does not correlate with change in promoter
H3K4me3 levels Depicted are Scatterplots of transcriptional change (x-axis) mea-
sured by Nanostring assay versus change in H3K4me3 levels at promoter regions of
respective genes (y-axis) measured by ChIP-Seq analysis for oblong (A) and dome
stage (B). Blue line represents linear regression, grey shaded area represents 95%
confidence interval to linear regression.
of genes that are activated later during early gastrulation stages.
To analyze the effect of H3K4me3 reduction on later activated genes, I first chose genes
that showed strongest reduction (more than 2fold reduction at all stages, and more than
4fold reduction at dome stage). From these, I chose genes that are transcriptionally
activated at different stages: I chose 17 genes that show first increase in transcript
levels at dome stage or later. If H3K4me3 affects genes that are later activated, these
should show significant changes in transcription activation during H3K4me3 reduction.
Furthermore I chose 14 genes that are activated early after genome activation, until
oblong stage, and thus should not be affected by H3K4me3 reduction as observed by
NanoString assays.
To test for changes in transcription activation of these genes, I performed RT-qPCR
experiments. For each gene, expression levels were monitored for one stage before, and
at least three consecutive stages after their respective transcription activation. Experi-
ments were performed for at least three biological replicates, monitoring transcription
levels in H3HA-injected and K4M-injected embryos. H3K4me3 reduction at respective
gene promoters, and the transcription profile upon K4M overexpression for one repre-
sentative gene of each class are shown in Figure 4.11.
When monitoring transcription levels of genes that are activated early during develop-
ment, I was unable to identfy transcriptional changes. This is consistent with results
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Figure 4.11: Local H3K4me3 reduction does not result in transcriptional change
of target genes A) H3K4me3 levels of H3HA (blue) and K4M (red) samples from
high to dome at akap12b promoter region (dashed line). B) Relative expression of
akap12b to normalizer gene (eif4g2a) at stages 512 to oblong stage measured by
RT-qPCR. H3HA samples are depicted in blue, K4M samples in red. n =4, error
bars = s.d. C) H3K4me3 levels of H3HA (blue) and K4M (red) samples from high
to dome at rpl26 promoter region (dashed line). D) RT-qPCR experiments showing
the relative expression to normalizer gene for rpl26a at stages dome to 70% epiboly.
H3HA overexpression samples are depicted in blue, K4M overexpression samples in
red. n = 3, error bars = s.d.
obtained by NanoString experiments. Next I assessed transcriptional changes from the
17 genes that are activated later than dome stage. Again, no significant changes in
transcription levels could be observed. This suggests that like early activated genes,
genes that are activated at dome stage and later do not rely on H3K4me3 establishment
for their activation.
K4M overexpression resulted in a strong reduction, but not a complete loss of H3K4me3
levels at promoters, as analyzed by ChIP-Seq experiments. Therefore it cannot be
excluded that the remaining levels of H3K4me3 at promoters are sufficient to allow for
transcription activation in zebrafish embryos. Additionally it is possible that remaining
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levels of H3K4me2 (which was not monitored during this study) might compensate for
the lack of H3K4me3.
The experimental procedures did not allow for parallel monitoring of local H3K4me3
reduction by ChIP experiments and transcription analyses by RT-qPCR or NanoString.
Therefore it cannot be excluded that in samples taken for transcription analyses, the
respective promoters were not reduced for H3K4me3. However, since reduction of
H3K4me3 at specific promoter elements was reproducible over developmental stages
(Figure 4.6), and Western Blots performed in parallel to RNA extraction confirmed
global reduction it is unlikely that variation in H3K4me3 reduction is causal for the
absence of a transcriptional effect.
4.7 Conclusion
In conclusion, I could show that overexpression of histone H3 constructs with K4-to-M
substitution (K4M) resulted in a drastic reduction of global H3K4me3 levels, possibly
by representing a dominant-negative inhibitor for H3K4me3 establishment. K4M over-
expression resulted in strong, reproducible H3K4me3 reduction at the majority of gene
promoters during multiple stages of embryonic development. However, transcription
analysis both on early activated genes as well as genes that are first activated during
early gastrulation (dome stage) were unable to identify changes in transcription acti-
vation upon reduction of H3K4me3. Thus, H3K4me3 reduction seems not to affect
transcription activation during early zebrafish embryogenesis.
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5 RESULTS III: PROMOTERS RICH IN CPG AND
H2A.Z GAIN H3K4ME3 EARLY
H3K4me3 has been shown to be established at more than 60% of gene promoters during
zebrafish early embryonic development (Zhang et al., 2014). It has been proposed that
H3K4me3 enrichment poises genes for future transcription activation (Bernstein et al.,
2006; Lindeman et al., 2011; Vastenhouw et al., 2010). Yet, I was unable to identifiy
significant transcriptional changes upon H3K4me3 reduction during early zebrafish
development. This raises the question, why H3K4me3 is established at the majority
of promoters during early developmental stages, if it is not involved genome activation.
To better understand, which genes gain H3K4me3 during zebrafish embryogenesis, I
grouped genes by their embryonic transcriptional profile and analyzed which group is
favored for H3K4me3 establishment (section 5.1). Next, to address whether specific
features of chromatin might be involved in H3K4me3 establishment during embryo-
genesis, I further analyzed H3K4me3 regions for specific features in the underlying
DNA sequence (section 5.2), and a possible correlation with histone variant H2A.z
(section 5.3). Together, these analysis have the potential to shed light on the underlying
cues that lead to H3K4me3 establishment during early embryonic development.
5.1 H3K4me3 levels increase over developmental time at all gene
classes
H3K4me3 is known to be enriched at promoters that are actively transcribed. However,
recent studies proposed that H3K4me3 enrichment precedes transcription activation in
embryonic development, and poises genes for future transcription activation (Bernstein
et al., 2006; Lindeman et al., 2011; Vastenhouw et al., 2010).
During analysis of H3K4me3 reduction, I showed that H3K4me3 establishment in-
creases over developmental time (Table 4.5). However, it is not clear whether these
increasing levels are caused by Set1-mediated H3K4me3 establishment coupled to ac-
tive transcription, or whether H3K4me3 becomes continuously established independent
of transcription. The here obtained time series of H3K4me3 enrichment over develop-
mental stages shortly after genome activation allows to address, which mechanism of
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H3K4me3 establishment dominates in early embryonic development.
If H3K4me3 is established independent of active transcription, I expect that actively
transcribed genes are not enriched for H3K4me3 compared to not transcribed genes.
On the contrary, if transcription-coupled H3K4me3 establishment predominates in ze-
brafish embryos, genes with increasing transcript levels should be preferentially marked
by H3K4me3, and transcriptionally silent genes should be depleted from H3K4me3. To
understand whether H3K4me3 is enriched at transcriptionally activate genes, I classi-
fied genes based on their embryonic transcription profiles. Classification of genes into
different embryonic transcription clusters was performed before, however either only
a small subset of all genes were used for classification (Aanes et al., 2011), or classi-
fication was solely based on zygotic transcription activation (Harvey et al., 2013). To
allow for the analysis of all known zebrafish genes, I made use of a recently published
zebrafish embryonic transcriptome (Pauli et al., 2012) that monitors transcription levels
up to 5 days post fertilization. I classified the genes into the following groups (for
classification criteria see subsection 2.3.5):
1. Genes that are maternally provided
2. Genes that are not maternally provided, but will be transcribed during embryonic
development until day 5
3. Genes neither provided maternally nor transcribed by the embryo until day 5
4. Genes that cannot be classified to either of these groups; this group is considered
as a random choice of genes.
To assess H3K4me3 enrichment, I used the obtained ChIP-Seq data for H3HA-injected
embryos at all analyzed stages (high to dome). At each stage, H3K4me3-enriched
regions (peak) were identified by using MACS2. H3K4me3 density plots have shown
that H3K4me3 enrichment is found within +/-2.5kb of TSS (Figure 4.5). To examine
whether an individual gene could be considered positive for H3K4me3 enrichment, I
tested whether a peak could be found within close proximity to its TSS (+/-2.5 kb) for
each of the four analyzed stages. I then analyzed, whether a specific class of genes is
enriched for H3K4me3-positive promoters.
When analyzing H3K4me3 enrichment, I observed that over developmental time more
gene promoters become H3K4me3-positive (Figure 5.1 A). While at high stage only
around 5,000 promoters (13%) are H3K4me3-positive, this number gradually increases
to more than 20,000 promoters (61%) at dome stage. Interestingly, at each stage, a
proportion of all classes is marked by H3K4me3 (Figure 5.1 A). This suggests that
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Figure 5.1: Maternal genes are overrepresented in H3K4me3 enrichment A)
Number of MACS2-identified H3K4me3 peaks at stages high to dome. The
fraction of peaks at gene promoters of maternally provided (blue), zygotic expressed
(green), not expressed (grey) and random fluctuating genes (black) are indicated. B)
Percentage of genes covered with peaks was calculated for each group, and compared
to average percentage at the specific stage. Depicted is the percentage of over- or
underrepresentation to average of H3K4me3-peak coverage per gene class. Gene
classes are colored as in (A). C) Similar to B), but zygotic genes were split in early
activated genes (detectable transcription levels prior to dome, dark green) and late
activated genes (light green). D) Percentage of overrepresentation of H3K4me3-peak
coverage at maternally-provided genes which have stable (light blue), decreasing
(blue) or increasing (dark blue) transcription levels.
H3K4me3 is continuously established over developmental time, even at genes that
are not transcribed. Since not-expressed genes become H3K4me3-positive as well,
H3K4me3 cannot merely be consequence of active transcription in the zebrafish em-
bryo. These results corroborate with findings of previous studies (Lindeman et al.,
2011; Vastenhouw et al., 2010).
Next I addressed whether a specific class of genes is overrepresented in H3K4me3-
positive promoters. Therefore I tested whether the percentage of genes positive for
H3K4me3 in each class is different to to total percentage per stage. I plotted percentage
of over- or underrepresentation compared to average percentage for each gene class
on 4 consecutive stages (Figure 5.1 B). This analysis shows that maternally provided
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genes are overrepresented in H3K4me3-positive promoters, while not-expressed genes
are underrepresented at each analyzed stage. The random outgroup as well as genes
zygotic activated genes are neither over- nor underrepresented for H3K4me3-positive
promoters. If H3K4me3 is thought to poise genes for activation, zygotic genes should
be preferentially marked by H3K4me3. This could not be observed in these analysis,
suggesting that transcriptional poising is not the dominating reason for H3K4me3 es-
tablishment.
Not-expressed genes are underrepresented for H3K4me3-positive promoters at each
stage. Therefore, while not being the only cause for H3K4me3 establishment, active
transcription could contribute to H3K4me3 establishment. To address this hypothesis, I
subdivided the class of zygotic activated genes. Because these genes have no transcrip-
tion levels prior to genome activation, their timing of first transcription activation can
be assessed based on transcript levels. I subdivided purely zygotic genes in:
• genes that become transcriptionally activate until dome stage and
• genes that have no transcripts until dome, but become transcriptionally activate
during embryonic development until 5dpf.
Both subcategories of zygotically activated genes gained in number of H3K4me3 pos-
itive genes. However, their enrichment for H3K4me3-positive genes is different (Fig-
ure 5.1 C). If other features than transcriptional activity would allow for enrichment of
H3K4me3 in specific classes, no change should be observed over developmental stages.
While genes activated late after genome activation are not enriched for H3K4me3 at any
stage, early activated genes change their likelihood of being marked with H3K4me3
over developmental time. While first their likelihood of being marked with H3K4me3
is not different from average, at dome stage they are overrepresented in H3K4me3
(Figure 5.1). These genes were chosen to be activated until dome, thus more and more
genes of this class become transcriptionally active over developmental time. These
results suggest that active transcription of these genes leads to their higher chance of
gaining H3K4me3 over developmental time.
Interestingly, the class of genes that is strongest overrepresented in H3K4me3-positive
genes at all stages are maternally provided genes. This overrepresentation could be
explained by a higher fraction of actively transcribed genes among the class of maternal
genes. To determine whether transcription activity contributes to the overrepresentation
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of maternal genes, I further subclassified maternally provided genes into the following
classes:
• genes that have stable transcription levels over time,
• genes that show increasing RNA levels after genome activation, and
• genes that show decreasing RNA levels.
It is likely that genes that show decreasing RNA levels are less transcriptional activity
than genes with increasing RNA levels. Thus, this classification allows me to decipher
whether active transcription contributes to the likelihood of gaining H3K4me3 at mater-
nal genes.
Interestingly, when analyzing the percentage of H3K4me3-positive promoters in these
subclasses, all maternally provided genes show a higher probability of H3K4me3 ap-
pearance at their promoters than expected from average percentage (Figure 5.1 C),
irrespective of their transcriptional activity. No difference between the subgroups could
be observed at any stage. This suggests that the higher fraction of H3K4me3-positive
promoters in maternally provided genes is not due to zygotic transcription, but is caused
by other mechanisms.
Taken together, these findings suggest that there are two modes of H3K4me3 establish-
ment during early embryonic development:
1. H3K4me3 is established with active transcription. Not-transcribed genes are
underrepresented in H3K4me3-positive promoters compared to all other classes.
Furthermore, while zygotic genes that become activated in late developmental
stages are underrepresented for H3K4me3, zygotic genes genes activated dur-
ing early stages switch from being not enriched to being overrepresented for
H3K4me3-positive promoters. This suggests, that active transcription guides
H3K4me3 establishment to promoters that otherwise would not gain H3K4me3.
This is in line with a Set1-mediated recruitment of H3K4me3 establishment (Kro-
gan et al., 2003; Ng et al., 2003).
2. H3K4me3 is established independent of transcription during embryonic develop-
ment. This becomes evident from H3K4me3 being present at genes that are not
transcribed in zebrafish embryos. At dome stage, 5,300 of those genes (40% of
all not-transcribed genes) are H3K4me3-positive. Furthermore, zygotic activated
genes are marked by H3K4me3 prior to their activation. This is in line with
previous findings that identified H3K4me3 at transcriptionally inactive loci in
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zebrafish development (Lindeman et al., 2011; Vastenhouw et al., 2010; Zhang
et al., 2014).
Because I could show that reduction of H3K4me3 levels does not change transcrip-
tional output of affected genes during early embryonic development, it is possible that
H3K4me3 establishment is a mere consequence of chromatin accessibility during early
embryogenesis (Bogdanovic et al., 2011; Schneider et al., 2011; Wen et al., 2009).
However, if H3K4me3 is not solely a cause of active transcription, nor needed for robust
transcription activation, it is unclear why H3K4me3 is established to promoters during
early embryonic development.
5.2 H3K4me3 is gained at CpG-rich elements
To understand, what makes promoters gain H3K4me3 independent of transcription,
I analysed the promoter sequence of genes that are neither provided maternally, nor
expressed during embryonic development until day 5. According to embryonic tran-
scriptome data (Pauli et al., 2012), around 13,000 genes have no detectable transcript
levels during embryonic development. Of these, 5,300 have an H3K4me3 peak in close
vicinity to their transcription start sites at dome stage. I analyzed the GC content as
well as the CpG density of the DNA sequence of TSS +/-2.5kb according to Takai and
Jones 2002. I plotted the distribution of promoters over the range of GC-content and
CpG observed-to-expected ratio (termed ’CpG density’). When comparing H3K4me3-
positive to H3K4me3-negative non-transcribed genes, I found that both groups of genes
show the same average GC-content (Figure 5.2 A), suggesting that a bias towards
specific nucleotide content is not predictive for H3K4me3 establishment.
CpG density shows two population of promoters: genes with low CpG content (below
genome-wide average CpG density of 0.7) and genes with high CpG content (above
genome-wide average). Interestingly, the majority of H3K4me3-positive promoters
have a high CpG-content, while H3K4me3-negative are more likely to have low CpG-
content (Figure 5.2 B).
To determine whether this preference for CpG content - but not for GC content - is
not only restricted to non-transcribed genes but also reflected in H3K4me3 enrich-
ment genome-wide, I analyzed H3K4me3 enrichment by metagene plots. I divided
all genes in low-GC content and high GC-content (below and above average promoter
GC content of 0.35, respectively), or low and high CpG density (below or above average
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CpG density of 0.7, respectively). I plotted the average density of reads identified in
H3K4me3 ChIP-Seq experiments at dome stage around TSS for each of these classes
separately. Low GC-content promoters showed lower levels of H3K4me3 when com-
pared to high GC-content promoters (Figure 5.2 C). Because I have shown before
that GC-content does not distinguish between the number of H3K4me3-positive and
-negative promoters, it is possible that H3K4me3 levels at individual promoters with
high GC-content are higher than on low GC-content promoters.
Figure 5.2: H3K4me3 is enriched at CpG-rich promoters A,B) Smoothened
histograms representing gene density of non-transcribed genes either negative (red)
or positive (blue) for H3K4me3 enrichment at dome stage. Depicted is gene density
according to GC content (A) or CpG content (B) at the respective promoter. Dashed
line indicates average GC- or CpG content. C,D) Metagene profile over all annotated
promoters with either high (black) or low (grey) GC content (C) or CpG content (D)
at dome stage.
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When comparing average H3K4me3 density on promoters with high CpG density to low
CpG density, a striking difference could be observed. At low CpG density promoters,
H3K4me3 enrichment is almost undetectable compared to genes with high CpG density
promoters (Figure 5.2 D). Together with the observation that not-transcribed genes that
are positive for H3K4me3 have in general higher CpG density, this suggests that CpG
content might be involved in transcription-independent H3K4me3 establishment.
5.3 H2A.z marks overlaps with H3K4me3 at promoters of non-
transcribed genes
H3K4me3 establishment could also be stimulated by other features of promoter chro-
matin. One candidate that could allow for H3K4me3 establishment is the histone
variant H2A.z. This histone variant replaces the canonical H2A at specific genomic
features by active nucleosome exchange (Kobor et al., 2004; Mizuguchi et al., 2004).
H2A.z-containing nucleosomes were found to be less stable compared to canonical
nucleosomes, leading to higher nucleosome turnover and increased DNA accessibility
at promoter regions (Jin and Felsenfeld, 2007; McKittrick et al., 2004). To be able
to compare H2A.z enrichment to H3K4me3, I performed a ChIP-Seq experiment for
H2A.z at dome stage, when H3K4me3 is robustly established. Manual inspection of
the genome-wide distribution of H2A.z revealed that H2A.z is enriched at TSS and
overlaps with H3K4me3 enrichment at dome stage (Figure 5.3 A). To address whether
H2A.z is generally enriched at TSS, I plotted the read density of ChIP-Seq samples
over annotated TSS. Indeed, H2A.z is highly enriched within +/-1.5kb of TSS.
I have observed that H2A.z and H3K4me3 are both enriched at TSS of genes during
embryonic development, and manual inspection showed that H2A.z and H3K4me3
enrichment overlap at individual loci. Thus, the presence of H2A.z might be predictive
for H3K4me3 enrichment. To address this hypothesis, I quantified the level of H2A.z
at individual promoters based on an analysis published in Zhang et al. 2014. In brief,
all reads that fall within a region of +/-2.5kb around individual TSS were counted, and
normalized by library size. These values were used separate genes in a groups of high
and low H2A.z levels (above or below 2fold of average H2A.z enrichment). Next I
plotted the H3K4me3 read density over TSS for both groups separately. Strikingly,
H3K4me3 is significantly more enriched at promoters that have high H2A.z levels.
Thus, high levels of H2A.z overlap with, and might influence, H3K4me3 establishment.
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establishment
Figure 5.3: H2A.z is enriched at promoter regions and overlaps with H3K4me3
enrichment A) Representative genomic region showing H3K4me3 enrichment (blue)
and H2A.z enrichment (violet) overlap at gene promoters. Input chromatin depicted
in black. B) Metagene profile over annotated TSS plotting the read density of H2A.z
ChIP-Seq reads at dome stage. C) Metagene profile for H3K4me3 enrichment over
promoters that are either high (blue) or low (light blue) in H2A.z enrichment.
5.4 High CpG density and H2A.z enrichment are predictive for
H3K4me3 establishment
Both high CpG content and high H2A.z levels overlapped with stronger H3K4me3 en-
richment. If CpG content and H2A.z enrichment is causal for H3K4me3 establishment,
I expect that genes marked by H3K4me3 without transcriptional activity are either rich
in CpG content, or enriched for H2A.z, or both.
To test this hypothesis, I grouped genes according to their transcriptional activity. Clas-
sification based on RNA-Seq data does not allow to confidently state whether mater-
nally provided genes are actively transcribed, as transcription might contribute to stable
RNA levels. To allow for classification of maternally provided genes as well, I used
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the H3K36me3 enrichment as a marker for transcriptional activity. Previous studies
have shown that H3K36me3 enrichment within the gene body correlates with active
transcription RNA-Polymerase II, and thus is an experimental marker for ongoing tran-
scription (Zhang et al., 2014). I used H3K36me3 data obtained for zebrafish dome
stage embryos to identify genes without active transcription according to Zhang et al.
2014. Of these genes, I analyzed H3K4me3-positive and -negative loci for their CpG
content and H2A.z content. In this analysis I considered promoter regions to have high
H2A.z levels, if they have 2fold higher than average H2A.z enrichment, and high CpG
content if CpG content was higher than average (0.7 observed-to-expected ratio) in their
promoter region.
Most of the 9,147 H3K4me3-positive yet transcriptionally inactive genes are both high
Figure 5.4: H2A.z and CpG density predict H3K4me3 establishment. A) Venn
diagram displaying the fraction of genes that are transcriptionally inactive and en-
riched for H3K4me3 at dome stage based on previously published data (Zhang et al.,
2014). B) Venn diagram displaying the fraction of genes that are transcriptionally
inactive and are H3K4me3-negative at dome stage based on previously published
data (Zhang et al., 2014). CpG content and H2A.z enrichment were considered high,
if the values were above the average or higher than 2fold average of all promoter
values, respectively.
in H2A.z enrichment and CpG content (64%). 78% of H3K4me3-positive promoters
of non-transcribed genes have CpG-levels above average, and 74% show high H2A.z
levels. Less than 6% of H3K4me3-positive, non-transcribed genes are neither marked
by H2A.z nor contain high CpG content in their promoters. On the contrary, in the
analyzed 8047 non-transcribed H3K4me3-negative genes, this fraction is larger than
50% (Figure 5.4). While around 48% of those genes have promoters with high CpG
content, only 2.5% are marked with H2A.z, and only 1.5% (126 genes) are marked
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with both. Together, these results suggest that H2A.z and CpG content cooperate to
allow for H3K4me3 establishment independent of transcription.
5.5 Maternally provided genes are enriched for H2A.z and CpG
content
I have shown before that H3K4me3-positive promoters are overrepresented in mater-
nally provided genes, irrespective of their transcription status (Figure 5.1). I could fur-
ther show that H3K4me3-positive promoters of non-transcribed genes have high CpG
content and high H2A.z enrichment (Figure 5.4). If CpG content and H2A.z enrichment
are predictive of H3K4me3 establishment, these features should be overrepresented in
maternally provided genes as well.
To test this hypothesis, I compared maternally provided genes against all genes that
Figure 5.5: H2A.z and CpG density are overrepresented in maternal genes Venn
diagram displaying the fraction of genes that are high in CpG content or H2A.z
enrichment of maternally provided (A) and not maternally provided genes (B) based
on previously published transcription data (Pauli et al., 2012). CpG content and
H2A.z enrichment were considered high, if the values were above the average or
higher than 2fold average of all promoter values, respectively.
are not maternally provided for CpG content and H2A.z enrichment as described above
(section 5.3). I did not consider transcription activity, as this seems not to influence
the overrepresentation of H3K4me3 promoters in maternal genes. 78% of maternally
provided genes have a high CpG content, and 51% are enriched for H2A.z, with an
overlap of 43%. While this is less than observed for H3K4me3-positive yet untran-
scribed genes (Figure 5.4), this could be explained by the lower fraction of H3K4me3-
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positive promoters in maternally provided genes (84% to 100%, respectively). 14% of
maternally provided genes have neither of the two chromatin states. When analyzing
not maternally provided genes, both the number of promoters with high CpG content
(55%) and high H2A.z enrichment (33%) are lower, and only 25% of these promoters
have both features. 37% of not maternally provided genes have neither of the features.
While the difference between these fractions is not drastic, it very well reflects the
difference in H3K4me3 enrichment found at dome. 86% of maternal genes were found
to be H3K4me3-positive, while 14% are not marked, and only 48% of not maternally
provided genes are positive for H3K4me3 (Figure 5.1).
While these results are based on correlation only, they suggest that high density of
CpG and high levels of H2A.z are chromatin features that might explain the increased
amount of H3K4me3-positive promoters in maternally provided genes.
5.6 Conclusion
In conclusion, these results show that the number of genes marked with H3K4me3 in-
creases over developmental time. Increased H3K4me3 establishment is found on both,
actively transcribed as well as non-transcribed genes. Genes that become activated dur-
ing embryonic development are not overrepresented for H3K4me3-positive promoters,
but become increasingly marked by this modification when they become transcription-
ally activate, suggesting that transcription contributes to embryonic H3K4me3 estab-
lishment. Interestingly, maternally provided genes are overrepresented for H3K4me3-
positive promoters independent of their transcription status, suggesting for transcription-
independent H3K4me3 establishment at these genes specifically.
By analyzing chromatin features that correlate with H3K4me3, I could further show that
genes marked by H3K4me3 independent of transcription are enriched for CpG density
(but not GC-content), and H2A.z enrichment. Both H2A.z enrichment and high CpG
content are overrepresented in maternally provided genes as well, suggesting that these
features together result in a higher fraction of H3K4me3-positive genes in this subgroup
of genes. These results indicate that H2A.z enrichment and high CpG content represent
features of embryonic chromatin that might be involved in H3K4me3 establishment
independent of transcription.
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Early zebrafish development relies on robust and timely activation of specific genes
(Kane et al., 1996; Newport and Kirschner, 1982). While progress has been made
to identify key regulators of genome activation (Chan et al., 2009; Lee et al., 2013b;
Leichsenring et al., 2013; Liang et al., 2008), it remains elusive which general mech-
anisms further contribute to activation of transcription during embryonic development.
It has been proposed that chromatin plays a crucial role in preparing the embryonic
transcriptome for robust activation (Kane and Kimmel, 1993; Prioleau et al., 1994). In
this context, the histone modification H3K4me3 might be a crucial player for the onset
of transcription, as it is thought to prepare key developmental genes for robust activation
during embryogenesis (Bernstein et al., 2006; Lindeman et al., 2011; Vastenhouw et al.,
2010).
In this study, I investigated whether H3K4me3 establishment is involved in zebrafish
zygotic genome activation. Mutation of the histone methyltransferases Mll1 and Mll2
did not result in loss of H3K4me3 during early embryogenesis, possibly due to com-
pensation of their loss by other H3K4-specific Histone methyltransferases (section 6.1).
Instead I was able to achieve robust reduction of H3K4me3 levels in early zebrafish em-
bryos by introduction of H3K4-to-M constructs (K4M). K4M seems to act as dominant-
negative substrate for H3K4me3 establishment. I analyzed changes in H3K4me3 levels
genome-wide by quantitative ChIP-Seq experiments, which showed that the majority of
gene promoters had reduced H3K4me3 levels upon introduction of K4M (section 6.2).
Reduction of promoter-associated H3K4me3, however, did not result in significant
changes of transcription activation. Neither early zygotic activated genes, nor genes
that become transcriptionally active during early gastrulation stages were affected by
H3K4me3 reduction (section 6.2). If not involved in transcription activation, it is
puzzling why H3K4me3 is established at more than 60% of all promoters at early
developmental stages. Future studies have to address whether H3K4me3 establishment
is a mere consequence of a permissive chromatin state during early developmental
stages (section 6.3), and whether it might be important for later developmental stages,
where it might be important for transcription regulation during lineage commitment in
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a generally repressive chromatin environment (section 6.4). Finally I analyzed, which
genomic features allow for H3K4me3 establishment independent of transcription. I
found that H3K4me3 is preferentially established at promoters with high CpG content
and strong H2A.z enrichment, suggesting that these features might favor H3K4me3
establishment during early developmental stages (section 6.5). Together, these findings
suggest that H3K4me3 is established at CpG-rich promoters during early embryonic
stages, but does not influence early transcription activation in zebrafish embryos.
6.1 Neither Mll1 nor Mll2 are the main histone methyltransferase
for H3K4me3 establishment in early zebrafish development
During my thesis I aimed to interfere with H3K4me3 establishment by genetic ablation
of H3K4-specific histone methyltransferases. I generated zebrafish mutants for the
histone methyltransferases mll1, mll2 and the HMT complex protein ash2l. However,
none of the generated maternal-zygotic mutants showed global reduction of H3K4me3
levels, even though increased mortality during larval development was observed in mll1
and mll2 mutants (section 3.2).
Mll1 and Mll2 share components for their enzymatic active protein complex in vivo
(Dou et al., 2006; Miller et al., 2001; Yokoyama et al., 2004). Additionally, other
H3K4-specific HMTs exist that are able to establish H3K4me3 (section 1.3, Shilati-
fard 2012). Therefore it is possible that H3K4me3 establishment by Mll1 and Mll2
can be compensated for by other HMTs. Indeed it was shown that interference with
Mll1 resulted in little changes of H3K4me3 levels at promoters (Guenther et al., 2005;
Terranova et al., 2006; Wang et al., 2009, 2012). Furthermore it was shown that loss of
Mll1 can be compensated for by the presence of other HMTs in mouse embryonic stem
cells (Denissov et al., 2014). However, the same authors found that Mll2 has a unique
role in establishing H3K4me3 at bivalent domains (Denissov et al., 2014). Therefore,
while Mll2 seems not to be involved in bulk H3K4me3 establishment (Hu et al., 2013b;
Lubitz et al., 2007), it might be important for transcription regulation of genes in-
volved in further development. The here obtained data suggests that in zebrafish, mll2
mutation does not result in embryonic lethality and failure of germline development.
Furthermore, Mll2 seems not to be involved in global H3K4me3 establishment during
embryonic development (Figure 3.6). However, the possible effect on specific genomic
features, such as bivalent domains, was not addressed in this study. Further ChIP-Seq
experiments addressing H3K4me3 distribution in mll2 mutant zebrafish embryos will
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show whether this unique role of Mll2 is also present in zebrafish development.
Despite little effects on global H3K4me3 levels, both mll1 and mll2 mutation resulted
in increased mortality during larval stages. It is possible that molecular mechanisms
other than H3K4me3 establishment are causal for this phenotype. In plants, most
phenotypes caused by HMT mutations are associated with the absence of the respective
protein, but not its role in H3K4me3 establishment (Fromm and Avramova, 2014).
Furthermore, knock-out studies in mice suggested that Mll1 has specific molecular
functions independent of its role in H3K4me3 establishment, as mll1 mutations with
a deletion of the SET-domain have a different phenotype than full mll1 knock-out (Jude
et al., 2007; Mishra et al., 2014; Terranova et al., 2006). Therefore it is possible that the
observed phenotypes for mll1 and mll2 mutants are not driven by changes in H3K4me3
levels, but by the absence of Mll1 and Mll2 proteins.
While mutation of mll1 or mll2 alone did not have an effect on H3K4me3 establishment,
double-mutants could address whether Mll1 and Mll2 together are the main actors to
establish H3K4me3 in early embryogenesis. Generation of mll1-mll2 double-mutants
might allow to address this question. Another strategy to test whether Mll1/Mll2 es-
tablish bulk H3K4me3 is to genetically interfere with menin1, which is a shared essen-
tial complex component specific to Mll1/Mll2 (Agarwal and Jothi, 2012; Yokoyama
et al., 2004). These genetic interference strategies could be used to study the effect
of locus-specific H3K4me3 reduction during later developmental stages in a possible
more repressive chromatin environment (section 6.4).
6.2 H3K4me3 reduction does not affect transcription initiation
during genome activation
Global reduction of H3K4me3 could be achieved by overexpression of H3K4-to-M
(K4M) histone proteins. Upon H3K4me3 reduction, I analyzed transcription activation
of early activated genes. Because H3K4me3 has been shown to mark the majority of
gene promoters (Lindeman et al., 2011; Vastenhouw et al., 2010) and to facilitate tran-
scription factor recruitment (Flanagan et al., 2005; Vermeulen et al., 2007), I expected
to observe a decreased transcriptional output of the majority of activated genes. In
contrast, no transcriptional changes could be observed. During the course of this study
I analyzed 98 early zygotic genes (without maternal contribution) over at least four
consecutive stages by two different methods (section 4.6). I further analyzed 17 genes
which are activated during gastrulation stages. For none of these genes, general tran-
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script levels were changed upon H3K4me3 interference, and their onset of transcription
was not different when compared to samples without H3K4me3 interference. These
experiments suggest that H3K4me3 reduction does not affect transcription activation of
genes during early stages of zebrafish embryonic development.
The here described method results in a reduction, but not a complete loss of H3K4me3.
Furthermore, assaying genome-wide H3K4me3 levels relied on ChIP-Seq experiments,
which represents an average picture over multiple embroys. Therefore it cannot be ex-
cluded that individual embryos, and even cells, might have different levels of H3K4me3
left at their promoters. Thus it cannot be excluded that remaining levels of H3K4me3
are sufficient to allow for transcription activation.
It has been shown previously that H3K4me3 might have little effects on transcription
activation. Interference with H3K4me3 establishment upon rapid gene induction trig-
gered by stimuli showed that only a subset of genes relies on H3K4me3 establishment
for their activation (Clouaire et al., 2014). In mouse neural progenitor cells, knock-
down of Wdr5, an essential COMPASS component (Wysocka et al., 2005), resulted
in transcriptional reduction of only a small subset of genes (Benayoun et al., 2014).
Furthermore, clonal depletion of histone lysine 4 in all histone genes resulted in no
apparent changes of genes involved in Drosophila wing disc development (Hödl and
Basler, 2012). These experiments have shown that H3K4me3 seems not to be im-
portant for transcriptional activity in differentiated systems. The here obtained results
complement these observations with evidence that H3K4me3 seems not to be involved
in general transcription activation of previously inactive genes in a developing embryo.
However, it cannot be excluded that the here analyzed early activated genes are insen-
sitive to H3K4me3 interference. While these findings suggest that H3K4me3 is not a
general regulator of transcription activation, further experiments should focus on whole
transcriptome analysis to address, whether a specific subset of genes might be sensitive
to loss of H3K4me3.
H3K4me3 reduction did not result in transcriptional changes during early embryonic de-
velopment (section 4.6). This raises the question why so many genes acquire H3K4me3
early during genome activation (section 5.1). In the next sections I will discuss potential
explanations for why H3K4me3 is established during genome activation (section 6.3),
and what its potential function might be (section 6.4).
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6.3 The timing of H3K4me3 establishment might be determined
by a permissive chromatin state
The establishment of H3K4me3 coincides with genome activation. Importantly, both
actively transcribed as well as not transcribed genes gain H3K4me3 at their promoters
(section 5.1). Genes that are transcribed most likely acquire H3K4me3 by transcription-
coupled recruitment of Set1 COMPASS complexes (section 1.3). Indeed I could show
that early zygotic genes become progressively overrepresented for H3K4me3-positive
promoters when they are transcribed, while genes activated later than the here ob-
served developmental stages for H3K4me3 establishment are not overrepresented for
H3K4me3-positive promoters (Figure 5.1). However, because also transcriptionally in-
active genes acquire H3K4me3, transcription-coupled H3K4me3 establishment cannot
be the only mechanism.
Transcripts coding for all essential COMPASS components are present in zebrafish
embryos before genome activation (Pauli et al., 2012; Sun et al., 2008). This raises the
question why H3K4me3 cannot be established before genome activation. Recent obser-
vations in our laboratory suggest that histones act as general inhibitors for chromatin
binding (Joseph et al., in preparation). Histones are thought to be present in excess
during stages prior to genome activation. The excess of histones might compete with
transcription factors and other proteins for binding to DNA. In this model, regulatory
chromatin modifications might only be established coinciding with genome activation,
when the excess of histones compared to zygotic DNA has decreased. Future exper-
iments could address whether the increase of histone content by micromanipulation
results in a delay of the establishment of H3K4me3.
These observations might explain why H3K4me3 is not established earlier, but do not
address why H3K4me3 is established early, even though it is not involved in gen-
eral transcription activation. It is believed that the genome of early embryos is in
a permissive state, which facilitates DNA binding of regulatory proteins during early
development (Bogdanovic et al., 2011; Schneider et al., 2011; Wen et al., 2009). Many
post-translational modifications that allow for heterochromatin establishment are only
established after genome activation (Fadloun et al., 2013; Lindeman et al., 2011; San-
tenard et al., 2010). Additionally, an embryo-specific linker histone H1M is present
during development, that might allow for a less compacted chromatin state (Gao et al.,
2004; Saeki et al., 2005). This linker histone is progressively lost and replaced by the
more repressive somatic linker histone H1S (Steinbach et al., 1997; Yang et al., 2013).
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Furthermore it was found that the regulatory potential of many epigenetic modifications,
as for example DNA methylation, is temporarily muted during early embryonic stages,
and complete transcription regulation potential is only acquired in later developmental
stages (Schneider et al., 2011). Together these findings suggest that after genome
activation, when competition with histones is overcome, embryonic chromatin is in
a permissive state that favors DNA interaction of regulatory proteins. In the course
of further embryonic development, the chromatin might gradually become more repres-
sive, and transcription activation increasingly relies on transcription-favoring chromatin
modifications. In this model (depicted in Figure 6.1), H3K4me3 establishment cannot
be established at transcriptionally inactive genes during later developmental stages,
when the chromatin is in a repressive state. Instead, H3K4me3 is established during
early stages, when a permissive chromatin state allows for the recruitment of H3K4-
specific HMTs to transcriptionally inactive loci. Therefore, H3K4me3 is a consequence
of a permissive chromatin state during genome activation, but not involved in transcrip-
tion activation at ZGA.
To test this hypothesis, transient interference by H3K4-specific inhibitors might be
a valuable strategy. Inhibition of HMTs during genome activation, and a following
depletion of the inhibitor would show, whether H3K4me3 can be established during
later developmental stages. So far, no H3K4-specific HMT inhibitor has been reported,
however recent advances in deciphhering the protein complex structure might allow
the design of potent inhibitors in the near future (Mersman et al., 2012; Senisterra
et al., 2012). Another approach to achieve temporal control might be to genetically
modify essential HMT complex components to allow for their temporal mislocaliza-
tion upon stimulus. By addition of specific dimerization domains to HMT complex
proteins, and overexpression of a membrane-targeting domain, mislocalization could
be achieved either by light-induced dimerization (Simmich et al., 2012) or by small-
molecule treatment (Hathaway et al., 2012). Due to the rapid cell cycle within the
zebrafish embryos, nuclear proteins are regularly distributed within the cytoplasm, thus
making this strategy feasible. These experiments have the potential to reveal whether
H3K4me3 is a consequence of a permissive chromatin state during genome activation.
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Figure 6.1: Model for the role of H3K4me3 in embryonic development Zebrafish
zygotic transcription commences during early developmental stages (black), after
general repression by histones (grey) is overcome. Zygotic transcripts drive differ-
entiation, which begins during early gastrulation stages and leads to decision for
specific cell fates during further embryonic development (dark blue). H3K4me3
establishment (green) coincides zygotic genome activation at CpG-rich promoters
in a generally permissive chromatin environment. During early stages, reduction of
H3K4me3 has no effect on transcription activation. However, promoter-associated
H3K4me3 might gain in importance (light blue) by regulating cell lineage speci-
fication during later stages, when a repressive chromatin state prevails. Stages of
embryonic development adapted from Kimmel et al. 1995.
The here obtained data suggests that H3K4me3 has no effect on genome activation. This
is seemingly in contrast to the current understanding, that H3K4me3 facilitates tran-
scription (Flanagan et al., 2005; Vermeulen et al., 2007), and is important for activation
of developmental regulators (Bernstein et al., 2006; Lindeman et al., 2011; Vastenhouw
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et al., 2010). It may be possible, however, that H3K4me3 is not required for robust
transcription activation in the permissive chromatin environment of the early embryo,
and only plays a role in later developmental stages, when the chromatin environment
becomes increasingly repressive (Bogdanovic et al., 2011; Schneider et al., 2011; Wen
et al., 2009). Evidence for this hypothesis comes from the observation that loss of
H3K4me3 by replacement of wildtype histones with methylation-defective H3.3 in
Xenopus eggs resulted in loss of transcription activation of genes involved in muscle
differentiation (Ng and Gurdon, 2008).
To test whether H3K4me3 indeed plays a role in transcription later during develop-
ment, one could monitor the activation of lineage-specific transcription profiles upon
H3K4me3 interference during stages later than gastrulation. However, the here im-
plementented approach to reduce H3K4me3 did not allow for studying transcription
regulation in later developmental stages, because both overexpression of H3K4-to-M
and control H3HA constructs was detrimental to embryonic development later than
nine hours post fertilization. Therefore it is necessary to further elaborate on tools to
interfere with H3K4me3. Reduction of H3K4me3 on a subset of genes would reduce
possible deleterious effects to embryonic development, thus allowing to address the
question whether activation of these genes is affected later during embryonic develop-
ment. This may be achieved by genetic interference with COMPASS components that
are involved in targeting H3K4me3 activity to specific genes, yet are not necessary for
global H3K4me3 establishment (discussed in section 6.1). Further approaches could be
based on transient H3K4me3 interference as discussed above (section 6.3). Together,
these experiments could address whether H3K4me3 is established due to a specific
window of opportunity, and whether it is involved in transcription activation later during
development.
6.5 CpG-content and H2A.z enrichment might be predictive for
H3K4me3 establishment during genome activation
In the previous section I hypothesized that H3K4me3 establishment is a consequence
of the permissive chromatin state that allows for the recruitment of HMT complexes. In
this study I provided evidence that CpG density, but not general GC content, predicts
H3K4me3 establishment. Maternally provided genes have more CpG-rich promoters
than other classes, which might explain their higher-than-average fraction of H3K4me3-
positive promoters (Figure 5.5). Furthermore, genes that are not transcriptionally active
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have to recruit H3K4me3 by transcription-independent mechanisms. I could show that
non-transcribed, yet H3K4me3-positive genes are generally CpG-rich as well (Fig-
ure 5.4). These observations are in line with studies of genome-wide H3K4me3 dis-
tribution in different cell lines, where H3K4me3 was found to be enriched at CpG-
rich DNA (Mikkelsen et al., 2007). Furthermore, experiments in mouse embryonic
stem cells found that introduction of synthetic CpG-rich DNA elements resulted in de
novo establishment of H3K4me3 and H3K27me3 at sites of integration (Wachter et al.,
2014).
The number of CpG-dense promoters alone could not explain the large amount of
H3K4me3-positive promoters in zebrafish embryos. Another candidate that could fa-
cilitate H3K4me3 establishment is the histone variant H2A.z. This histone variant has
been shown to be actively incorporated into chromatin independent of DNA replication
(Goldman et al., 2010), and to increase histone turnover by nucleosome destabilization
at promoter elements (Jin and Felsenfeld, 2007; Jin et al., 2009; Weber et al., 2014).
In the context of zebrafish development, H2A.z incorporation and the resulting higher
histone turnover might allow for recruitment of HMT complexes, as was shown in
mouse embryonic stem cells (Creyghton et al., 2008; Hu et al., 2013c). I have analyzed
the genome-wide distribution of H2A.z, and its correlation with H3K4me3. I found
that early established H3K4me3 is enriched at promoters high in H2A.z levels. Even
though solely based on correlation I hypothesize that presence of H2A.z at promoters
might favor H3K4me3 establishment.
High CpG content and high H2A.z levels together might be sufficient to explain H3K4me3
overrepresentation in maternally provided genes (Figure 5.5), and 94% of non-transcribed,
yet H3K4me3-positive genes have either of the two features, or both (Figure 5.4). There-
fore, CpG content and H2A.z enrichment together could be predictive for H3K4me3
establishment early during embryonic development.
However, while almost all genes with high H2A.z levels are H3K4me3-positive, not
all CpG-rich promoters are marked by H3K4me3 (48% of non-transcribed promoters
have high CpG-levels, Figure 5.4). One explanation for this discrepancy might be DNA-
methylation. DNA methylation occurs on CpG dinucleotides, and promoter-associated
CpG islands are differentially methylated during zebrafish embryonic development (An-
dersen et al., 2012; McGaughey et al., 2014). Methylated CpG islands have been shown
to prevent both H2A.z and H3K4me3 establishment at promoters in human cell lines
(Okitsu and Hsieh, 2007; Zilberman et al., 2008). Future analysis have to address
whether methylation of CpG islands prevents H3K4me3 establishment during zebrafish
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development.
Both H2A.z and H3K4me3 have been shown to be enriched at CpG elements (Mikkelsen
et al., 2007; Obri et al., 2014). However, since it has been shown that H2A.z incorpora-
tion is not facilitated by H3K27me3 establishment (Illingworth et al., 2012), it is possi-
ble that CpG-rich promoter elements allow for H2A.z incorporation prior to H3K4me3
establishment. Once established in chromatin, both H3K4me3 as well as H2A.z were
found to interfere with DNA methylation in human cell lines (Balasubramanian et al.,
2012; Conerly et al., 2010). Therefore, H3K4me3 and H2A.z might prevent erroneous
DNA methylation.
Unifying these results, a permissive chromatin state during early embryogenesis could
allow for H2A.z and H3K4me3 establishment at unmethylated CpG-islands (Figure 6.1),
whereas DNA methylation prevents H3K4me3 establishment. The presence of H2A.z
and H3K4me3 could prevent excessive DNA methylation during later stages, thus might
prevent silencing of genes important for cell specification when a more repressive
chromatin state is established.
Future studies might shed light onto the order of events in this process. For example, it
would be interesting to study DNA methylation patterns upon H3K4me3 interference
by K4M overexpression as performed in this study. These experiments would address
whether early H3K4me3 establishment indeed restricts spreading of DNA methylaton,
and thus prepares local chromatin for faithful transcription activation during later devel-
opmental stages.
Furthermore, in the light of recent developments of gene editing (Hoshijima et al., 2016;
Hwang et al., 2013) it might be possible to change specific promoter sequences by
scrambling of CpG dinucleotides without affecting GC-content. Since GC-content is
less predictive for H3K4me3 enrichment, this strategy might allow to dissect, which
sequence preference allows for H3K4me3 establishment. Furthermore one could inter-
fere with H2A.z establishment. Since H2A.z is actively incorporated into chromatin,
interfering with H2A.z-specific chromatin remodeling by genetic ablation could help
to understand the role of H2A.z in establishing an open chromatin conformation during
early zebrafish embryogenesis. Alternatively, transient overexpression of ANP32E
could be used to specifically evict H2A.z from chromatin during zebrafish development.
These experiments would unravel whether CpG content or H2A.z enrichment are essen-
tial for H3K4me3 establishment during genome activation (Mao et al., 2014; Obri et al.,
2014). More importantly, if this addition of CpG-rich elements in zebrafish embryos
can be performed with temporal control - either by specific CRISPR localization or
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guide-RNA expression - this experimental set-up would unravel whether H3K4me3
establishment depends on a window of opportunity during zebrafish embryonic devel-
opment. Together, these experiments would address the functional connection between
DNA methylation and histone modifications, and their cooperative role in transcription
regulation during lineage commitment.
6.6 Conclusion
In this study I could show that H3K4me3 reduction does not have an influence on
zygotic transcription activation. H3K4me3 is preferentially established at CpG-rich
promoters and correlates with H2A.z enrichment. Based on the here presented results
it seems likely that early H3K4me3 establishment at CpG-rich, H2A.z-enriched pro-
moters is a consequence of a generally permissive chromatin state during early em-
bryogenesis. While H3K4me3 seems not to be involved in zygotic genome activation,
it remains to be addressed in future experiments whether H3K4me3 is important for
transcription activation during later stages, when a repressive chromatin environment
prevails. Further studies will additionally address, whether H3K4me3 establishment is
restricted to early developmental stages, and prevented from later stages.
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Vector information pCS2+-H3HA A) Vector map of pCS2+ backbone including
H3-HA sequence. Orange, ORF; blue, Origin of replication; green, Primer binding
sites. B) Insert sequence coding for wildtype H3.1 with linker sequence (green) and
HA-tag sequence (blue) at the 3’ end of insert.
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Vector information pCS2+-K4M A) Vector map of pCS2+ backbone including H3-
HA sequence with basebair change to allow K4-to-M substitution. Orange, ORF;
blue, Origin of replication; green, Primer binding sites. B) Insert sequence coding
for wildtype H3.1 with AAG (K)-to-ATG (M) codon substitution at bp 13-16 (red),
and linker sequence (green) and HA-tag sequence (blue) at the 3’ end of insert.
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Vector information pCS2+-K4E A) Vector map of pCS2+ backbone including H3-
HA sequence with basebair change to allow K4-to-E substitution. Orange, ORF;
blue, Origin of replication; green, Primer binding sites. B) Insert sequence coding
for wildtype H3.1 with AAG (K)-to-GAG (E) codon substitution at bp 13-16 (red),
and linker sequence (green) and HA-tag sequence (blue) at the 3’ end of insert.
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Vector information pCS2+-KDM5A A) Vector map of pCS2+ backbone including
mouse KDM5A exonic sequence. Orange, ORF; blue, Origin of replication; green,
Primer binding sites. B) Insert sequence coding for full-length mouse KDM5A with
single FLAG tag sequence at the 3’ end of insert.
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Vector information pCS2+-KDM5B A) Vector map of pCS2+ backbone including
mouse KDM5B exonic sequence. Orange, ORF; blue, Origin of replication; green,
Primer binding sites. B) Insert sequence coding for full-length mouse KDM5B with
single FLAG tag sequence at the 3’ end of insert.
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Vector information pCS2+-KDM5C A) Vector map of pCS2+ backbone including
mouse KDM5C exonic sequence. Orange, ORF; blue, Origin of replication; green,
Primer binding sites. B) Insert sequence coding for full-length mouse KDM5C with
single FLAG tag sequence at the 3’ end of insert.
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Vector information pCS2+-KDM5D A) Vector map of pCS2+ backbone including
mouse KDM5D exonic sequence. Orange, ORF; blue, Origin of replication; green,
Primer binding sites. B) Insert sequence coding for full-length mouse KDM5D with
single FLAG tag sequence at the 3’ end of insert.
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Vector information pCS2+-zfKDM5Bb A) Vector map of pCS2+ backbone includ-
ing zebrafish KDM5Bb exonic sequence. Orange, ORF; blue, Origin of replication;
green, Primer binding sites. B) Insert sequence coding for full-length zebrafish
KDM5Bb with single FLAG tag sequence at the 3’ end of insert.
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NanoString timeseries Normalizers Shown are 12 genes chosen to be normalizers
for RNA levels over early embryonic development. Plots represent their normalized
RNA count values measured by NanoString assay over developmental time from
RNA samples of H3HA (red) or K4M (blue) introduction. Note the changed color
code compared to figures in results. Error bars indicate technical variation of 10% of
respective count value. This was estimated from variation in assay-internal positive
controls as well as normalizer gene variation.
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NanoString timeseries K4M introduction I Depicted are normalized RNA counts
of zygotic activated genes over six stages at zygotic genome activation as measured
by NanoString (I of VI). H3HA introduction (red) is compared to K4M introduction
(blue). Note the changed color code compared to main matter figures. Error bars
indicate technical variation of 10% of respective count value. This was estimated
from variation in assay-internal positive controls as well as normalizer gene variation.
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NanoString timeseries K4M introduction II Depicted are normalized RNA counts
of zygotic activated genes over six stages at zygotic genome activation as measured
by NanoString (II of VI). H3HA introduction (red) is compared to K4M introduction
(blue). Note the changed color code compared to main matter figures. Error bars
indicate technical variation of 10% of respective count value. This was estimated
from variation in assay-internal positive controls as well as normalizer gene variation.
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NanoString timeseries K4M introduction III Depicted are normalized RNA counts
of zygotic activated genes over six stages at zygotic genome activation as measured
by NanoString (III of VI). H3HA introduction (red) is compared to K4M introduction
(blue). Note the changed color code compared to main matter figures. Error bars
indicate technical variation of 10% of respective count value. This was estimated
from variation in assay-internal positive controls as well as normalizer gene variation.
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NanoString timeseries K4M introduction IV Depicted are normalized RNA counts
of zygotic activated genes over six stages at zygotic genome activation as measured
by NanoString (IV of VI). H3HA introduction (red) is compared to K4M introduction
(blue). Note the changed color code compared to main matter figures. Error bars
indicate technical variation of 10% of respective count value. This was estimated
from variation in assay-internal positive controls as well as normalizer gene variation.
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NanoString timeseries K4M introduction V Depicted are normalized RNA counts
of zygotic activated genes over six stages at zygotic genome activation as measured
by NanoString (V of VI). H3HA introduction (red) is compared to K4M introduction
(blue). Note the changed color code compared to main matter figures. Error bars
indicate technical variation of 10% of respective count value. This was estimated
from variation in assay-internal positive controls as well as normalizer gene variation.
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NanoString timeseries K4M introduction VI Depicted are normalized RNA counts
of zygotic activated genes over six stages at zygotic genome activation as measured
by NanoString (VI of VI). H3HA introduction (red) is compared to K4M introduction
(blue). Note the changed color code compared to main matter figures. Error bars
indicate technical variation of 10% of respective count value. This was estimated
from variation in assay-internal positive controls as well as normalizer gene variation.
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Splicing and divergent transcription are not changed upon H3K4me3 reduction
A) RT-qPCR experiments showing the relative expression of rpl26a containing the
first intron compared to rpl26a mRNA level at stages dome to 70% epiboly. B) RT-
qPCR experiments showing the relative expression of upstream regions of rpl26a
locus compared to rpl26a mRNA level at stages dome to 70% epiboly. H3HA
overexpression samples are depicted in blue, K4M overexpression samples in red.
n = 3, error bars = s.d.
ChIP-Seq libraries
ChIP-Seq experiment and library statistics
genotype/
treatment
experiment stage Total library unique
mappable
reads
H3HA H3K4me3
ChIP
high 52,064,470 6,165,525
H3HA ChIP Input high 60,570,494 9,059,513
K4M H3K4me3
ChIP
high 50,811,576 6,410,505
K4M ChIP Input high 52,685,461 8,616,120
H3HA H3K4me3
ChIP
oblong 49,730,067 3,927,642
H3HA ChIP Input oblong 47,304,317 4,700,641
K4M H3K4me3
ChIP
oblong 51,423,111 5,050,954
K4M ChIP Input oblong 50,462,787 6,456,628
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H3HA H3K4me3
ChIP
oblong2 62,136,515 13,954,143
K4M H3K4me3
ChIP
oblong2 73,118,381 6,910,026
H3HA H3K4me3
ChIP
sphere 84,226,793 11,770,538
K4M H3K4me3
ChIP
sphere 71,015,396 12,482,032
H3HA H3K4me3
ChIP
dome 84,432,377 12,193,878
K4M H3K4me3
ChIP
dome 70,543,169 9,257,326
wildtype H3K4me3
ChIP
oblong 47,513,081 1,462,206
wildtype ChIP Input oblong 50,966,520 5,470,004
mll1 mutant H3K4me3
ChIP
oblong 34,115,775 1,351,487
mll1 mutant ChIP Input oblong 63,551,908 10,012,384
wildtype H3K4me3
ChIP
dome 30,297,685 6,102,726
wildtype ChIP Input dome 97,860,279 22,383,030
mll1 mutant H3K4me3
ChIP
dome 53,001,118 11,304,856
mll1 mutant ChIP Input dome 75,892,432 19,262,817
wildtype H2A.z ChIP dome 87,807,652 37,528,879
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Extended experimental discussion
Increased fraction of reads observed in MNase-ChIP-Seq experiments
When performing ChIP-Seq experiments, I obtained Sequencing data comprising of 30
to 50 million reads of 75bp length per sample (see Table 1). Surprisingly, of these reads,
only a fraction of total reads could be aligned to a single position in the genome (around
3% for oblong stage and 20% for dome stage), while a much larger fraction of reads
was assigned to multiple regions with the same probability. Since this phenomenon was
also observed in Input chromatin samples taken before immunoprecipitation procedures
(Table 1), it is unlikely to be caused by an antibody bias towards specific genomic
features. Additionally, these results cannot be explained by poor quality of the obtained
sequencing reads, as more than 95% of the reads showed good sequencing quality
throughout their length of 75 basepairs (data not shown).
To address whether these results could be an artifact from aligning the reads to zebrafish
genome, I repeated alignment with two different bioinformatics algorithms (bwa and
bowtie). Additionally I used two different options for mapping by bowtie. The default
setting uses the whole read for alignment, and adds a penalty for each mismatch. The
’seeding-method’ uses a subregion of the read for initial perfect matching, and expands
the matching in both directions as far as possible. These three different mapping strate-
gies were performed on all samples. However, none of these attempts increased the
fraction of uniquely mappable reads significantly. I therefore concluded that the high
fraction of multi-mappers does not result from errors within the analysis or chromatin
immunoprecipitation. It might rather result from a bias in chromatin preparation, such
as a bias in MNase restriction, or an influence of chromatin architecture on DNA
accessibility in early zebrafish embryos. Since no attempt improved data quality, I
proceeded with the results obtained by the experimental procedures described above.
Published bioinformatics tools for quantitative ChIP-Seq are not applicable
to analyze H3K4me3 reduction in mll1 mutant embryos
In order to determine whether H3K4me3 levels at specific promoters are affected upon
H3K4me3 interference, I aimed to compared the ChIP-Seq data from unaffected and
globally reduced H3K4me3 samples using algortithms that analyze local enrichment
between different samples. I aimed to implement previously established algorithms that
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analyze local enrichment between different samples. While a number of algorithms are
reported for differential ChIP peak analysis, not all are applicable for the experimental
setup presented here (Steinhauser et al., 2016).
Specific tools were designed to identify differential transcription factor binding (e.g.
ChIPComp, MMDiff, DBChip, Homer, ODIN). These rely on motif binding informa-
tion and defined local enrichment, which does not apply to histone modification data.
Other algorithms (ChIPDiff with edgeR option, diffreps, RSEG, histone HMM) rely on
providing biological replicates for each timepoint, to assess biological variation over
which differentially enriched regions could be identified. However, since H3K4me3
is established increasingly over time, different time-points show too strong intrinsic
variation to allow for estimation of biological variation. Therefore, our time-point data
cannot be used as replicate samples.
Two different bioinformatics algorithms are applicable to the experimental setup here:
DiffBind and MA-Norm. Both estimate biological variation from within one dataset
and therefore do not rely on providing replicate data for each timepoint. However, Diff-
bind was unable to identify significant differences between mll1 mutants and wildtype
samples. This can be explained by too low numerical counts for analyzed promoter
regions. The resulting estimated biological noise within the samples is too high to
call significant differentially bound regions between ChIP samples. Diffbind uses DE-
Seq2 as an algorithm to estimate biological variation, which is designed for transcript
analyses and thus relies on a higher number of reads bound to a region considered
positive (e.g. over the whole distance of gene bodies). Therefore I decided to use MA-
Norm to identify differentially bound regions. MA-Norm compares two samples by
assuming that most peaks do not change in intensity. This allows for normalization of
peaks by average difference, and identification of significantly different regions after
normalization.
I performed MA-Norm analysis comparing mll1 mutant samples with wildtype sam-
ples at oblong and dome stages. At oblong stage, MA-Norm identifies 20.60% that are
more than 2fold increased, and 17.99% that are more than 2fold decreased in H3K4me3
reduction in mll1 mutants (Figure ?? A). At dome stage, 14.42% are 2fold increased,
and 7.43% are decreased in H3K4me3 enrichment (Figure ?? B). This corroborates the
observation that H3K4me3 levels inmll1 mutants are rather increased than decreased.
However, only 1.35% of regions identified by MA-Norm are increased for H3K4me3
enrichment in both stages, and only 0.88% are reduced (Figure ?? C). This suggests,
that the results obtained by MA-Norm analysis do not correlate between different de-
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Identification of H3K4me3 level changes by MA-Norm Depicted are the fractions
of MA-Norm-identified regions that are unchanged (grey), more than 2fold increased
(red) or more than 2fold decreased (green) in mll1 mutant embryos at oblong (A) and
dome stage (B), as well as the fractions changed in both stages (C).
velopmental stages. Indeed, no correlation can be seen when fold changes at common
regions were compared to each other (Figure ?? A).
MA-Norm bases the differential binding analysis on peak regions identified by other
algorithms. In my case, MACS2 was used to identify significantly enriched regions,
and MA-Norm to identify differentially bound regions. To understand whether the
algorithm correctly reflects changes within the sample, I analyzed the size of identified
regions by the MA-Norm algorithm. Interestingly, while MACS2 identifies a minimal
peak size of 180 basepairs, regions that show differential binding by MA-Norm analysis
are as small as 80 basepairs. This suggests that MA-Norm subdivides peak regions and
thus does not reflect changes over the whole peak region. Indeed, as shown in Figure ??
C), MA-Norm identified regions that were smaller than identified peaks identified by
MACS2. Furthermore, regions identified as significantly changed were enriched for
regions of that smaller size. This suggests that MA-Norm subdivides identified peak
regions, and favors smaller sized, less-intense peaks, which most likely have lower
biological significance (Figure ?? B). Thus I find that MA-Norm is not applicable on
the dataset analysed here, as too many regions of low intensity are overrepresented, and
significantly called regions are not reproducible between stages.
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MA-Norm does not correctly reflect changes in H3K4me3 levels A) The fold
change as calculated by MA-Norm do not correlate for oblong and dome stage. B)
Peak length distribution was plotted for MA-Norm analyzed regions (blue), identified
peak regions by MACS2 (red) and regions identified as 2fold changed between
wildtype and mll1 mutants. Total MA-Norm regions and significantly changed
regions are enriched for small-sized regions. C) Representative genomic region
illustrating that MA-Norm focuses on small-sized regions subdivided from peak
regions as identified by MACS2.
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